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ABBREVIATIONS
HPLC High pressure liquid chromatography
AUFS Absorbance units full scale
BHA Butylhydroxyanisole
PA Prealbumin
IVN Intravenous Nutrition
4NQO 4-Nitroquinoline-N-oxide
CRBP Cellular retinol-binding protein
CRABP Cellular retinoic acid-binding protein
RBP Retinol-binding protein
LDL Low density lipoprotein
HDL High density lipoprotein
TFA Trifluoroacetic acid
SbCL3 Antimonytrichloride
NaN3 Sodium azide
K f capacity ratio
R s
Resolution
IS Internal Standard
«F
Ratio of the distance travelled by the solute to 
the distance travelled by solvent front
H:THF:Fac Hexane:tetrahydrofuran:formic acid
EDTA Ethylene diamine tetracetic acid
RID Radial immunodiffusion
PEG Polyethylene glycol
CRP C-reactive protein
TG Triglyceride
TPN Total parenteral nutrition
-Fe Iron-deficiency
+Fe Iron-sufficient
IU International Units
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SUMMARY
This thesis describes the development of specific 
assays for separation and extraction of vitamin A (retinol) and 
its metabolites, retinal, retinoic acid, retinol acetate, retinol 
palmitate and its pro-vitamin carotene. The assay employed a 
liquid/liquid extraction procedure which gave reproducible 
recoveries for retinol and its metabolites. This was followed by 
a high pressure liquid chromatography (HPLC) procedure using a 
silica column with hexane:tetrahydrofuran:formic acid as mobile 
phase. This gave excellent chromatographic efficiency and 
resolution of metabolites and resulted in a highly sensitive and 
specific assay for all the compounds analysed. The assay was 
used for serum, and was modified to be applicable also for liver 
and nutritional solutions. A major benefit of this assay 
compared with previous methods is that all retinol metabolites 
can be separated on a single column without requirement for 
expensive gradient systems.
The HPLC method was compared with the more commonly 
used fluorimetric method. Fluorimetry provided a more rapid 
result but was found to be affected by triglyceride and other 
interfering substances. HPLC was therefore a more accurate assay 
for patients likely to be receiving nutrients or drugs which 
would interfere with the fluorimetric method.
A number of studies were performed on vitamin A status 
in man and rats.
Retinol is the only retinoid found in measurable 
amounts in serum of normal man and rats and those with 
certain types of tumour and disease.
In all studies in man, serum retinol correlated well 
with its carrier protein, retinol-binding protein 
(RBP).
There is a significant fall in serum retinol concen­
tration during the day in normal individuals.
The effect of intravenous nutrition (IVN) on serum 
retinol was studied. Retinol palmitate was found to be 
unstable in fat emulsion, but it can be protected from 
degradation if stored in the dark at room temperature 
for 24 hours or at 4°C for 7 days. Infusion of 750 pg 
retinol palmitate intravenously in Intralipid leads to 
no change in serum retinol, and the retinol palmitate 
is cleared from the serum within 4 hours. Oral retinol 
palmitate (160 mg) was also rapidly cleared within 8 
hours, and with no effect on serum retinol. The main 
effect on serum retinol concentration in patients 
receiving IVN was the presence of an acute phase 
reaction rather than the dose of retinol provided. In 
the absence of an acute phase reaction (eg long term 
IVN) serum retinol was normal or increased to normal in 
patients receiving IVN. In such patients, this 
reflects improved protein status as well as adequate 
vitamin A provision.
(xvii)
Rats fed on a vitamin A deficient diet developed low 
concentrations in liver after 2 weeks, and in serum 
after 5 weeks. The rapidity of this response may 
relate to the rate of growth of the rats. Signs of 
vitamin A deficiency were not seen up to 8 weeks of 
vitamin A free diet.
Serum retinol does not correlate with liver stores of 
retinol palmitate in either man or rats except in 
severe deficiency. Assessment of overall retinol 
status therefore requires liver analysis.
The effects of various neoplastic diseases on retinol 
status in man were studied.
There was no relationship between the serum retinol 
concentration and the presence of oral cancer or 
leukoplakia. Oral Crohn's Disease did however lead to 
low serum retinol concentrations.
There were no significant differences in serum retinol 
or liver retinol palmitate between patients with colo­
rectal or gastric cancer and those with benign disease. 
The presence of metastases at the time of surgery had 
no effect on serum or liver vitamin A.
In patients more than one month post operation for 
colorectal cancer, there was no significant difference 
in serum retinol or cholesterol from controls.
\
These studies have therefore failed to show any 
association of serum or liver vitamin A with colorectal 
or oral cancer.
(xviii)
8) The effect of the oral carcinogen (4-nitroquinoline-
N-oxide) was studied in rats. Rats treated for 32 
weeks developed oral tumours and had low serum and 
undetectable liver vitamin A. Rats treated for 8 weeks 
or 14 weeks had not developed tumour but atypia scores 
were increased, and serum and liver retinoids were very 
low. The amount of the fall in serum retinol 
correlated with the rate of increase in weight of the 
rat. These results suggest that there is increased 
requirement for retinol during the early stages in 
development of oral tumours in rats.
9) Iron deficiency led to earlier development of oral
tumour in rats with oral carcinogen, but this had no 
effect on serum or liver vitamin A.
Taken overall, these studies indicate that there is a 
complex relationship between vitamin A status, protein status, 
neoplastic disease and the presence of an acute phase reaction. 
Interpretation of serum retinol results in relation to aetiology 
of disease or effect of treatment requires careful consideration 
of these factors.
1) INTRODUCTION
1.1) History
The first evidence for the existence of Vitamin A came 
when Hopkins (1906 and 1912) showed that a diet of natural fats 
and oils fed to young rats led to good growth, whereas other fats 
fed to similar rats did not. His experiments suggested the 
existence of an "Accessory Food Factor". Osborne and Mendel 
(1913) and McCollum and Davis (1913) extracted the same growth 
factor from butter, egg .yolk and cod-liver oil with ether, 
showing that it was fat soluble. McCollum and Davis (1913) came 
up with the name "fat soluble A" to distinguish it from "water 
soluble B" which they had found in whey, yeast and rice 
polishings.
McCollum and Simmonds (1917) found that this "fat 
soluble A" factor was capable of preventing xerophthalmia. 
Fridericia and Holm (1925) showed it also prevented night 
blindness. In 1920 Drummond named the active lipid "vitamin A".
Mellanby (1918), distinguished vitamin A from fat- 
soluble vitamin D since it was ineffective in the cure of 
rickets. Rosenheim and Drummond (1920) showed the first 
relationship between vitamin A and the plant pigment carotene, 
which was extracted by Steenbock- et al (1921) and found to be a 
growth-promoting substance in plants. When the structure of 
beta-carotene and that of retinol was elucidated by Karrer-et al 
(1930, 1931 and 1933), the pro-vitamin role of beta-carotene 
became obvious.
1.2) Chemistry of vitamin A
The chemistry of retinol and its derivatives have been 
reviewed (Isler et al 1967, 1970). Vitamin A is a fat soluble, 
long chain alcohol which exists in a number of isomeric forms. 
The most active form and that most usually found in mammalian 
tissues is the all-trans vitamin A (stereoisomer).
Isomers with cis configuration at the 11 or 13 position 
occur less commonly and have somewhat lower biological activity. 
The alcohol form is known as retinol, consisting of a hydro­
carbon chain with a beta-ionone ring at one end and an alcohol 
group at the other (Figure 1).
The terminal alcohol group can be oxidised in the body 
to an aldehyde (retinal) or a carboxylic acid group (retinoic 
acid) .
Beta-carotene is the only carotenoid which has a 
structure identical with retinol in both halves of the molecule 
(Figure 2).
Retinol itself is a pale yellow crystalline substance, 
soluble in fat and fat solvents, but not in water. Naturally- 
|occurring vitamin a is found only in the animal kingdom, although 
pro-vitamin A (carotenoids) occurs in the vegetable kingdom. 
Retinol is often found in an esterified form and esters such as 
the acetate and palmitate are sometimes preferred for nutritional 
and medicinal use. Vitamin A, especially the free alcohol, is 
sensitive to oxygen, acids and ultraviolet light. Vitamin A2 is 
closely related to Vitamin A-|, but contains an additional double 
bond in the beta-ionone ring (3-dehydroretinol) . It has about
H,C
RETINOL
R
CH2OH
RETINAL CHO
RETINOIC ACID COOH
Figure 1: Structure of vitamin A and its derivatives

3.
half the biological activity of retinol, but is of little 
biological importance. It occurs with vitamin A in fish liver
011 (Davidson et al, 1979).
One international unit of vitamin A is defined as 0.3 pg 
of all-trans retinol. Generally 1 pg of retinol is assumed to be 
biologically equivalent to about 6 ug of beta-carotene, or about
12 pg of mixed diet carotenoids (Recommended Dietary Allowances, 
1980).
1.3) Absorption
Huang and Goodman (1965) studied the absorption of 
retinol from the diet, which was present in the form of long- 
chain fatty acid esters of retinol. The steps of the absorption 
process begin in the intestine, where hydrolysis of retinyl 
esters take place, and the resulting retinol is then absorbed 
into the mucosal cell. Goodman and Olson (1969) proved that 
dietary carotene was converted to retinol primarily in the 
intestinal mucosa. In the mucosal cell retinol is re-ester ified 
with long-chain, mainly saturated fatty acids and incorporated 
into chylomicrons. The chylomicrons are absorbed in the lymph 
and enter the circulation. All the chylomicrons and retinyl 
esters are removed from circulation by the liver. (Figure 3).
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1.4) Transport of Retinol
Kanai et al (1968), studied the transport of retinol. 
They showed it is carried in plasma, bound to a specific 
transport protein, retinol-binding protein (RBP) . This protein 
is a single poly-peptide chain with a molecular weight of about 
21,000-22,000. Kanai et al (1968) later described this relation- 
•ship and the role of RBP to retinol. Retinol binds to the 
apoprotein on a 1:1 molar proportion and the holo-protein 
circulates in plasma on a 1:1 molar basis with prealbumin (PA). 
According to Raz et al (19-70) their data strongly suggested that 
RBP has a single binding site for retinol and that the PA has a 
single binding site for the holoprotein. The combination 
involves a protein-lipid (RBP-retinol) and a protein-protein 
(RBP-PA) interaction. Petersen (1971) added the fact that 
retinyl esters do not bind to RBP.
Goodman (1969) and Petersen (1971) found that under 
controlled conditions retinol is differentially removed from the 
RBP-retinol complex at a faster rate, than from the RBP-PA 
complex. They suggested that no covalent bonding is involved and 
that the protein-protein interaction serves to stabilize and 
protect the bound retinol molecule.
1.5) Intra-cellular binding proteins
A number of tissues from rats, human and other species 
contain a soluble intra-cellular protein with binding specificity 
for retinol (cellular retinol-binding protein, CRBP) , and for a 
similar protein with binding specificity for retinoic acid 
(Cellular retinoic acid-binding protein, CRABP) (Goodman, 1984). 
Both CRBP and CRABP have a molecular weight close to 14,600 and
single binding sites for one molecule of retinoid ligand. The 
intra-cellular binding proteins differ in a number of major ways 
from plasma RBP (Goodman, 1984) . Ong et al (1982) indicated 
that CRBP is not tissue specific. Chytil, (1984) found that 
CRABP allows specific transfer of retinoic acid into the nucleus 
and to chromatin which was not influenced by CRBP.
Chytil and Ong (1984), Roberts and Sporn (1984) and 
Lotan (1980) investigated the possibility that there is a 
relationship between the intracellular retinoid-binding proteins 
and cancer, or between the proteins and the anti-carcinogenic 
activity of retinoids. Chytil and Ong (1979) suggested that the 
intracellular binding proteins may play a direct role in the 
biological expression of vitamin A activity (eg analogous to 
steroid hormone receptors).
As indicated later, retinoids affect cell differenti­
ation and proliferation, and are thought to affect gene 
expression in target cells (Roberts and Sporn, 1984) . Kato ert 
al (1985) in a recent report, found that both cellular binding 
proteins were present in all tissues and organs examined. They 
suggest that both proteins are involved in critical biochemical 
functions in many types of cells throughout the body. The nature 
of these functions, and of the regulatory processes that control 
the tissue levels of CRBP and CRABP, needs more investigation.
1 .6) Biological Action of Vitamin A
Vitamin A (retinol) is necessary for normal vision, 
reproduction and maintenance of function of the epithelial cells.
In general vitamins function in the body as co-factors to 
enzymes involved in intermediary metabolism.
Figure 4 illustrates the biological action of the three 
natural retinoids.
Retinal, which is responsible for the visual cycle, is 
reversibly formed from retinol in the body. The conversion of 
retinol to retinoic acid is irreversible. In the visual process, 
vitamin A plays a very special role. Vitamin A, in the form of 
its aldehyde, retinal, combines with the protein opsin to form 
rhodopsin (Weber, 1983). Numerous studies in vivo and in vitro 
have established that vitamin A (retinol and retinoic acid) is 
required for the normal differentiation and maintenance of 
epithelial tissues; however, the molecular mechanism of these 
effects have not yet been revealed (Lotan, 1980). Mueller et al 
(1978) explained that epithelial tissues undergo continuous 
replacement, and cells are progressively changing their pheno- 
tyPe f probably in response to hormonal, nutritional or other 
environmental stimuli. These factors may influence specific 
metabolic pathways directly or they may modify metabolism by 
altering the expression of genes, thus producing new proteins 
and/or glycoconj ugates. In several tissues exposure to certain 
hormones may induce proliferation of specific cells. During cell 
replication inductive events may lead to irreversible changes in 
cell phenotypes due to alterations in the spectrum of their 
inducible genes.
Vitamin A appears to induce proliferation and 
differentiation of the basal germinative layer of epithelial 
cells and, according to this, its mechanism of action is similar 
to the action of steroid hormones.

Mills (1983) studied the effect of vitamin A on cellular 
differentiation under conditions of deficiency and excess of 
vitamin A. Deficiency results in squamous metaplasia in the 
epithelium of the different organs. Excess of vitamin A sup­
presses keratinisation of epithelial tissue, and also causes a 
variety of toxic effects (Bollag, 1974). Retinol is accumulated 
by the liver, and prolonged, chronic ingestion of high doses of 
vitamin A results in the destruction of liver parenchymal cells. 
Acute ingestion of high doses may cause brain-stern oedema, 
leading to headaches, then coma, followed by death (Hicks, 1983).
In an attempt to avoid the toxicity, chemical modifi­
cation has been tried, usually of the cyclic or polar end groups 
of retinol. This has resulted in numerous compounds, called 
retinoids (Rustin, 1983). These synthetic retinoids are not 
stored in liver, so they do not appear to damage the organ 
(Rustin, 1983). Retinoids have been used in treatment of skin 
disease and certain types of cancer, and also in studies of the 
prevention of carcinogenesis (Meyskens, 1982; Kessler and 
Meyskens 1984 7 Meyskens et al 1985 ) . Further studies
are needed to elucidate their role, fate and their relationships 
to cell differentiation or proliferation.
1.7) Deficiency of vitamin A
Vitamin A is an essential substance, and for the lack of 
it many people in the world suffer ill-health, blindness or even 
death. Vitamin A deficiency seems to be the most common 
nutritional deficiency disease in the world. The most tragic 
manifestation of the deficiency is blindness in young children. 
This occurs since vitamin A operates in vision as ret inaldehyde
(Section 1.6), which forms the chromophoric group of visual 
pigment. If there is insufficient vitamin A, inadequate amounts 
of rhodopsin visual pigment are formed. In man, rods which are 
the location of rhodopsin are sensitive to light of low 
intensity, and this is first affected. This is followed by 
xerophthalmia or dryness of the eyes, and then by keratomalacia 
with melting or dense scarring of the cornea (Pirie, 1983) .
Vitamin A deficiency leads to damage to epithelial 
tissues, and apparently also to nerves and bony structures 
(Aykroyd, 1958). Oomen (1958) hypothesised that many clinical 
phenomena may be conditioned by vitamin A deficiency eg urinary 
calculus, bronchopneumonia, and fatty infiltration of the liver. 
These suggestions have not been confirmed.
Most available evidence suggests that the course of 
Vitamin A deficiency is due to reduced dietary intake of vitamin 
itself. Gopalan et al (1960); Venkatachalam and Gopalan (1960) 
suggested that there are other factors playing a significant role 
in vitamin A deficiency. Because of the inter-relationship 
between protein nutritional status and vitamin A metabolism, it 
has been suggested that protein intake is perhaps one of the 
factors which may be related to vitamin A deficiency. With 
protein deficiency, a poor absorption of vitamin A and carotenes 
from the diet may also occur (Srikantia, 1975).
Infection can play a role in the development of vitamin 
A deficiency, because infections are known to increase the 
requirement for many nutrients including vitamin A, and alter 
their metabolism (Srikantia, 1975).
There are several infectious diseases associated with 
xerophthalmia. The commonest is upper respiratory disease with 
fever and cough, and diarrhoea (Pirie, 1983), since vitamin A 
deficiency causes keratinization of epithelium in the trachea and 
loss of mucus cells and thinning of the gut epithelium.
Sauter, (1976) found that measles also seems to lead to 
keratomalacia. Dosseter and Whittle (1975) explained that the 
measles virus may infect the cornea, and fever will reduce 
vitamin A transport, since with stimulation protein-energy 
malnutrition will increase-and this will be made worse by the 
loss of protein through the gut wall.
Sivakumar and Reddy (1972) indicated that absorption of 
vitamin A is impaired in infectious diseases, and serum vitamin A 
and proteins are depressed (National Institute of Nutrition, 
Hyderabad, 1980). Marks (1968) suggested that transport of 
vitamin A may be affected as a result of depletion of carrier 
proteins.
Loss of resistance to infection has been established in 
animals as well as in man in cases of vitamin A deficiency 
(Clausen, 1935). He believed that an early adequate diet, 
particularly one rich in vitamin A, tends to prevent the develop­
ment of vitamin A deficiency and minimise the effect of 
infection.
Finally, the degree of vitamin A deficiency varies from 
one area to another and from one animal species to another. The 
deficiency in the same species varies according to age, sex and 
environmental condition. To treat vitamin A deficiency, a high
daily intake is needed, as soon as it occurs. However, due to 
the toxicity of high doses of vitamin A, the treatment must be 
handled with care.
1.8) Assessment of vitamin A status
For the past 10 years, workers have been developing new 
or modified methods, with a view to providing information for the 
evaluation of nutritional status.
Sauberlich et al (1974) indicated that for many 
nutrients, biochemical laboratory techniques have been investi­
gated, developed and employed in assessing nutritional status. 
The majority of these techniques involved:-
a) measurement of the nutrient level in the blood
b) measurement of the urinary excretion rate of the 
nutrient
c) measurement of the urinary metabolites of the nutrient.
d) measurement in blood or urine of abnormal metabolic 
products resulting from deficient or submarginal intakes 
of the nutrient
e) measurement of changes in blood components or enzyme 
activities that can be related to intakes of the 
nutrient.
f) load, saturation and isotopic tests.
In the past, the assessment of vitamin A status usually 
involved examining for night blindness or detecting clinical 
eye-signs of vitamin A deficiency (Section 1.7).
Rodriguez and Irwin,(1972), Peterson et al (1974), 
Carney and Russell, (1980) used the consequent increase in visual 
threshold after intake of vitamin A as a measure of vitamin A
status, and vitamin A deficiency has been detected successfully 
(Russell et al 1973, Carney and Russell, 1980). This could be a 
valuable measurement when considered with plasma retinol concen­
tration.
Dark adaptation can be faulty for reasons other than 
vitamin A deficiency (Morrison et al 1978). It would not be 
practicable to use this test widely because of the cost of the 
apparatus and co-operation of the subjects who are mostly young 
children.
Another aid in determining vitamin A status is the 
assessment of dietary intake. Calculating.the dietary intake of 
vitamin A and provitamin is difficult, because of the different 
content of carotenoid in food, the maturation effect on carotene 
content, the rapid conversion of provitamin A to inactive 
carotenoids biologically, and isomerization and losses during 
storage and food preparation. The estimation from food com­
position therefore provides only a qualitative indicator (Olson, 
1982). These tests are helpful in confirming vitamin A deficiency 
but are ineffective in evaluating marginal or normal states of 
vitamin A nutrition.
Measurement of plasma retinol concentration may help in 
the determination of vitamin A status. Blood samples can be 
readily obtained for screening purposes and for sequential 
studies. Although clinical vitamin A deficiency is always 
associated with a low plasma retinol, there are limitations in 
interpreting plasma concentrations. The plasma retinol concen­
trations can rise and fall for reasons unconnected with the 
vitamin A status of the body. If dietary protein is inadequate,
RBP biosynthesised in the liver will be affected and plasma 
retinol concentration will also be affected (Arroyave et al. 
1961, Glover and Muhilal, 1976). Also retinoids other than 
retinol, depress the plasma retinol concentration as a 
consequence of diminishing the demand of tissues for retinol 
itself (Underwood, 1974, Keilson et al 1979, Loerch et al 1979). 
Various diseases can affect the output of the retinol-RBP complex 
by the liver or its metabolism by the kidney; thus lowering or 
raising the plasma retinol concentration (Smith and Goodman, 
1971, Kindler. 1972, Underwood, 1974).
A new approach is carried out by Loerch et al (1979) 
'relative dose response1, based on the increase in the plasma 
retinol concentration brought about by a dose of vitamin A. If a 
low plasma retinol concentration is due to lack of reserve in the 
liver, the relative dose response is high. If little effect 
occurs, the low level is due to other factors. A more effective 
approach is the use of isotope dilution assay. When a dose of 
radioactive retinol is given to rats or humans on a vitamin 
A-free diet, equilibration between plasma retinol and liver 
retinol occurs within 7 and 15 to 26 days respectively and total 
body retinol can be calculated (Rietz et al 1973; Sauberlich _et 
al 1974).
More than 90% of the total body reserve of vitamin A is 
stored in the liver of a well-nourished individual. Bhat and 
Lacroix (1983) found that in liver tissue retinol palmitate 
constituted 79% of the total esters. Thus analysis of liver 
retinol palmitate concentration should generally provide a good
estimation of total body storage. There are however obvious 
difficulties in obtaining liver from patients and practical 
difficulties with autopsy specimens.
It is not known to what extent human liver is capable of 
concentrating vitamin A. Davies and Moore (1935) gave vitamin A 
to rats until their livers appeared incapable of holding any 
more; on examination the levels reached 10,000 IU/g (3,000 pg/g).
Smith and Malthus (1962) found that the capacity of human liver 
to store retinol in the form of retinol esters is very large. 
They reported values as high as 3,500 pg/g. In general, Pearson 
(1967) found the ranges are of 100-300 pg/g in well-nourished 
human populations. Olson (1979) classified the severity of 
deficient liver retinol levels, as inadequate (less than 20 
pg/g)/ critical (less than 5 pg/g), or absent (less than 0.6 
pg/g).
1.9) Daily requirements of vitamin A
Srikantia et al (1975) pointed out that man's require­
ment of vitamin A was not accurately known. Firstly, there have 
been few studies designed to evaluate direct human requirements 
of vitamin A. Secondly, the capacity of human liver to store 
vitamin A is not known. Finally, although the role of vitamin A 
in vision has been well established, its role in other physio­
logical functions in the body are not fully understood.
Hume and Krebs (1949) suggested that 750 pg of retinol 
represents the daily needs of a healthy adult to maintain 
reasonable body stores in both sexes. In pregnancy there is no 
need to increase the amount except in lactation, when a minimal
additional amount may be considered necessary. Recommended daily 
intake HMSO (UK) 1979 was also 750 u g , while recommended daily 
allowances by the National Academy of Sciences (USA) 1980 was 
1000 ug. These amounts are required to maintain an adequate 
blood concentration and to prevent all deficiency symptoms for 
adults. An intake above the requirement is considered necessary 
in order to produce liver storage. Excessive vitamin A is toxic 
to both children and adults and should be avoided. The committee 
believes that not more than 2250 ug retinol should be given to 
adults daily.
1.10) Requirements of vitamin A in disease
Nutrition in general is good for wound healing and other 
complications occurring after surgery. An adequate supply of 
energy, amino acids, trace elements, and other micro-nutrients is 
important. When some of these nutrients are lacking, oedema in 
the edges of wounds or wound rupture may occur, as an indication 
of poor healing. Harvey and Howes (1930) observed that surgical 
wounds in the stomach of the rat healed in relation to the state 
of nutrition. Bozzetti et al ( 1975) have demonstrated the 
improved collagen synthesis in the wounds of patients receiving 
adequate parenteral nutrition. Tenenbaum et al (1986) found 
that supplementary vitamin A increases collagen content in the 
gastrointestinal tract of normal rats, and prevents the decrease 
in tissue collagen content following injury. Winsey et al 
(1986) showed that dietary vitamin A supplements prevented the 
inhibitory effect of preoperative x-irradiation on healing of 
colon anastomoses. The requirement of vitamin A in disease has
not been thoroughly investigated, but commercial tube feeds for 
sick persons or those in the post-operative period usually 
contain the recommended amount for individuals in health.
1.11) Intravenous nutrition (IVN)
In recent years, total parenteral or intravenous 
nutrition (IVN) has become possible in maintaining nutrition in 
seriously ill hospital patients. It is widely accepted that a 
daily supply of energy and nutrients is necessary to maintain a 
patient in an optimal state of nutrition, and to give a good 
resistance to illness and-trauma (Richards and Kinney, 1977; 
Kleinberger and Deutsch, 1983) . The content of the intravenous 
solutions should contain the basal nutritional requirements, and 
also help to make up any losses or deficiencies present.
Intravenous feeding is particularly valuable in 
situations where oral feeding or tube feeding is not possible. 
Shenkin and Wretlind (1978) stated that the intravenous nutrients 
should be in the same quantity and form as are normally trans­
ferred to the blood from the intestine after adequate oral 
feeding.
Dudrick and Rhoads (1971) suggested that IVN may 
eventually be used to correct metabolic diseases, or to treat 
patients with malignant disease, by using a diet which starves 
the tumour, but at the same time supports the patient's 
nutrition.
Intravenous nutrition consists of the different 
nutrients, water, amino acid, fats, carbohydrates, minerals and 
vitamins. For efficient utilisation of all nutrients, they should
be administered at optimal doses to correct existing deficiency, 
and to prevent the occurrence of new deficiencies during 
nutritional support.
Vitamin A delivery in intravenous solution has been 
studied by many workers. Allwood (1982) found that the stability 
of vitamins in TPN depends on a number of factors, including 
adsorption to the container, the effects of ultraviolet light and 
the presence of trace elements. Hartline and Zachman (1976) 
found that the major factor in decreasing vitamin A adminis­
tration to the patient was absorption of the vitamin to the 
chamber and tubing of the administration bottle. This was 
confirmed by Gillis et al (1983) who suggested a re-examination 
of the method of solubilization of fat-soluble vitamin and the 
materials used in the manufacture of clinical infusion equipment. 
Because of the variations of vitamin A stability, individual 
workers require to demonstrate its stability in the conditions of 
study.
1.12) Nutrition and Cancer
The relationship between diet and nutrition and their 
effect on cancer received little attention before 1942 when 
Tannenbaum and later Ross and Bras (1965), studied the effect of 
diet in reducing animal tumours. The relationship between 
dietary factors and carcinogenesis in humans has been actively 
studied since then.
Epidemiologists and experimentalists have found that 
nutrition in general is related to the development of cancer in 
three ways (Reddy et al. 1980):-
i) food additives or contaminants may act as carcinogens or
co-carcinogens or both.
ii) nutrient deficiencies may lead to biochemical
alteration
iii) change in the intake of selected macro-nutrients may 
produce metabolic and biochemical abnormalities, which 
increase risk of cancer.
Rivlin (1982) tried to explain the relationship between 
nutrition and cancer and suggested that it may be useful to 
consider the relationship between at least four major items.
First, some dietary factor may influence the development 
of certain tumours.
Second, the development of cancer often has major
effects upon the nutritional status of patients.
Third, the treatment of cancer may effect nutritional
status.
Fourth, great advances have been made in the nutritional 
management of patients with cancer using intravenous, enteral or 
oral feeding.
Although the relationship between nutrition and cancer 
is complex, they interact in a number of important ways and to an 
increasing extent nutritional factors have been found useful in 
both the prevention and treatment of cancer.
1.13) The relationship between vitamin A and cancer
Vitamin A is required for normal growth and differen­
tiation of epithelial tissues, vision and reproduction, as 
described in Section 1.6 earlier. Farber, (1981) studied a two 
step model of carcinogenesis on which most of the understanding 
of the action of retinoids has evolved (i) initiation: the
irreversible genetic alteration of a target cell by carcinogen 
and (ii) promotion, which results in a phenotypic expression of 
that genetic alteration. Krinsky and Deneke, (1982) Nettesheim 
and Williams, (1976) suggest that vitamin A may interact with 
initiation of a cancer either by direct involvement with the 
initiator or by increasing susceptibility to carcinogens due to 
vitamin A deficiency.
The antipromotion effects of retinoids may occur through 
at least three different mechanisms. Boutwell, (1982) found that 
retinoic acid (retinoids) inhibited ornithine decarboxylase 
activity, a key enzyme in the process of tumour promotion. Sporn, 
(1980), Elias and Williams, (1981) hypothesized that retinoids 
may directly compete with promoting agents for control of 
cellular differentiation by effects on cellular protein 
synthesis. Sporn and Newton (1981) showed that retinoids block 
the effects of transforming growth factors in vitro, and may 
compete with growth factor to prevent expression of malignant 
growth.
Bjelke and his colleagues (1975) found an inverse 
association between the incidence of lung cancer and the intake 
of dietary vitamin A. He also found that decreased vitamin A 
intake was associated with an increased risk of cancer of the
colon (Bjelke, 1974) . This negative association may be under­
estimated because of inaccuracy in measuring the dietary 
variable. Peto et al (1981) indicated that dietary 
beta-carotene correlated inversely with human cancer risks, and 
if dietary beta-carotene is truly protective there are a number 
of theoretical mechanisms where it might act. Some of these 
mechanisms do not directly involve its 'provitamin A' activity.
On the other hand measurement of retinol levels in serum 
may reflect a relationship between vitamin A and cancer. 
Atukorala et al (1979) in a retrospective study of serum 
retinol, found low serum concentrations in patients with lung 
cancer. Ibrahim et al (1977); Wahi et al (1962) found low serum 
concentration of retinol in patients with oral cancer. In a 
prospective study, low serum retinol levels were associated with 
an increased risk of lung cancer (Wald et al 1980). The 
association was greatest for men who developed lung cancer. Basu 
et al (1976); Atukorala et al (1979) suggested that the low 
levels may have been a result of the cancer rather than a 
precursor.
Kummet and Meyskens (1983) supported the conclusion that 
vitamin A is a natural inhibitor for the development of cancer, 
but due to the multiple factors which contribute to the develop­
ment of cancer, it is difficult to distinguish the exact role 
that vitamin A plays. As described earlier, due to toxicity, 
the side effect of using vitamin A as treatment for cancer, 
synthetic compounds (retinoids) have been developed. Further 
careful studies are needed in future to establish the use of 
these compounds in preventing cancer.
1.14) Role of cholesterol in cancer and relation to vitamin A
Dietary cholesterol and vitamin A are both transported 
from the intestine in chylomicrons produced during absorption of 
fat (Goodman, 1962, Redgrave, 1970). Both cholesterol and 
vitamin A are deposited in the liver after catabolism of the 
chylomicrons (Goodman et al 1965, Fidge. et al 1 968) . The 
vitamin A and cholesterol are initially removed from the hepatic 
sinusoid into parenchymal cells. Vitamin A is presumably then 
transferred from the parenchymal cells into the perisinusoidal 
fat-storage cells. The fatrstorage cells appear to play no part 
in the metabolism of chylomicron cholesterol, which has been 
shown to be localised in the non-phagocytic fraction of liver 
cells (Redgrave and Vakakis, 1976; Redgrave, 1970; Nilsson and 
Zilversmit, 1971).
In human blood, most cholesterol is found in two types 
of lipoprotein particles, low density lipoprotein (LDL) and high 
density lipoprotein (HDL). These two lipoproteins have opposing 
physiological roles (Peto, 1981).
In recent years, considerable interest has been given to 
the association, between low serum cholesterol concentration and 
the increased incidence of cancer, especially colon/rectal cancer 
(Williams et al 1981) and the correlation between serum concen­
tration of cholesterol and the retinoids (Kark et al 1982).
There are several explanations for these associations. 
Kark et al (1982) suggested that the inverse relationship 
between serum cholesterol and cancer incidence may be secondary 
to an association of serum retinol with cancer. This suggested 
that the inverse relationship may reflect a vitamin A/cancer
relationship by way of the correlation between serum retinol and 
cholesterol. Smith and Hoggards (1981) supported this, and 
indicated that the relationship is with LDL-cholesterol. They 
found also a possible link between serum beta-carotene and serum 
cholesterol. Adams et al (1985) indicated that association 
between low serum cholesterol concentration and cancer risk is 
likely to be indirect, and may be mediated through vitamin A 
metabolism. One possible mediator is carotene, since LDL is 
involved in the transport of carotene. Most evidence of a 
relationship between cholesterol concentration and cancer has 
implicated primarily total cholesterol and LDL-cholesterol and 
not HDL-cholesterol, (Wald et al 1980; Rose and Shipley, 1980, 
consistent with the suggestion that low cholesterol level may be 
a metabolic consequence of cancer rather than a precursor.
Rose et al (197 4) in a six-country prospective study 
identified only 90 persons with coronary heart disease who also 
in due course developed colon cancer. Cruse et al (1979) 
suggested that cholesterol may act as a co-carcinogen within the 
colon. Unfortunately, many details remain obscure. Further 
studies on dietary intake of fat, coronary heart disease, 
beta-carotene and retinol metabolism and the relation to cancer 
are needed.
1 .15) The objects of the present study were:-
1) To develop a specific high pressure liquid chromato­
graphy method to separate retinol and its metabolites.
2) To investigate the effect of nutritional status, on
serum and liver vitamin A.
3) To investigate the role of vitamin A status in cancer,
using serum and liver vitamin A measurements.
2) Methods
! Statistical Methods
I In general, results throughout this thesis are
expressed as mean ± SD (standard deviation). Comparison of means 
| has been made by Student's t-test. Where results were not normally 
I distributed, median and range is stated and comparison of groups 
has been made by Mann-Whitney test.
Analytical Methods
2.1) Methods of measuring Retinol
2.1.1) Colorimetric Method
The Carr-Price method (1926) has been extensively used 
and involves the treatment of vitamin A with antimony tri­
chloride. The blue colour thus obtained has a maximum absorbance 
at 620 mp.
This method has been widely used in the past but there 
are disadvantages. The colour formed is temporary and must be 
read within 5-15 seconds. The method is extremely sensitive to 
moisture, which results in a turbid solution (Moore, 1957) . It 
is not specific for retinol, since carotenes are measured at the 
same time and a correction is made for the colour given. The 
reagent is corrosive, is a source of danger to the instrument 
and difficulty may arise in the cleaning of cuvettes. The method 
is therefore unsuitable for routine use.
Because of these limitations, a variety of methods for 
the determination of vitamin A in serum and food have been 
applied and modifications to the Carr-Price method have been 
made.
Bessey et al (1946) developed an UV spectrophotometrie 
method to determine vitamin A and carotene by reading the 
extinction at 325 nm and 460 nm respectively before and after 
irradiation of the serum with ultraviolet light of a wavelength 
between 310 and 400 nm. Vitamin A and carotene were destroyed 
under these conditions. These determinations required expensive
24 •
equipment and haemolysed blood has been found to give higher 
carotene values. Results tend to be unreliable, due to the 
higher blanks after irradiation (Sobel and Snow, 1947).
The Carr-Price method and its modification are unsuit­
able for measuring vitamin A in food products, because of 
problems with turbidity and non-specific interference.
Neeld-Pearson (1963) developed a method where tri- 
fluoroacetic acid (TFA) reacts with vitamin A, to form a compound 
with a blue colour. This blue colour has a maximum absorption at 
616 mu. The procedure is- the same as the Carr-Price method 
except that TFA replaces the SbCl3 . This method shows increased 
sensitivity and specificity, but since carotene reacts with TFA 
a correction is applied. A large percentage of stored specimens 
contain an artefact which gives a colour with TFA, similar to 
that given by vitamin A.
Most of these experiments measured total vitamin A and a 
correction is needed to obtain the true retinol value, because of 
the colour given by carotene. The colour produced is unstable. 
Precision and accuracy are poor due to interference.
2.1.2) Fluorimetric method
Many procedures have been published using the property 
that vitamin A (Retinol) and its derivatives (ester forms) 
fluoresce in ultraviolet light.
Thompson et al (1971) developed a method using 
excitation wavelengths of 330 and and 360 nm and emission was 
measured at 480 nm. They tested the interference of other 
derivatives, and only phytofluene (a carotene-like pigment 
present in tomatoes) had a large value of fluorescence, which
might interfere with the retinol results. T h e ; comparison of 
their method with other previous workers gave a good correlation 
except that due to phytofluene interference a correction formula 
was needed. They were unable to assess accuracy as the true 
level of retinol in the blood was not known.
Drujan et al (1968) obtained normal values for vitamin 
A (Retinol) in human blood samples. They suggested that there 
was probably no interference due to phytofluene. The diet of the 
volunteers was very low in vitamin A in this study.
Kahan (1966) used an extraction system of waterrethanol- 
rcyclohexane (1:5:5). He found that there was a linear 
relationship between fluorescence and concentration of retinol 
acetate within the range of 0.2-300 pmol/1. The deviation at 
levels higher than 300 pmol/1 is due to concentration quenching. 
He claimed to have demonstrated specificity by confirming that no 
interference occurred from haemoglobin, bilirubin, cholesterol, 
other fat-soluble vitamins and carotenoids, which had no 
detectable fluorescence. Hansen and Warwick (1966 and 1968) 
confirmed that finding, although the retinol level was above the 
accepted normal value, due to the presence of phytofluene.
Leitner et al (1960) estimated vitamin A and caro­
tenoids. They found that sex, food as well as season affected 
the levels of vitamin A and carotenoids in blood samples.
Previous workers have developed their fluorimetric 
methods using different solvents, excitation and emission wave­
lengths. They did not give adequate accuracy due to the presence 
of phytofluene, also there was no mention of precision or per­
centage recovery and they used a formula to correct interference
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of phytofluene. The treatment of the sample and standard may 
have been different, since standards were extracted from aqueous 
solutions rather than from preparations using vitamin free serum.
As part of the present study, a comparison was performed 
between a fluorescence method and a high performance liquid 
chromatography method (HPLC).
2.1.2.1 Fluorescence method for vitamin A analysis, used in this 
study
Absolute alcohol "Analar" cyclohexane (fluorescence 
grade), BDH, England, retinol acetate (Sigma). Perkin Elmer MPF 
3 spectrofluorimeter used with setting for retinol excitation 340 
nm, emission 470 nm with slit width 10 nm for both f and 
sensitivity setting as required.
Method
The method used for measuring vitamin A in plasma was a 
modification of that of Kahan (1966) and Thompson et al (1973). 
The principle is that the plasma sample is diluted in aqueous 
ethanol and retinol extracted into cyclohexane and determined by 
fluorimetry.
To 1 ml of distilled water, add 500 ul of distilled 
water, plasma or working standard of retinol acetate.
5 ml of ethanol 99.5% is added, the solution mixed by 
shaking, then 4 ml of cyclohexane is added, the mixture shaken 
well, centrifuged and the upper cyclohexane layer removed. The 
fluorescence was measured with a setting of zero with blank 
solution and 50 with standard.
pmol/1 retinol = Fluorescence intensity of sample x C 
Fluorescence intensity of standard 
Where C = concentration of standard
2.1.2.2 Vitamin-free serum
The method used was adapted from Schade, (1981) . 15
grams activated charcoal powder (Norit 01, Searle) was added to 
100 ml serum pool, and stirred with a magnetic rod overnight at 
4°C. The preparation was ultracentrifuged at 40,000 rev/min at 
10°C for half an hour. The supernatant was cleared with 
crystalline cellulose and centrifuged (sometimes serum was so 
clear after ultracentrifugation that this step was not 
required). The mixture was checked on HPLC for absence of 
retinol, then 0 .1% sodium azide (NaN3) was added and aliquots 
were stored at -20°C. Figures 5-7 show serum before and after 
charcoal, compared with vitamin-free sera from horse serum 
(Bovine, Wellcome), from Victoria Infirmary, Glasgow, from 
Western Infirmary, Glasgow (dried plasma) and from serum exposed 
to UV light for one hour, respectively.
Results
Different types of charcoal were used (10-18 mesh) 
activated for gas absorption (BDH). The best results obtained by 
us were with activated charcoal powder (Norit 01, Hopkins, 
Williams). Different types of filter were used also, as suggested 
by Schade (1981), but ultracentrifugation was most effective at 
removing charcoal. Figure 5 shows that a vitamin-free serum was 
prepared by this method.
* Joyce Robertson, Department of Biochemistry, Victoria Infirmary 
Department of Biochemistry, Western Infirmary
- 0.01
ir>
CN
co
U
Z
<
COcc
o
.-0.01
RETENTION VOLUME (m l)
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Figure 7: Chromatograph of vitamin-free serum
(A) of Western Infirmary, Glasgow,
(B) serum treated for one hour under 
UV light
Peak identification:-
1 - Retinol
2 - solvent peak
2.1.2.3 Fluorescence Assay:
1) linearity and accuracy of method
A calibration curve was prepared using retinol acetate 
in alcohol and was found to be linear (Figure 8). A calibration 
curve was also prepared for retinol acetate using vitamin-free 
serum. It was also linear, except that there was a reduction 
compared with retinol acetate standard in alcohol. A retinol 
standard at 10 pmol/1 in vitamin free serum gave a value of 3.6 
pmol/1 against the retinol acetate standard in alcohol and a 
reading of 6.7 pmol/1 against the retinol acetate standard in 
serum. This suggests that the standards have been more poorly 
extracted from serum, and that retinol and retinol acetate may 
be extracted to different extents.
2) Comparison of retinol with retinol acetate as 
standard
Many workers have used retinol acetate as standard, 
although the retinoid in serum is retinol. Figure 9 and Table 1 
shows the actual retinol concentration compared with the measured 
concentration by fluorescence against retinol acetate standard.
The table and figure show that increasing concentrations 
of retinol, lead to linear increases in fluorescence. However, 
the calculated concentration of retinol is very low, relative to 
its actual concentration. A retinol standard was therefore 
investigated.
3) Retinol standard curve (linearity)
A calibration curve was prepared using retinol in 
alcohol as standard (Figure 10). It was found linear over a wide 
range (0-10.5 pmol/1). This was compared with that of standard
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alcohol (□) and vitamin—free serum (+)
60-,
30-
20 -
10 -
20 1 3 54
SERUM RETINOL CpMOL/L)
Figure 9: Fluorometric assay of serum retinol concentration -
A calibration curve using retinol acetate standard 
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TABLE 1
MEASURING DIFFERENT RETINOL CONCENTRATIONS AGAINST RETINOL 
ACETATE STANDARD
Actual Concentration 
of retinol std 
(pmol/1)
Fluorescence
(units)
Calculated 
retinol cone 
(pmol/1)
0.4 1 0.1
0.7 2 0.2
1.0 nO 0.4
1.1 4 0.5
1.4 • 5 0.6
1.8 6 0.7
2.1 7 0.8
3.2 11 1.3
3.5 11 1.3
4.2 15 1.8
5.3 17 2.0
10.5 30 3.6
Retinol acetate
(4.0) 50
60 -
30 -
10 -
122 6 8 100 4
RETINOL CjJMOL/L)
Figure 10: Fluorometric assay of retinol. A calibration
curve of standard retinol in alcohol (n ), and 
in serum (+)
retinol in vitamin-free serum. No difference in fluorescence was 
obtained (Table 2). This contrasts with the reduction in 
retinol acetate extraction from vitamin-free serum.
Previous studies have suggested that either hexane or 
cyclohexane may be used for extraction (Kishi et al 1981) . The 
fluorescence of retinol standard extracted with these solvents 
was studied (Table 3).
It is clear that fluorescence is much greater when 
hexane is used as solvent. Other retinol derivatives were 
therefore studied in a similar way (Table 4). Retinol and 
carotene are more efficiently extracted by hexane, whereas 
retinal appears to be equally extracted by cyclohexane and 
hexane. Retinoic acid does not appear to fluoresce under these 
conditions.
Discussion
These studies have indicated the importance of using 
retinol as standard rather than the commonly used retinol 
acetate. If we compared the fluorescence of the same concen­
tration of retinol in Tables 1 and 2, which were read against 
retinol acetate standard and retinol standard respectively, it is 
found that the retinol form of the vitamin gives a fluorimetric 
response about 1.7 times that of the retinol acetate form. This 
result agrees with that of Garry et al (1970) who suggested the 
use of retinol as the primary standard in the fluorimetric 
procedure, rather than the more stable acetate derivatives. Kishi 
et al (1981) used hexane instead of cyclohexane for extracting 
retinol from plasma, whereas retinol acetate was used as 
standard. In this study we found that the fluorescence increased
TABLE 2
STANDARD CURVE OF RETINOL
Actual Concentration 
of retinol std 
(pmol/1)
Fluorescence 
in alcohol 
(scale units)
Fluorescence in 
vitamin-free 
serum (scale 
units)
0.4 3 3
0.7 5 5
1.0 5 5
1.1 6 6
1.4 8 8
1.8 *10 10
2.1 12 12
3.2 17 17
3.5 19 19
4.2 21 21
5.3 27 27
10.5 50 50
TABLE 3
FLUORESCENCE.OF RETINOL IN CYCLOHEXANE AND HEXANE
Actual concentration 
of retinol std 
(pmol/1)
Fluorescence 
in cyclohexane 
(scale units)
Fluorescence 
in Hexane 
(scale units)
0.4 1 4
1.0 3 10
2. 1 7 20
4.2 15 40
10.5 30 110
Retinol acetate 50 50
TABLE 4
COMPARISON OF RETINOL, RETINAL, RETINOIC ACID, CAROTENE 
FLUORESCENCE
Actual Concentration 
(pmol/1)
Fluorescence 
in cyclohexane 
(scale units)
Fluorescence . 
in Hexane 
(scale units)
Retinol (10.5) 30 110
Retinal (10.5) 20 20
Retinoic acid (10.5) 1 0
Carotene (1.1) 11 27
Retinol acetate (4.2) 50 50
3Q
3 times with hexane extraction compared to cyclohexane. Hexane 
therefore extracts more retinol than cyclohexane. In addition, 
the retinoic acid, retinal and carotene fluoresce less than 
retinol. Therefore the concentration calculated is less than 
that added. Frolik and Olson (1984) suggested that retinol and 
its esters are the only naturally-occurring retinoids that 
fluoresce under normal conditions.
In this study (Section 3.2.2) we found that triglyceride 
may effect the fluorimetric method possibly as a quenching 
factor. This may be due -to the large particle-size of tri­
glyceride which scattered the beam causing quenching. The 
disadvantages of the fluorimetric method were therefore:-
1) the fluorimetric method did not give an accurate value 
when retinol acetate was used as standard and 
extraction was less efficient than retinol
2) quenching may occur with some compounds* eg triglyceride 
and beta carotene and also with haemolysis.
3) a correction formula is used to allow for phytofluene 
presence.
4) Basu et al (1982) reported that vitamin A, phytofluene 
or both could be reduced in cancer and the effects could 
be variable. The results in cancer patients should be 
confirmed with valid methods of analysis eg HPLC.
5) Garry et al • (1970) suggested that phytofluene concen­
tration varied from 0-5 times that of vitamin A.
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Because of the disadvantages of the fluorimetric method, 
we developed an HPLC method. This should be more specific, 
accurate and precise and could separate all retinol derivatives 
on one system.
2.1.3) High performance liquid chromatography (HPLC)
2.1.3.1 Background
High performance liquid chromatography (HPLC) has been 
used for the analysis of retinol and its derivatives. McCormick 
et al (1978) reported a reverse-phase HPLC procedure and DeRuyter 
and Deleenheer (1978) used ultraviolet detection at 330 nm with a 
reverse-phase packed column. The authors extracted retinol and 
retinyl esters according to the Bligh and Dyer (1959) procedure. 
The sensitivity of this method was 0.2 pmol/1 for retinol and 0.4 
pmol/1, for retinyl esters. The authors did not discuss other 
interferences although they suggested that this method could be 
used for the assessment of vitamin A absorption and for the 
determination of serum retinol (normal, subnormal and above 
normal concentration).
Catignani and Bieri (1983) reported an assay for retinol 
and alpha-tocopherol in serum or plasma by HPLC in which reverse 
phase uBondapak C-jg, 10 urn column was used with 95:5 methanol: 
water as mobile phase. The peak height of vitamins were measured 
against an internal standard to obtain the quantity of each. 
According to DeLeenheer et al (1979) 95% of vitamin A in serum 
is retinol. Esterified forms of vitamin A such as retinol 
palmitate appear in the blood only after ingestion of a vitamin 
A-containing meal and can be measured by the method of Catignani
and Bieri (1983). Long retention times are involved and the 
normal concentrations of the esters was found to be below 
detection in the post-absorptive state. The authors did not 
discuss using vitamin-free serum for calibration of the assay but 
they achieved good recovery when they correlated results with 
Neeld and Pearson (1963) colourimetric methods using trifluoro- 
acetic acid, (r = 0.8).
Palmskog (1980) reported an assay for determination of 
two aromatic retinoic acid!analogues with anti-psoriatic activity 
in which a reverse-phase -column was used. The sensitivity of 
this method was 0.035 pmol/1 and experimental error below 9%, in 
a concentration range 0.1-1.6 pmol/1. He believed that a method 
is needed for the separation of retinol and its derivatives, 
particularly if the retinoid is used as an anti-cancer drug, to 
see if there are any other metabolites present in serum. This 
may also be helpful in analysing toxic effects.
Roberts et al (1978) reported an HPLC assay with 
excellent recoveries and high resolution, using reverse-phase 
with a solvent mixture of acetonitrile:water. The quoted 
sensitivity was 1 nmol/g tissue for retinyl esters and less than 
0.3 nmol/g tissue for retinol, using dual-wavelength detection at 
365 nm and 325 nm. They achieved a separation of most retinol 
derivatives in tissue. The problem was the appearance of an 
artifact peak caused by a refractive index change during the 
change of mobile phase concentration from 80% to 98% (aceto- 
nitrile: water) . A further drawback of the HPLC procedure was 
reported by Frolik et al (1978), who found that the column inlet 
blocked after 40-50 sample injections.
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De Ruyter and De Leenheer (1976) reported an HPLC 
straight-phase assay to determine retinol in serum using 10 pm 
(15 cm x 0.2 cm id) column with petroleum ether:dichloromethane:- 
isopropanol, (80:19.3:0.7) as mobile phase. The quoted 
sensitivity was 0.2 pmol/1 (50 pg/1) and linearity was demon­
strated up to 5.2 pmol/1 (1.5 mg/1). They achieved a separation 
of retinol from all other derivatives except retinoic acid, 
which had k* = 5.2 while retinol k* = 5.0 (Section 2.1.3.2 for 
k' measurement). They also succeeded in producing vitamin-free 
serum by irradiating an aliquot of serum sample with long wave UV 
light (>320 nm) for 3 hours.
Although they produced vitamin-free serum the procedure 
was standardised by using different values of retinol in alcohol 
and the analytical recovery of retinol from serum was determined 
by adding known quantities of retinol to serum.
McCormick et al (1978) achieved a separation of the 
mixture of four synthetic vitamin compounds - retinoic acid, 
retinol, retinal and retinol palmitate using reverse-phase pC-jg- 
Bondapak column (4 mm id x 30 cm) at 313 nm with 0.01 M sodium 
acetate methanol: water (80:20) with 90-95% recovery. The 
procedure took 26 min. This method has been difficult to 
reproduce in our laboratory (Table 9).
Few of these assays incorporated an internal standard 
and none of the authors have reported the investigation of 
possible interference by other drugs. This is surprising in view 
of the common use of drugs in most patients.
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HPLC methods used are shown in Table 5. The drawback 
of each method can be seen in terms of variable or uncertain 
recovery, failure to separate retinol metabolites and lack of
•5
specificity data.
One of the aims of this study was therefore to develop 
and validate a sensitive, accurate, precise method for retinol 
and its derivatives in biological materials.
2.1.3.2 Development of HPLC method for retinol and its 
derivatives
Materials and Equipment 
Materials
Retinol, retinal, retinoic acid, retinol palmitate,
carotene and also retinol acetate, were obtained from Sigma
Chemical Company (Dorset, England). Hexane, HPLC grade was
obtained from Rathburn Chemicals (Walkerburn, Peebleshire,
Scotland). Tetrahydrofuran stabilizer with 0.1% quinole, BHA
(butylhydroxide anisole) were obtained from Sigma. Methanol and
all other reagents were obtained from British Drug Houses (Poole,
Dorset, England).
Evaluation of Performance
Definitions: K 1: the capacity factor or distribution ratio is a
function based on retention times, a measure of the capacity of
the column to retain a given sample.
k ' =  t r - t n  =  
to tQ
tQ = retention time of the unretained peak(solvent peak) 
tr = retention time of the given peak 
tR = the adjusted retention time
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R s = the resolution of two chromatographic peaks is a measure of
their separation.
Rs = 2 t7-t1 
W1+W2
t-j and t2 are the retention distances of peaks 1 and 2 
respectively. W-j and W2 are the peak base widths (in same units 
as t-j and t2) for peaks 1 and 2 respectively (Pryde and Gilbert, 
1979).
Choice of retinol acetate as internal standard (IS) 
Relevant factors in the choice of retinol acetate as 
internal standard are that it has a similar structure to the 
analyte; it is stable; it has an acceptable k' value (Table 12); 
it is easily extracted; from aqueous solution; it is available 
commercially; and it is resolved from retinol and its derivatives 
on the HPLC column (Figure 11). The main advantages of using an 
IS are that it eliminates errors from pipetting during the 
evaporation of solvent and the variation in extraction.
Apparatus
Four HPLC systems were used:-
1) Varian HPLC system (Varian Associates, Walton, Thames, 
England)
2) A Pye-Unicam HPLC system (Cambridge, England) consisting 
of an LC-XPS single piston reciprocating pump, Alc-UV 
variable wavelength detector and a PM 8521 single pen 
recorder.
3) A Gilson HPLC system (Middleton, USA) consisting of a 
Gilson 302/5S piston pump, Holochrome, HM/HPLC and 
Rikadenki single pen recorder.
----(------------r------------ f-
6 3 0
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Chromatography of a mixture of retinol 
and its metabolites. Peak identities are
1 - retinol acetate (IS)
2 - retinal
3 - retinoic acid
4 - retinol.
4) Cecil instrument Cg 212 reference variable wavelength
RE54, servoscribe 15 recorder and Magnus pump.
The stainless steel column (4 mm ID x 25 cm) was 
obtained from Shandon Southern (Runcorn, England) slurry packed 
with 5 p ODS Hypersil (Shandon Southern) using a Shandon slurry 
packer and fitted with a valve adaptor (Shandon Southern). Also a 
3 p ODS column with same description was used.
Another stainless steel column (4 mm ID x 25 cm) was 
obtained from Shandon Southern (Runcorn, England), slurry packed 
with 5 p silica (Hypersil C002 3H) Shandon Southern. The 
injection value was fitted with a 20 pi loop.
Methods
Reverse phase HPLC studies
A reverse-phase material (ODS Hypersil) was used to 
attempt to separate retinol from retinal, retinoic acid, retinol 
palmitate, and retinol acetate as IS. The liguid chromatographic 
method was developed as follows
a) Polarity investigation
Methanol: water were first used as a mobile phase, to 
elute the retinol and its derivatives. Increase in polarity was 
effected by increasing water relative to the methanol. The 
changes in k 1 of retinol and its derivatives were studied 
(Table 6). This study failed to separate retinol from its 
derivatives, particularly retinal.
b) pH control
The above aqueous solutions were adjusted to pH 5.2 
using 0.05 M phosphoric acid, but failed to change k 1 for retinol 
and its derivatives.
TABLE 6
COMPARISON OF k', WITH SOLVENTS CONTAINING DIFFERENT PROPORTIONS
OF MEOH: WATER
k ’
Solvent^.
Retinol Retinoic Acid Retinal Retinol palmitate
95:5 2.0 1.0 2.0 & 
3.5
*
92:8+ 1.75 1.6 1.58 *
90:10 3.0 1.0 3.5 *
85:15 8.0 9.5 8.3 &
80:20 16.8 10.5 16.5 44.0
75:25 29.8 11.5 29.5 *
+ Cecil Instrument used 
* Retinol palmitate (Nil) no peak
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c) Ion-pair
1-octane sulphonic acid was used as ion-pair at a 
concentration of 27 mg/1 in methanol: water, also 0.01% tetra-n- 
butylamine, 0.01% DL-N-octdylamine, while 0.1% hexane sulphonic 
acid, 0.01% tetraethylamino bromide (TEABr), 0.01% Do-decyltri- 
methylaminobromide (DDTMABr) were used with 0.05 M phosphoric 
acid (Table 7) .
d) Column particle size
3 ji particle size ODS column with same conditions of 
methanol: water containing .0.05 M phosphoric acid + 0.01% (TEA 
Br) or 0.01% (DDTMABr) and methanol: water containing 0.01 M 
sodium acetate were also studied ( Table 8)
e) Method of McCormick et al (1978)
We attempted the separation method as described on Page
33 and results are shown in Table 9.
By using different column size particles, pH and 
different ion-pair as well as the method of McCormick et al 
(1978) we failed to obtain a different k' for retinol and 
retinal. Although retention time is changed, there is still an 
overlap between the other derivatives and retinol.
f) The mixture of methanol: water (85:15) combination was
further investigated by adding different ion-pairs to this eluant 
and k' was studied (Table 10). No improvement in separation 
was found.
TABLE 7
COMPARISON OF K 1, BETWEEN SOLVENTS CONTAINING DIFFERENT PROPORTIONS
OF METHANOL:WATER WITH ION-PAIR AGENTS USING 5 pm ODS COLUMN
K f.
Methanol: v 
water.
Retinol Retinoic
Acid
Retinal Retinol
Acetate
95:5 1.0 1.0 1.1 1.5
(1.0) (1.0) (1.0) (1.3)
90:10 2.3 2.3 2.5 3.7
(2.0) (2.0) (2.1) (3.2)
85:15 4.0 4. 1 4.2 7.2
(4.1) (3.7) (4.2) (7.4)
80:20 9.3 10.1 9.9 20
(9.1) (7.3) (9.3) (18.5)
75:25 19 21.2 19.8 took more
(19) (11.0) (19.3) than 1 hour
70:30 70 high
pressure
high
pressure
Solvent A Methanol: water containing 0.05 M phosphoric acid + 0.01% TEA Br 
( ) results obtained with solvent B Methanol:water containing 0.05 M
phosphoric acid + 0.01% DDTMA Br.
TABLE 8
COMPARISON OF K T, BETWEEN SOLVENTS CONTAINING DIFFERENT PROPORTIONS
OF METHANOL:WATER WITH ION-PAIR AGENTS USING 3 jjm ODS COLUMN
K ’
Solvent A N .  
or B
Retinol Retinoic
acid
Retinal Retinol
acetate
95:5 1.6 1.9 2.0 30 •
(1.5) (0 .8) (1.5) (3.5)
90:10 3.8 4.5 4.4 8.3
(3.7) (1.2) (3.8) (7.5)
85:15 9.8 11.0 9.9 took time
(9.0) (4.1) (9.0)
80:20 21.1 26.2 21.2
(15.0) (11.6) (14.7)
75:25 h i g h  p r i s s u r e
Solvents were as in Table 7
TABLE 9
COMPARISON OF K f, USING THE SAME CONDITIONS AS 
McCormick et al 1978
Solvent Retinol Retinoic Acid Retinal
80:20 22.0 5.0 21.0
90:10 3.9 — 3.9
Solvent: 0.1 M sodium acetate methanol:water
TABLE 10
COMPARISON OF K* WITH METHANOL:WATER PROPORTION (85:15) 
AND DIFFERENT ION PAIR AGENTS.
^ ^ \ S o l v e n t s
Compound
A
(K’)
B
(KT)
C
(K1)
D
(K’)
Retinol 3 *.8 3.4 3.0 3.2
Retinoic Acid 4.1 3.0 1.9 0.2
Retinal 3.9 3.2 3.0 3.2
Retinol acetate 7.1 5.9 5.4 5.8
Retinol palmitate After 1 hour and half (nil)
Solvent A: Methanol:water (85:15) containing
27 mg/1 1-octane sulphonic acid
Solvent B: Methanol:water (85:15) containing
0.01% tetra-N-butylamine
Solvent C: Methanol:water (85:15) containing
0.01% Dodecyltrimethylamine
Solvnet D Methanol:water (85:15) containing 
0.01% D-1-N-octdylamine
Straight Phase chromatography
a) TLC: Thin layer chromatography
Thin layer chromatography provides a rapid method of 
studying mobile phase in a straight-phase system. Dc-plastik- 
folien (Kieselgel 60 F254) (E. Merck, Dermstadt) was used. 20 
pi samples were applied about 0.8 cm from the lower edge of the 
plate. The plates were developed in a darkened rectangular 
chamber in 250 ml of solvent by ascending chromatography at room 
temperature for about 30 min. Immediately upon removal from the 
chamber, the compounds were.detected by exposure to a UV lamp at 
254 nm. The Rp of retinol and its derivatives were studied with 
different solvents (Table 11).
Definition
The Rf value is the ratio of the distance travelled by 
the solute to the distance travelled by the solvent front:
Rf = distance of solute 
distance of solvent
The k' value in HPLC is related to the Rf value in TLC
by:~
k' = 1/RP - 1
or
Rf = 1/1+k'
The k 1 value measures the ratio of the time spent by the 
solute in the stationary phase to the time spent in the mobile 
phase (Pryde and Gilbert, 1979). K' can be calculated from Rp 
(Table 11)
TABLE 11
COMPARISON OF Rf and K' ( ) - WITH DIFFERENT SOLVENTS PROPORTIONS
BETWEEN RETINOL AND ITS DERIVATIVES
-— ^ ( k  ’ )
Solvent
Retinol Retinoic
Acid
Retinal Retinol
Acetate
Diethyl ether 0.97(0.03) 1.0 (0 .0) 1.0 (0.0) 1.0 (0.0)
Dichloromethane 0.34(2.9) 0.07(13.3) 0.45(1.2) 0.97(0.03)
Chloroform 0.51(0.96) 0.29(2.45) 0.94(0.06) 1.0 (0 .0)
Acetic Acid ’ 0.84(0.19) 0.87(0.15) 0.88(0.14) 0.84(0.19)
Dichloromethaierethanol: 
ammonia 90:10:0.1 0.87(0.15) 0.46(1.17) 0.98(0.02) -
75:10:0.1 0.97(0.03) 0.02(50.0) 1.0 (0 .0) 1.0 (0 .0)
75:1:0.1 0.43(1.3) 0.00(0.0) 0.75(0.33) 0.94(0.06)
Dichloromethane:ethanol;; 
formic acid 90:10:01 0.91(0.1) 0.93(0.08) with solvent front
75:10:0.1 0.99(0.01) 0.96(0.04) v with solvent front
75:1:0.1 0.48(1.08) 0.33(2.03) 0.8(0.25) 0.99(0.0)
10% methanol in 
benzene 0.57(0.75) 0.5(2.0) 0.92(0.09) 1.0 (0 .0)
Benzene* 0.21 (3.76) 0.06(15.67) 0.36(1.78) 0.68(0.47)
Chloroform* 0.54(0.85) 0.26(2.85) 0.88(0.14) 0.98(0.02)
80:20 cyclohexane: 
ether 0.21(3.76) 0.23(3.35) 0.57(0.75) 0.78(0.28)
1% tetrahydrofuran: 
hexane 0.08(11.5) 0.04(24) 0.15(5.67) 0.28(2.57)
10% ethanol in 
petroleum ether 0.38(1.6) 0.42(1.4) 0.52(0.9) 0.71(0.4)
* silica gel plates used.
b) HPLC on silica column
A straight-phase (Silica column) was used to separate 
retinol and its derivatives. Those solvents which gave different 
Rp and k' (calculated as on Page 38) between retinol and its
derivatives on TLC were investigated using HPLC.
Most of the solvents which were promising from TLC 
studies proved unsatisfactory when used in an HPLC system. 
However, we approached an acceptable k ’ value and resolution 
value (Rs) between retinol, retinal, retinoic acid and retinol 
acetate by using straight phase HPLC and Hexane: tetrahydrofuran: 
formic acid (93:7:0.1) proportion (Table 12). The resolution 
between retinal and retinoic acid had a satisfactory Rs = 1.6, 
whereas Rs = 0.87 was found between these compounds using Hexane: 
ether: formic acid (93:7:0.1). Resolution with Rs <1 is usually
not successful due to overlap of peaks.
Optimised HPLC method for measurement of retinol and its 
derivatives
The mobile phase consisted of Hexane:tetrahydrofuran:- 
formic acid (93:7;0.1), at ambient temperature, with a flow rate 
1 ml/min, wavelength 325 nm, chart speed 0.5 cm/min, scale 
expansion (absorbance settings AUFS) varied depending upon the 
samples injected. An example of the separation of standards is 
shown in Figure 11.
Extraction procedure - modification of Schade (1981) method
0-100 pi of an aqueous solution which contained a 
standard amount of retinol or its derivatives was transferred to 
C 14/ C 15 QQ tubes at 37°C and evaporated under oxygen-free 
nitrogen. 200 ul of vitamin-free serum was added and equili-
TABLE 12
COMPARISON OF K* , BETWEEN RETINOL AND ITS DERIVATIVES ON STRAIGHT 
PHASE (HPLC), USING DIFFERENT SOLVENTS
Solv^ nt^ ''"'
Retinol Retinoic Acid Retinal Retinol
Acetate
Dichloromethane:ethanol:
formic acid
75:1:0.1 0.7 1.2 1.6 1.3
Dichloromethane 1.7 1.9 1.9 0.13
Chloroform 0.0 0.0 0.05 0.05
Dichloromethane:ethanol: 
ammonia 75:1:0.1 0.1 0.0 0.1 0.2
10% ethanol in petroleum 
ether 0.23 0.41 0.11 0.06*
2:98 ether:petroleum ether° 10.8 10.6 5.8 1.2
Petroleum ether:dichloro­
methane: isopropanol + 
80:19.3:0.7 0.14 0.24 0.24 0.26
10% dichloromethane . 0.38 0.32 0.32 0.0
1% tetrahydrofuran :hexane 0.05 0.14 0.19 0.09
Hexane:tetrahydrofuran : 
formic acid 93:7:0.1 4.0 0.9 0.7 0.2
Hexane:ether:formic acid 
93:7:0.1 4.6 2.1 1.9 0.7
* appears with solvent peak 
not good peak shape 
+ 80-100°C peteroleum ether
40 .
brated for 10 minutes. The mixture was vortexed and 200 ul of an 
aqueous solution of IS was added. The mixture was extracted with 
1.0 ml hexane by vortexing for 5 minutes, and then centrifuged. 
Cyclohexane and diethyl ether were also studied. 0.5 ml of 
supernatant was transferred and the remainder was re-extracted 
with a further 1.0 ml hexane. The combined extracts were 
evaporated under oxygen-free nitrogen. The residue was dissolved 
in 100 ul hexane, eluent or cyclohexane. Table13 shows the % 
relative recovery of retinoic acid, retinal and retinol. The 
sensitivity was equivalent to 1.2 ng (0.2 pmol/1) for retinol, 
retinal and 6.0 ng (1.0 pmol/1) on column for retinoic acid.
These results are not satisfactory for recovery of 
retinol and its derivatives. The results for hexane/hexane agree 
with those of Schade,( 1981), who achieved a reasonable 
recovery only of retinol and retinol acetate, with an ODS column 
and methanol as solvent.
Extraction method used in Western Infirmary, Glasgow
0-100 pi of an aqueous solution containing a standard 
amount of retinol or its derivatives was mixed well in a C14/C15 
QQ tube with 0.5 ml vitamin-free serum and 100 pi of an aqueous 
solution of IS. The mixture was equilibrated for 10 minutes. 2 
ml methanol was added, mixed, equilibrated for another 10 minutes 
and 2 ml distilled water was then added. 3 ml diethyl ether was 
added, and tubes were shaken for 15 minutes and centrifuged at 
2500 rpm for 10 minutes. The ether layer was transferred to a 
fresh tube and the aqueous phase was re-extracted with another 3 
ml diethyl ether. The ether layers were combined and evaporated 
to dryness at 40°C under a stream of nitrogen. Dried extracts
TABLE 13
Relative % recovery of retinoic acid,, retinal and .retinol from serum 
following extraction and solubilisation by different organic solvents.
_________________________________________________ %_Recovery_______________
Solvents for Solvent used Retinoic Retinal Retinol
extraction to dissolve residue Acid
Cyclohexane
Hexane
Cyclohexane 
Hexane 
Diethylether Hexane 
Hexane Eluent
Hexane 
Cyclohexane
Cyclohexane
Hexane
10
30
30
27
30
34
20
40
40
15
7
15
15
80
20
15
41 .
were dissolved in hexane. Eluent was used also instead of 
methanol, which is immiscible with the mobile phase. Vitamin- 
free serum from the Western Infirmary was compared with freshly 
prepared vitamin free serum from Glasgow Royal Infirmary. (Tables 
14 and 15).
Better results were obtained with the vitamin-free serum 
prepared in Glasgow Royal Infirmary because the serum used by the 
Western Infirmary gave a peak of retinol with our method. They 
used reconstituted dried plasma in preparing vitamin-free serum. 
These recoveries are however still unsatisfactory.
Extraction method of Ito, et al (1974)
The method had 4 steps. The plasma was lyophilized and 
extracted twice with chloroform:methanol (1:1) containing 5 0 pg 
of BHA/ml. Then the precipitate was re-extracted twice with 
methanol containing 50 pg of BHA/ml. The supernatants were 
combined, evaporated, and the residue was dissolved, and injected 
onto the column.
The results seem satisfactory with lyophilization and 
full extraction for both % relative recovery and absolute 
recovery ( ) for retinol, retinoic acid and retinol acetate if
compared to Ito et al (1974) (Table 16). The procedure was too 
long so a modification was done by a reduced extraction to one 
step chloroform: methanol (1:1) and with no lyophilization (Table 
17) .
The results show a good satisfactory % relative and 
absolute recovery for retinol, retinoic acid and retinol acetate, 
while poor recovery for retinal. However, a satisfactory 
separation of all derivatives was achieved. Although the
TABLE 14
Comparison of absolute and relative % recovery of retinoic acid 
retinal and retinol between Western and Royal Infirmary methods 
(Glasgow)
Compounds Western Infirmary 
Serum
% absolute recovery
Royal Infirmary serum
% Absolute % Relative 
Recovery Recovery
Retinoic acid 100% 100% 90%
Retinal 27% 23% 58%
Retinol 50% 78% 65%
TABLE 15
Relative % recovery of retinoic acid, retinal and retinol following 
solubilisation by different organic solvents.
Compounds % Relative recovery
Hexane Eluant
Retinoic acid 95 7
Retinal 58 29
Retinol 53 -
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recovery of retinal was low, it is still adequate to detect and 
quantitate retinal in serum. Accurate quantitation of retinal 
would require improved recovery.
No difference was found in retention time, k ! or 
recovery if air is used instead of nitrogen to dry the residue 
(Figure 12) .
Solubilizing solvent selection
Different solvents were used to dissolve residues of 
retinol and its derivatives after extraction. The k' was 
measured (Table 18) . .
Therefore cyclohexane, dichloromethane, and chloroform 
could all be used, but we chose the mobile phase as the solvent 
to dissolve residue because it gave good Rs between retinal and 
retinoic acid, Rs = 1.6. Other agents failed due to interference 
with solvent peak, or internal standard. The immiscibility of 
some give an artifact peak or produced high pressure. 
Preparation of standard curve for HPLC analysis of retinol and 
its derivatives
0-150 pi of retinol and its derivatives were dried in 
C14/C15 QQ tubes with nitrogen. 200 pi of vitamin-free serum was 
added and equilibrated for 10 minutes. 50 pi of internal 
standard was added, mixed, then 1 ml of chloroform; methanol 
(1:1) containing 50 ug butylhydroxieanisolewas added, shaken for 
15 minutes and centrifuged. The upper layer was transferred to 
empty tubes and dried with air. The residue was dissolved in 100 
pi of mobile phase used for HPLC, vortexed for 15 seconds and 2 0 
pi injected manually on the column.
c«oCN32
-0JD1
9 - 6  3 0
RETENTION VOLUME (ML)
Figure 12: Chromatography of retinol and its 
metabolites drying by air (A) and 
nitrogen (B)
Peak identities as in Figure 11.
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Linearity and sensitivity
The linearity was determined as a function of on column 
sample weight. 20 pi aliquots of aqueous solution of retinol 
over a concentration range of 0-4.5 mg/1 (0-15.7 pmol/1) 
equivalent to 0-90 ng on column weight were studied.
The assay for retinol was linear over the range 0-90 ng 
on column sample weight for extraction from serum with internal 
standard or for directly injected aqueous standard equivalent to 
0-4.5 mg/1 (0-15.7 pmol/1).
Similarly for retinoic acid linearity over a range of 
0-60 ng/ml equivalent to 0-3 mg/1 (0-10.5 pmol/1) was found.
The lowest detectable serum concentrations (defined as a 
signal to noise ratio of 2) was 60 pg/1 (0.2 pmol/1) for retinol 
and 50 pg/1 (0.17 pmol/1) for retinoic acid. The sensitivity was 
equivalent to 1.2 ng retinol and 1.0 ng on column for retinoic 
acid.
Recovery
Solutions of retinol and retinoic acid in serum covering 
the range of 0-3 mg/1 (0-10.5 pmol/1) were analysed. The 
difference in detection response between the extracted and 
directly injected aqueous standard represented the absolute 
percentage recovery (Table 19). Sera of known vitamin A 
concentrations (prepared from vitamin-free serum) to which 
internal standard had been added were assayed and the results 
compared with calibrations to represent relative recovery.
TABLE 19
Absolute %-recovery of retinol, retinoic acid 
and retinal from serum (n = 20)
Compound % Absolute Recovery
x* ±SD %CV
Retinol 91.5
Retinoic Acid 88
Retinal 36
2.3 2.6
2.8 3.3
3.6 10.0
The relative recovery of retinoic acid was 93 + 5.7%, 
retinol was 95.3 _+ 3.7% and retinal 25.7 _+ 3.7%. Recovery of 
retinol and retinoic acid was satisfactory, and although that of 
retinal was poorer, it was considered adequate for further 
studies.
Precision
The precision was assessed by determining retinol and 
retinoic acid in 10 serum extracts at each of 3 different 
concentrations. Within-batch as well as between-batch studies 
were performed (Table 20). *
Precision was considered satisfactory over the concen­
tration range for retinol and retinoic acid, for the within-and 
between-batch samples. All except retinoic acid fell below 6% 
CV.
Accuracy and specificity
The possibility of interference by a number of drugs 
especially those taken by patients during treatment was checked 
by the addition of aqueous solution of drugs to vitamin-free 
serum. The drugs studied were Zinacef, Temazepam, Nitrazepam, 
Tagamet, Amoxil, Flagyl, Genticin , Kefzol, Ampicillin, Nebcin, 
Ceporin, Kannasyn, Penicillin, Cefotaxime Kefzol t Librium,
■ Chlora z a p a t e Ceporex, Oxazepam, Amikin,Clonazapamr Medazepam, 
Diazepam, Gentamicin, (vials and powder). 20 pi samples were 
then analysed on the HPLC column for peaks coinciding with the 
retention time of retinol and its analogues.
Some of those drugs showed peaks eluting late in the 
analyses. None of those drugs examined interfered with the assay 
of retinol and its derivatives.
TA
BL
E 
20
BG
M
G
CO
G•H
•H
O
G
o•H
O
G
• P
P
0)
P
T3
G
G
O
G
• P
P
G
P
GO
co
a)
• p
T3
G
P
co
GO
• P
CO
• P
a
G
P
PUl
l
G
0)
G £ i
6-5 £ a
p p CN r — C O ' — vO vO
> G G • • • • • •
O O rQ -4 " CN UO vO m
1
G
• H £ i .
6-S ,G a
P p G \ 0 0 vO vO ^—
> •r4 G . • • • • •
a s C O C O CN NT < r vO
CO
P
• H
G vO vO m vOi
vO m
■
G 1
o
1
o
l
o
1
o
l
o
1
o
p T— y— y— T— y— T“
G X X X X X X
t—1 CN CTi O O
o • • • • •
s CN m ' t o
G
O
• H
P CO
G p iP
P • H T—1 r P i—! i P t P
P G **--- —^ "yy. 0 0
G G 0 0 0 0 6 0 0 0 0
G e e e & e
a CO VO
G CO m o m m o
o G • • • • • •
o y-H.P o r ~~ CO o ' C O
X3 T)
•P • P
a a O
G G G
X ) a O a
G r—1 iP 1—1 • P • P • H
G o o o O O O
O G G G G G G
eu • H • P • H • P • P • P
6 P P P P P P
o G G G G G G
u pi Pi Pi Pi pci Pi
45 .
2.1.4 Comparison of HPLC and fluorometric methods for retinol
analyses
Sera from 70 healthy fasting adults were analysed by 
fluorometric as well as HPLC methods and the correlation was 
plotted (Figures 13 and 14).
A poor correlation of (r = 0.7) was found, which agrees 
with the results of De Ruyter and De Leenher, (1976). In 
general, it was found that the HPLC method gave higher results 
than fluorimetry.
Discussion
Considerable difficulty was found in developing a method 
of separating retinol, retinal and retinoic acid in serum, whilst 
using retinol acetate as internal standard (IS).
The HPLC described is highly sensitive and linear over a 
wide range. Other workers (Table 5) found that their HPLC 
procedure was less sensitive and linear over only 30% of our 
procedure and there was poor calibration for their method because 
vitamin-free serum was not used. Although De Ruyter and 
DeLeenher (1976) succeeded in separating retinol and its
■ X
derivatives, they failed with retinoic acid, which had a k = 5.2 
and might interfere with retinol (k * = 5.0).
The fluorimetric method is less sensitive and linear 
over only 20% of the range covered by the HPLC procedure, whereas 
the accuracy and sensitivity of the HPLC assay makes the use of 
the technique preferable to the fluorimetric method.
The fluorimetric procedure may be preferred where rapid 
results are required. However, for pharmacokinetic studies it is 
necessary to measure the unchanged drug and its major metabolites
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Figure 13: Correlation between serum vitamin A concentration
measured by fluorometric and HPLC methods in 
control patients
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: Correlation between serum vitamin A measured
by fluorometric and HPLC methods in cancer 
patients.
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in serum. The HPLC method generally gave higher results than the 
fluorimetric. This is surprising in view of the lack of 
specificity of the fluorimetric method, since other compounds 
were also detected. The possible reasons for this were: firstly, 
quenching may have occurred due to haemolysis or other substances 
in serum, which interferes with the fluorimetric method. For 
example, a control sample [(Clinical Chemistry QC (adjusted 
Bovine serum )] Rdien Fraction Centre was measured by both HPLC 
and fluorometric method F = 0.9 _+ 0.2 pmol/1 and HPLC = 2.3 _+ 
0.1 pmol/1. There are peaks other than retinol (Figure 15) by 
HPLC, which may have led to quenching in the fluorometric method.
Secondly, in the fluorometric method, if retinol is used 
instead of retinol acetate as standard, better results are 
obtained (Section 2.1.2.3 ) due to more effective extraction of
retinol than retinol acetate.
Thirdly, retinol and its esters are the only retinoids 
that fluoresce appreciably under normal conditions. Anhydro- 
retinol, retinoic acid and retinaldehyde do not fluoresce in 
conventional assay procedures but may do so at very low 
temperatures or under special conditions (Frolik and Olson 1984). 
So the fluorometric method measures retinol only and ester forms 
present and not total retinoids as was thought before. In 
experiments carriedout on "nutrition" patients (Section 3.2.3) 
retinol palmitate measured by HPLC gave higher results than 
fluorometry which measures total retinol and ester form. There 
may therefore be a saturation concentration for the fluoro­
metric method at which an increase in concentration may not lead 
to an increase in fluorescence.
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Figure 15: HPLC chromatograph of bovine
serum control. Peak identities are:-
1 - carotene
2 - retinol acetate (IS)
3 - unidentified peak
4 - retinol
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Kahan, (1966) found a linear relationship between 
fluorescence and concentration within the range of 0.2 - 300 
pmol/1. The deviation at levels higher than 300 pmol/1 is due to 
concentration quenching.
Phytofluene occurs in common fruits and vegetables and 
the levels in blood vary considerably, reflecting the consumption 
of foods such as tomatoes. The error introduced into the 
determination of vitamin A varies erratically from 20 to 200% and 
the mean elevation has been reported to be 30 pg/100 ml. 
(Thompson et al 1973) . Because of this a correction formula was 
used in earlier methods.
Experience in this laboratory indicates that in order to 
produce acceptable within and between-batch precision, all 
extraction procedures should employ an internal standard.
Many workers referred to before did not use an internal 
standard. The retinol acetate used in this study as IS exhibited 
similar chemical behaviour to retinol and was not found in any 
sera analysed. No previous workers mentioned the occurrence of 
this derivative in serum. It can be resolved from retinol and 
other metabolites on the HPLC column with no interference and is 
also commercially available.
The method presented here gives a simple reliable 
extraction procedure for the rapid determination of retinol and 
retinoic acid in serum. It also separates carotene and retinal 
from these substances but with poor recovery for retinal. This 
method could therefore be used to determine if retinal is 
present but if so a further quantitative method would be
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necessary. So far as is known, the method developed during this 
present study is unique in separating retinol and its derivatives 
in one chromatogram.
2.1.5 Development of an HPLC method for retinol palmitate
Previous workers used different methods to estimate 
retinol palmitate, and in this present work we used two methods, 
either direct HPLC analysis or saponification followed by 
analysis of total retinol.
Allwood (1982) used HPLC with 10 pODS column and 
ultraviolet (UV) detector at 325 nm. He succeeded in analysing 
retinol palmitate from TPN solution over a concentration range of 
0.75-3 pg/ml.
Kishi. et al (1981) used HPLC to determine the stability 
of retinol palmitate in TPN solution, using Hitachi Gel 3011 (4 
mm x 250 mm) column with UV detector at 254 nm.
Dahl (1982) used a reversed phase column (5 pODS) with 
detection at 254 nm. He succeeded in determining retinol 
palmitate in adults as well as infants receiving VitlipidR (Kabi 
Vitrum).
Finally, Hartline and Zachman (1976) analysed retinol 
palmitate by. a modification to the Neeld-Pearson technique (1963) 
using trifluoroacetic acid reagent with hexane extraction in 
place of petroleum ether.
Most of these methods succeeded in analysing retinol 
palmitate. They did not however mention interference of the 
other vitamin A derivatives, due to the fact that if these 
infusions are exposed to light, decomposition of retinol 
palmitate occurs. Allwood, (1982) mentioned the effect of trace
elements as well as amino acids on vitamin A in TPN solutions. 
For analysis of retinol palmitate a minor change in the polarity 
of mobile-phase is needed to the HPLC method we used to analyse 
serum retinol and other derivatives. We could therefore use only 
one system with a switch in polarity for analysis of all retinol 
metabolites.
Direct HPLC analysis of retinol palmitate 
Materials and Apparatus
IntralipidR (Kabivitrum, Stockholm, Sweden); 500 ml 
20% fat emulsion for intravenous use containing 100 g 
fractionated soya bean oil, 6 g fractionated egg phospholipids, 
11.25 g glycerol and water for injection to 500 ml (osmolality 
350 mosmol/kg water); VitlipidR (Kabi Vitrum) , 'adult' 10 ml was 
added aseptically. It is a sterile emulsion in the oil phase of 
an emulsion the same composition as Intralipid; 1 ml of it 
contains retinol palmitate (75 pg), vitamin D (0.3 pg) and 
vitamin k( (15 pg) . Potassium hydroxide, sodium sulphate, 
anhydrous sodium sulphite, isopropanol (BDH Chemicals Ltd, Poole, 
England) and other materials as in Section (2.1.3.2).
Apparatus
As described in the previous section for serum retinol 
investigation.
Methods
Polarity Investigation
Hexane : tetrahydrofuran: formic acid (93:7:0.1) was first 
used, and the polarity was changed by altering the ratio of 
hexane to tetrahydrofurane. K' of the metabolites were studied.
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In general, retinol palmitate eluted with the solvent 
peak. The retention time of retinol palmitate was not altered at 
most polarities (Fig 16). Only with a ratio of Hexane:tetra- 
hydrofuran :formic acid (99:1:0.1) was a successful separation of 
retinol derivatives obtained (Fig 17 Table 21).
Optimised Methods for Direct HPLC analysis of retinol palmitate
The mobile phase consisted of Hexane:tetrahydrofuran 
formic acid (99:1:0.1). The operating conditions were;
temperature ambient. Flow rate 1 ml/min, wavelength 325 nm, 
chart speed 0.5 cm/min Absorbance setting varied depending upon 
the samples injected.
Saponification of retinol esters 
Modification of van de Weerdhof et al (1973)
Nutritional emulsion (Intralipid) as well as standard 
amounts of retinol palmitate and retinol individually were added
(0-6 ml) to a 250 ml round bottomed flask with 50 ml 0.5 N
potassium hydroxide in ethanol and 1 ml of 10% sodium sulphite 
(Na2S03 ) solution. After refluxing for 30 min, the mixture was 
cooled in ice, 100 ml Hexane was added and the mixture was 
transferred into a separating funnel containing 50 ml of l.N 
potassium hydroxide solution and shaken for 10 sec. After 
separation the water layer was rejected. The hexane layer was 
washed with 50 ml IN potassium hydroxide solution and
subsequently three times with 50 ml of distilled water, and then 
dried with sodium sulphate (Na2so4) . it was then filtered, and 
20 pi of filtrate was injected on to the HPLC column.
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Figure 16: HPLC chromatograph showing retinol
palmitate standard (1), eluted with 
solvent peak with different preparation 
of mobile phase eg
93:7:0.1 Hexane:THF:Formic acid
95:5:0.1 Hexane:THF:Formic acid
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Figure 17: Chromatograph of vitamin A metabolites and
standard with mobile phase preparation 
of 99:1:0.1; H:THF:F.ac, peak identities 
are
1 - carotene
2 - retinol palmitate
3 - retinal acetate (IS)
4 - .retinal
5 - retinoic acid
Retinol was eluted at about 60 mins
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Modification of saponification procedure
Because all retinol palmitate was not hydrolysed using 
the above method (Figure 18)
1) Increasing the saponification times up to 2 hour, and
duration of shaking to 1 hour respectively was per­
formed. The concentration of potassium hydroxide (KOH) 
was increased from 0.5 N to 5 N KOH, but these changes 
did not improve efficiency of hydrolysis.
2) Standard retinol palmitate stock solution was prepared
in methanol as well as water.
3) Since retinol was eluted very late with retinol
palmitate HPLC method, Hexane:tetrahydrofuran:formic
acid (93:7:0.1) proportion was used for retinol analysis
following saponification.
Recovery and Linearity
Either retinol palmitate or retinol was added to 
Intralipid 20% emulsion covering the range of 0-2.5 mg/1 (4.8 x 
10“ % ) .  The mixture was saponified and analysed for retinol. 
Results were compared with direct injection of retinol standard. 
Results represent the percentage absolute recovery. The
theoretical calculation of conversion of retinol palmitate to 
retinol is:-
Retinol palmitate  —►Retinol + palmitic acid
1 mmol --------►  1 mmol
524.5 (MW) ------- ►  286.5 (MW)
Therefore 100 pg retinol palmitate produces 55 pg 
retinol after saponification.
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Figure 18: HPLC chromatograph of Intralipid emulsion
after saponification. The mobile phase 
was 93:7:0.1 (Hexane:THF;Formic acid) 
preparation. Peak identities are:-
1 - retinol palmitate in solvent peak
2 - retinol.
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Linearity was determined as a function of on-column 
sample weight by chromatographing 20 pi aliquots of the 
saponified solution of retinol palmitate over a concentration 
0-2.5 mg/1 (0-4.8 x 10” ^M) equivalent to 0-50 ng on-column 
weight.
Percentage absolute recoveries of retinol palmitate from 
standard solutions after saponification were 101% in methanol, 
and 64% in water (Table 22).
Thus, this method is satisfactory for standards and also 
for liver analysis (Section* 2.1.6 ), but is not suitable for
analysis of fat emulsions.
2.1.5.1 Extraction of retinol palmitate from serum
The method optimised in Section 2.1.3.2 for extracting 
retinol from serum was used here to measure recovery of retinol 
palmitate after extraction from serum and nutritional solutions. 
At the same time linearity and precision were studied, as well as 
sensitivity.
The chloroformrmethanol extraction failed to extract 
retinol palmitate fully from nutrition solution (Figure 19) due 
to the presence of large amounts of lipid and two layers formed.
However, the percentage absolute recovery was measured for 
standard retinol palmitate from serum extraction and was compared 
with direct injection on the same amount of retinol palmitate in 
Hexane:tetrahydrofuran:formic acid (99:1:0.1). The absolute 
recovery was 92jH.5% (x + 1SD) and linear over a range 0-0.4 
pg/column (0-38 pmol/1) . Sensitivity, as the lowest detectable 
concentration was 0.1 pmol/1. Precision for three different 
concentrations is shown in Table 23.
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Figure 19: Chromatograph of Intralipid emulsion
after extraction with methanol:chloroform 
(1:1) preparation.
Peak identities are:-
- 1 — unidentified peak in solvent peak
2 - retinol palmitate
TABLE 23
Precision•studies on retinol palmitate 
analysis in serum ( n = 10)
Mass Units Molar Units % CV
200 pg/1 4.9x10~7 5.0
-6
600 jjg/1 1.1x 10 3.7
—6
1.8 m g /1 3.4x10 . 1.5
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2.5.1.2) Measurement of retinol palmitate in fat emulsion (Dahl 
1982)
The amount of retinol palmitate in Intralipid emulsion 
was determined by HPLC, by dissolving the sample in isopropanol 
and injecting directly on the column.
1) An accurate amount of retinol palmitate standard was 
weighed (20 mg) and diluted with isopropanol solution to 
100 ml (solution 1).
2) 1 ml was pipetted from solution 1 and diluted to 100 ml 
with isopropanol as a working standard (solution 2).
3) A standard curve for three solutions was prepared using 
5, 10 or 15 ml from solution 2 diluted to 50 ml with 
isopropanol. This was directly injected on the column.
4) A standard curve for extraction from fat emulsion was 
prepared by pipetting 1 ml from solution (1), plus 10 g
of Intralipid 20% emulsion (with no Vitlipid) which 
was diluted to 100 ml with isopropanol. From this 
solution three different standards were prepared as in 
No. (3) , diluted with isopropanol. (Test injection I) . 
Three different standards were prepared and diluted with 
25.Og Intralipid 20%, diluted to 250 ml with
Isopropanol) instead of isopropanol. A further 1:2
/
dilution was also made.
5) Analysis of test emulsion was carried out by measuring 
1 g of the emulsion diluted to 10 ml with isopropanol. 
To assess recovery standard was added to the unknown
54 .
emulsion. (3). The absolute recovery, linearity, 
sensitivity and precision for four concentrations were 
studied.
Linearity and sensitivity:
The linearity was determined as a function of on-column 
sample weight by chromatographing 20 pi aliquots of retinol 
palmitate over a concentration range 0-2.5 mg/1 (4.8 x 10”  ^M) 
equivalent to 0-50 ng on column weight.
The assay for retinol palmitate was linear over the 
range 0-50 ng on-column -sample weight for extraction of 
Intralipid solutions or for direct injection of standard 
equivalent to 0-2.5 mg/1 (0-4.8 x 10”^M).
The lowest detectable concentration (defined as a signal 
to noise ratio of 2) was 30 pg/1 equivalent to 0.6 ng on column 
weight.
Recovery
Solutions of retinol palmitate in Intralipid covering 
the range 0-2.5 mg/1 (0-4.8 x 10“^M) were analysed. The 
difference in detector response between the standard with 
Intralipid solution and directly-injected aqueous standard 
represented the absolute recovery (Table 24).
Precision
The precision of analysis was assessed by determining 
retinol palmitate in 12 solutions each of 3 different concen­
trations 0.2 mg/1, 0.4 mg/1 and 0.6 mg/1 equivalent to 4.0 x 
10“7 , 8.0 x 10“7 M, 1.1 x 10“6 M) respectively (Table 25).
TABLE 2 4
Absolute % recovery of retinol palmitate 
from TPN solution ( n = 30)
Mass
Units
% (x) ± SD %CV
0.4
(mg/1)
97.7 ± 2.8 2.9
TABLE 25
Precision studies on retinol palmitate 
in TPN solution (n = 12)
Mass Units Molar Units % CV
200 Mg/1 4.0x10~ 7 3.1
400 pg/1 8.0x 10~7 2.9
600 Mg/1 1.1x 10~6 3.2
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2.1.5.3) Estimation of retinol palmitate in liver
Most of the previous workers estimated retinol in liver 
by saponifying retinol esters to retinol and measuring the total.
Olson et al (1979) hydrolysed retinol palmitate in 
liver by grinding with anhydrous sodium sulphate and leaving the 
mixture overnight under chloroform. Aliquots of the chloroform 
extract were then analysed either by spectrophotometric or 
Carr-Price assay. Both methods generally agreed within 8%.
Flores and Aranjo (1984) estimated vitamin A in liver, 
by homogenising the liver samples with 50 vol of 50% glycerol in 
water. Retinol was assayed spectrophotometrically in extracts of 
the non saponifiable lipids of the homogenates.
Table 26 shows some methods of extraction and esti­
mation of vitamin A in liver.
Most of the methods measured total vitamin A in the 
liver. In our studies we attempted to estimate retinol 
palmitate, retinol and total vitamin A by three different 
methods.
Sample preparation for retinol palmitate measurements (Bhat & 
Lacroix, 1983)
The specimen of liver was washed with cold phosphate- 
buffered saline and lyophilized overnight. The lyophilized liver 
v/as ground to a powder with a pestle and mortar and extracted 
with 20 ml 99% methanol per gm tissue and then with 50 ml of 
hexane per gm tissue. The methanol and hexane extracts were 
evaporated separately and the residues were combined after 
redissolving in Chloroform:Methanol (1:1). An aliquot was taken 
and injected on HPLC.
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1) The procedure was standardised by adding a known amount
of retinol palmitate to 1 g of liver tissue from vitamin 
A-deficient rats (Section 3.3.2.1) and taken through the 
entire procedure of lyophilization, extraction and 
estimation on HPLC.
2) The residue was dissolved in 10 ml/g tissue eluant
before injection.
Results
Absolute recovery of the above method was 62% (58-65%) 
but if a standard was dried.down under nitrogen then added to 
the homogenized liver, lyophilized and extracted, absolute 
recovery was 76% (70-80%) for a concentration range 0-36 ng 
on-column. If vitamin C and EDTA was added before lyophilization, 
recovery was 73% (70-75%) when another solvent was used instead 
of methanol/hexane to extract tissue, eg isopropanol, or mobile 
phase (H:THF:Fac) proportion of (99:1:0.1), the mean recovery was 
70% and 75% respectively. These recoveries were regarded as 
unsatisfactory, the losses probably being associated with the 
lyophilisation.
Modified method, without lyophilisation
This procedure was standardised by adding a known amount 
of retinol palmitate to several mg of liver tissues equilibrated 
10 min, homogenized, extracted with hexane:tetrahydrofuran:formic 
acid (99:1:0.1), shaken for 15 min and centrifuged at 2000 rpm. 
The supernatant was dried with air at 37°C. The residue was 
dissolved in a known amount of mobile phase, and 20 pi was 
injected on column. Dried liver can be used if the liver amount 
is small and treated as above.
.57.
HPLC Method
Hexane: tetrahydrofuran :formic acid (99:1:0.1) was used 
as mobile phase on a silica column for estimation of retinol 
palmitate.
Recovery
A solution of retinol palmitate covering the range 0-54 
mg/1 (0-2.7 mg/g) was analysed. The difference in detector 
response between the standard and the directly-injected aqueous 
standard solution represents absolute recovery. The mean 
recovery of 30 samples was 101.3 2.4% with a CV of 2.4%.
Linearity
The linearity was determined over a range of 0-54 mg/1 
(0-2.7 mg/g) equivalent to 0-1 pg on column. The assay for 
retinol palmitate was linear over the range, for extraction from 
homogenate solution or for direct injection of aqueous standard 
equivalent to 0-54 mg/1.
Precision
The precision was assessed by determining retinol 
palmitate in 10 liver extracts at each of 3 different concen­
trations 300 pg/g , 600 pg/g and 900 pg/g, which were prepared 
from the liver of vitamin A-deficient rats by addition of 
standards (Table 27).
TABLE 27
PRECISION STUDIES ON RETINOL PALMITATE IN LIVER
Measured retinol palmitate 
in liver
CV %
300 pg/g 4.9
600 pg/g 1.7
900 pg/g 1.5
58.
2.1.6) Estimation of total retinol in liver (Van de Weerdhof,
et al 1973
This was performed by saponification followed by 
measurement of total retinol.
Mean absolute recovery of added standard was 99.8% and 
linearity for retinol palmitate was satisfactory over a range of 
0-120 ng on-column weight (0-6 mg/g wet tissue).
Precision
The precision was determined by measurement of three 
different concentrations of retinol palmitate after saponifi­
cation. (Table 28).
2.1.7) Estimation of free retinol in liver.
The method was similar to that for serum retinol 
(Section 2.1.3.2) except that 5 ml of chloroformsmethanol (1:1) 
was used instead of 1 ml and 20 pi was injected. Dried liver can 
also be used.
Recovery
Solutions of retinol covering the range 0-4.5 mg/1 (225 
pg/g) were added before homogenisation, the difference in 
detector response between the standard and the directly-injected 
aqueous solution representing absolute recovery. The mean 
recovery of 20 analyses was 86.7% + 3.6 with a CV of 4.1%. 
Linearity
The linearity was determined over a range of 0-90 ng on- 
column weight equivalent to 225 pg/g.
The assay was satisfactory over that range.
\
Precision
The precision was assessed by determining retinol in 10 
preparations at each of three different concentrations, 37.5 
pg/g, 75 pg/g and 150 pg/g (Table 29).
Discussion
The major vitamin A derivative found in Intralipid 
emulsion containing Vitlipid (fat soluble vitamins) as well as in 
liver was retinol palmitate. To follow changes of vitamin in 
these solutions or tissues it was therefore necessary to develop 
a method for analysis of this metabolite.
Van de Weerdhof et al (1973) estimated vitamin A in food 
by converting the ester forms to retinol by saponification. A 
modification of this method was used in this study, with 
application of the high performance liquid chromatography method 
used for serum retinol measurement.
When the standard was analysed by this method it gave 
high sensitivity and linear results over a wide range and with 
virtually 100% absolute recovery when dissolved in alcohol and 
64% when dissolved in distilled water. The recovery from 
Intralipid emulsion was poor using this method. This method is 
therefore satisfactory to measure total retinol, which is 
produced from esters after saponification. For estimation of 
stability and delivery of retinol palmitate in this emulsion
after exposure to light, and investigation of the appearance of
\
any other compound during exposure to light, a more specific 
method is needed.
TABLE 28
PRECISION STUDIES ON TOTAL VITAMIN A IN LIVER (n
Measured total vitamin A
2 mg/g 
4 mg/g 
6 mg/g
2.3
TABLE 29
PRECISION STUDIES ON FREE RETINOL IN LIVER (n =
Measured free retinol 
in liver
CV %
37.5 pg/g 4.7
75 pg/g 4.2
150 pg/g 4.1
An investigation was carried out to find a method for 
extraction and estimation of retinol palmitate in this emulsion. 
The hexane: tetrahydrofuran:formic acid proportion of (99:1:0.1) 
was the best mobile phase to elute retinol palmitate. This 
solvent, which is less polar than that used in the HPLC method 
for serum retinol estimation was found to be satisfactory in 
terms of sensitivity, and absolute recovery. Around 100 samples 
can be measured per day, because each sample takes only 5 minutes 
to elute.
Retinol palmitate could be estimated in serum also, with 
an absolute recovery of 92 +_ 1.5% and the procedure was sensitive 
and linear over a wide range. This method can therefore be used 
to follow clearance of retinol palmitate from serum following 
oral or intravenous delivery.
Bhat and Lacroix (1983) extracted retinol palmitate and 
other esters from liver after lyophilisation and quoted approxi­
mately 85-95% recovery, whereas we only obtained a mean of 76% 
recovery using this method.
An investigation was carried out to find a good HPLC 
method for estimation of retinol palmitate in liver. The HPLC 
method described earlier gave a good absolute recovery 101.3 _+ 
2.4% and was highly sensitive and linear over a wide range (0-2.7 
mg/g). Although this method gave a separation of all the retinol 
derivatives, the retinol peak eluted very late (60 min after 
injection) . It was therefore necessary to use a separate method 
to measure retinol in liver extracts.
Van de Weerdhof et al (1973) method was used to estimate 
total vitamin A and the serum retinol procedure was used to 
estimate free retinol in liver with absolute recovery 99.8% and 
86.7 +_ 3.6% respectively.
Using these three methods we could therefore estimate 
total vitamin A, retinol palmitate, retinol and by the difference 
the other retinol esters. These methods could be used in fat 
emulsion or liver. All of these analyses can be performed using 
one apparatus with different extraction techniques and different 
polarities of the eluant.
2.1.8 Other biochemical measurements
1) Retinol-binding protein (RBP)
RBP was measured on Radial Immunodiffusion (RID) plates 
(Behring-werke) . Standard human serum (ORDT 02/03) (Behring- 
werke) was used with dilution. This method could detect RBP 
levels down to 5 mg/1. The normal range was 30-75 mg/1.
2) Prealbumin (PA)
PA was measured by RID in a similar way to RBP. This 
method could detect PA levels down to 30 mg/1. The normal range 
was 100-400 mg/1.
3) C-reactive protein (CRP)
C-RP was measured on the Abbott TDX Analyser by a 
fluorescence polarisation method. All reagents, standards and 
controls were supplied by Abbott laboratories. Minimum sample 
volume is 50 ul. The linearity of the method is from 0-250 mg/1. 
Higher concentrations required predilution in saline. The 
reference range is < 10 mg/1 .
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4) Transferrin
Transferrin was measured by a turbidimetric method on 
the Encore Centrifugal Analyser. The antiserum used was sheep 
Anti-transferrin supplied by the Scottish Antibody Production 
Unit (used at 1:40 dilution). The calibrator was calibrator 1 
(human serum) supplied by Atlantic Antibodies. The sample was 
prediluted 1:25 in 4% polyethylene glycol (PEG) in saline and the 
calibrator was prediluted 1:40 in 4% PEG in saline and a standard 
curve was prepared to cover the range 0.25-5.0 g/1. Samples and 
standards were spun for 10 min at 3000 rpm. The pipettor 1000 
was used to pipette prediluted sample or standard (10 pi), 
antiserum (250 }j1) and diluent (50 pi) prior to analysis. 
Reference range 2.0-4.0 g/1.
5) Cholesterol
A kinetic colorimetric test (CHOD-PAP Method) 
(Boehringer Mannheim) was used to measure cholesterol on a 
centrifichem analyser (Baker).
6) Triglycerides (TG)
Triglyceride was measured by a fully-enzymatic colori­
metric test (Merckotest). Triglycerides were hydrolyzed 
enzymatically to glycerol and free fatty acids by a special 
combination of lipases. The glycerol was measured enzymatically 
on a Centrifichem analyser and is proportional to the total 
triglyceride concentration.
7) Vitamin E
Plasma vitamin E was measured by a modification of the fluoro- 
metric method of Kahan (1966), and Thompson et al (1973). D-c(- 
tocopherol was used as standard (concentration 25 umol/1) with 
excitation wavelength 300 nm, and emission wavelength of 326 nm.
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3) RESULTS
3.1) GENERAL STUDIES ON SERUM RETINOL
3.1.1) Relation to time of day
The variation of serum retinol and retinol-binding 
protein were studied in 9 females, 10 males in relation to the 
time of collection at Glasgow Royal Infirmary. Volunteers aged 
19-43 were studied, weight 48-83 kg and heights 159-185 cm. The 
blood samples were collected at 8 am, 12 noon, 2 pm, 5 pm and 10 
pm. Samples correspond to after overnight fast; before and after 
lunch and dinner. The plasma was separated immediately and 
stored at -20°C until retinol and retinol-binding protein were 
analysed.
Table 30 shows that no significant difference in serum 
retinol levels have been found before and after ingestion of a 
normal meal (ie between 8 am and 12 noon, and 12 noon and 2 pm) . 
However, there was a highly significant difference (p < 0.001)
between paired 8 am and 10 pm samples (mean difference 0.23
pmol/1) . The regression coefficient for 8 am and 10 pm samples 
was r = 0.97. Figure 20 shows the correlation between serum 
retinol and RBP at 5 pm (r = 0.8).
Discussion
It can be concluded that for individuals on a normal 
oral diet the time of collecting the blood specimen for retinol 
analysis must be carefully controlled. However, the effect of a 
meal on serum retinol can largely be ignored. Serum retinol 
levels measured by HPLC did not change after a normal or high 
oral dose of retinol palmitate (Section 3.2.3). These results 
also confirm that it is not necessary to collect specimens from
TABLE 30
SERUM RETINOL AT DIFFERENT .TIMES DURING THE DAY 
(MEAN ± 1 SD) n = 19
Time 8 am 12.00 2.00
pm
5.00
pm
10.00
pm
Mean
jjmol/1 3.1 3.1 3.0 3.0 2.9
SD 0.94 0.92 0.94 0.89 - 0.77
SE 0.22 0.21 i 0.22 0.21 0.18
%CV 30.9 29.6 , 30.9 29.9 26.8
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Figure 20: Correlation between serum retinol and retinol- 
binding protein in volunteers
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patients in the fasting state. In all future studies every 
effort was therefore taken to obtain specimens from patients in 
the morning.
3.1.2) Normal Range
A random sample of 70 persons with no known ill health 
and between the age range 40-86 born in the Eastern District of 
Glasgow were studied (Section 3.3.1.1). A fasting sample of 
blood was taken from them and serum retinol measured (Table 31).
From this it was concluded that the reference range for 
males is approximately 1.2 - 5.6 pmol/1 (mean + 2 SD) and 1.3-4.5 
pmol/1 in females.
3.1.3) Stability of serum retinol
Venous blood samples were obtained from 3 healthy 
laboratory staff members, who had been previously found to have 
low, medium and high serum retinol concentration. The serum was 
kept at -20°C for up to 3 months. Each week the samples were 
thawed and serum retinol was measured by HPLC. Table 32 shows 
the precision of 30 analyses of each pool over the 3 month period 
and there was no change in concentration from the first week 
(0.4, 1.4, 3.8) to last week (0.4, 1.3, 3.7).
In the past the stability of retinol in frozen serum or 
plasma samples has been assessed primarily in samples stored in 
the dark for less than a year. The results obtained are 
dependent on the methods used for analysis (Table 33).
On the other hand, other factors may affect the 
stability eg temperature of storage, the volume of the sample 
since the larger the volume, the better is vitamin A stability 
Frolik and Olson (1984), handling and storage condition, and the
TABLE 31
SERUM RETINOL FOR NORMAL SUBJECTS (mean ± SD)
Subjects No. of subjects Serum retinol 
(jjmol/1)
Total 70 3.2 ±.0.9
Male 27 3.4 ± 1.1
Female , 31 2.9 ± 0.8
TABLE 32
STABILITY OF SERUM RETINOL (jjmol/1)
Concentrat ion First week Last week Mean CV %
Low 0.4 0.4 0.4 7.0
Medium 1.4 1.3 1.3 3.4
High 3.8 3.7 3.8 4.1
ST
AB
IL
IT
Y 
OF
 
SE
RU
M 
RE
TI
NO
L 
IN
 
PR
EV
IO
US
 
S
T
U
D
I
E
S
C
o
m
m
e
n
t
no
 
c
h
a
n
g
e
 
no
 
c
h
a
n
g
e
h
ig
h
e
r
20
%
 
d
e
c
re
a
s
e
(J 
G 
B
ie
r
i,
 
p
e
rs
o
n
a
l 
c
o
m
m
u
n
ic
a
ti
o
n
)
CO
CO 43
44 P
CD d
CO CD o
43 & 6
P
CD d i—1 m
6 0  Hd o cD ft •
cD o g P CD 00p  *H CD CD I
o  p t o > £ m
P  CD • CD *
CO ft CO CO
CD
P
d
P
cD
p
CD
f t  /—ve u o O O o0) o CM CM CM CM
H 1 1 1 1
U
ftft
P3
CD
CD CO
T3t CD cD
CD d CD 43
CO CD O ft
d CD •H
CO P CD
T3 CD f t CO &
O P 1 P
43 O P CD 43
P d P > P
CD i—i cD CD •H
s f t U P
vO i-H CTi
cD n-
OV O o vT— V
TJ
(3
cD vO cD .-4
vO cD
P C \ d
CD T--- O P
CO CD
p ft d
o CD d «H  CM •H
43 CO cD f t  r - . P
P CO 43 P cn <D
d CD CD cD -1— •Hft ft ft ft
freezing and thawing procedure. Kark et al (1981) reported that 
up to 12 cycles of freezing and thawing did not influence plasma 
retinol as measured by trifluoroacetic acid method (Neeld and 
Pearson, 1963). In our study (Figure 21 ) we did not find any 
change during a 3 month period of repeated freezing and thawing 
and hence further samples were stored under these conditions.
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Figure 21: Stability of serum retinol in 3 human pools
stored for 3 month periods.
3.2) NUTRITIONAL STUDIES
3.2.1) Stability of retinol palmitate in Intralipid solution 
(20%)
VitlipidR (10 ml) containing retinol palmitate (750 
pg/10 ml) was added to 500 ml Intralipid (20%) under aseptic 
conditions. Care was taken during preparation to protect the 
contents of the Intralipid bottle from exposure to daylight. An 
administration set (Transcoden Lensahn, W Germany) with 15 pm 
filter and air inlet was connected and adjusted to deliver 50 
ml/hour. The bottle was hung from a stand, 1 metre above ground 
level. The bottle was exposed to daylight, 0.45 metre from north 
facing windows. The experiments were started at 9 am and were 
organised in the period September and October. Samples were 
collected at 2 hour intervals into glass bottles. The last 
sample was allowed to stand in daylight and was further sampled 
at intervals to 168 hours.
Separate bottles of Intralipid 20% emulsion containing a 
similar amount of retinol palmitate were prepared. One was 
covered with a black plastic bag and stored at room temperature, 
and the other was kept in the dark at 4°C. They were sampled at 
similar times to the above. Solutions were analysed for retinol 
palmitate by the optimized HPLC method described previously 
(Section.2.1.5.2 ). 1 g of each mixture was dissolved in 10 ml
isopropanol. | The experiment (3 bottles/experiment) was repeated 4 times0 
Results
A typical result of the retinol palmitate content in Intralipid 20% emulsion 
exposed to daylight is shown in Figure 22. At 24 hour, 40% of 
retinol palmitate had been lost, whereas by 168 hours only 20%
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Figure 22: Stability of retinol palmitate in Iritralipid
emulsion for one week at 4°C (A ), room temperature 
(* ) or in sunlight (+ ).
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remained. When it was stored at room temperature and protected 
from daylight, or stored at 4°C, there was no significant loss of 
retinol palmitate after 24 hours. Storage in the dark at room 
temperature for one week led to loss of almost 20%. Repetition of 
the study gave virtually identical results.
Discussion
The stability and delivery of retinol palmitate in these 
emulsions was studied for one week using the HPLC procedure. It 
was found that after 24 hour of exposure to daylight 60% of 
retinol palmitate was still present.
Allwood (1982) using 3 L bags found only 7% retinol 
palmitate was delivered, assuming that infusion (100 ml/hour) was 
exposed to 12 hours daylight, followed by 12 hours darkness, with 
distance of 0.3metres from windows. In his study, with the same 
conditions as above except that a shade was put in the window, 
only 51% of retinol palmitate was delivered. Rates of 
degradation would be influenced by the flow rate which determines 
the exposure time. Other factors also may affect degradation, eg 
time of day, direction of the light, weather condition, location 
of the hospital, the amount of daylight exposure in the ward and 
the time of year. Our experiment was carried out in September 
and October, while Allwood carried his out in May and July.
He estimated retinol palmitate by adding Multibionta 
(BDH) solution to 3 L bags (1000 pg/1) , while we estimated 
retinol palmitate by adding VitlipidR (Kabi Vitrum) to 500 ml 
Intralipid 20% emulsion with concentration 1500 pg/1. Both 
studies confirmed that an emulsion stored at room temperature and 
protected from daylight, or at 4°C did not lose any significant 
retinol palmitate over a 24 hour period.
68.
Riggle and Brandt (1986) found that the decrease of 
available retinol in parenteral nutrition solutions was not due 
to photodecomposition. The decrease was due to uptake by the 
tubing, which was dependent on flow rate. A mean decrease of 26 
to 67% was seen if flow rate was changed from 75 ml/hour to 10 
ml/hour. In their study they used retinol, whereas recently 
Gutcher et al (1984) have suggested using the retinol palmitate 
form of vitamin A as a means of circumventing these losses. 
However, Kishi et al (1981) also using retinol palmitate demon­
strated 50% loss of vitamins, which was controlled partially by 
protecting the bag from light. In this study we used retinol 
palmitate and the loss is undetectable if stored at room 
temperature or 4°C for 24 hours.
3.2.2) Clearance of IV retinol palmitate from venous blood
Three patients receiving IVN, had the Intralipid 20% 
infusion, containing Vitlipid, commenced at 1 am and completed at 
9 am. Blood samples were collected at 9 am, 11 am and 1 pm. 
Serum retinol and retinol palmitate were measured by HPLC, while 
total vitamin A was measured by fluorimetric method. Triglyceride 
was measured as well in these three patients. Table 34 shows 
the results.
Discussion
Table 34 shows that retinol palmitate given intra­
venously is cleared from the blood sample after about 2 hours 
from the end of the infusion. Serum retinol levels did not change 
during infusion, although the total vitamin A shows a change at 9 
am. At the same time serum triglyceride shows a high value at 9 
am. It can be concluded that for measurement of serum retinol
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levels by the fluorometric method in patients treated with 
intravenous infusion, samples should be taken 4 hours after 
infusion of fat emulsion, so that there is minimal interference 
due to triglyceride or retinol palmitate.
3.2.3) Clearance of orally ingested retinol palmitate
In this study 6 normal male subjects age range between 
28-63 arrived on a Sunday evening to GRI and were fasted until 
next morning. Blood samples were taken from the subjects early 
in the morning then a meal was given consisting of:
380 ml full cream 
20 ml granulated sugar 
20 ml dried milk 
40 ml flavourite syrup
300,000 units of retinol palmitate (Crusha) , equal to 
160 mg/1 = 558.4 pmol/1.
The formula diet was made to one pint with distilled 
water, which was drunk within 15 minutes. Two hours after the 
meal, blood samples were taken and then after each two hours 
until 8 hours, or 10 hours. Normal hospital food was taken at 4 
hours and 8 hours and a further blood sample was taken after 24 
hours.Serum retinol and retinol palmitate were measured by HPLC 
and total retinoids by fluorimetry, as well as triglyceride and 
retinol-binding protein (RBP).
Results
The retinol palmitate and retinol concentration in serum 
by HPLC as well as total retinoid concentration by fluorimetry 
and triglyceride concentration are illustrated in Figure 23-28 
for each subject.
Figure 23: The change in serum (1) total retinol (violet)
by fluorometry; (2) retinol (black); (3) Retinol 
palmitate (green) by HPLC and (4) Triglyceride 
(red) after an oral dose of 300,000 IU of retinol 
palmitate in a fatty meal.
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Figure 24: The change in serum (1) total retinol (violet)
by fluorometry; (2) retinol (black), (3) Retinol 
palmitate (green) by HPLC and (4) Triglyceride 
(red) after an oral dose of 300,000 IU of 
retinol palmitate in a fatty meal.
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Figure 25: The change in serum (1) total retinol (violet)
by fluorometry; (2) retinol (black); (3) retinol 
palmitate (green) by HPLC and (4) triglyceride 
(red) after an oral dose of 300,000 IU of 
retinol palmitate in a fatty meal.
Subject 3
VI
TA
MI
N 
A 
(U
MO
L/
L)
14-
10 -
.2
0 3 6 9 12 15 18 21 24 27
TIME (HRS)
TR
IG
LY
CE
RI
DE
 
(M
MO
L/
L)
Figure 26: The change in serum (1) total retinol (violet)
by fluorometry; (2) retinol (black); (3) retinol 
palmitate (green) by HPLC and (4) triglyceride 
(red) after an oral dose of 300,000 IU of 
retinol palmitate in a fatty meal.
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Figure 27: The change in serum (1) total retinol (violet)
by fluorometry; (2) retinol (black); (3) retinol 
palmitate (green) by HPLC and (4) triglyceride 
(red) after an oral dose of .300,000 IU of 
retinol palmitate in a fatty meal.
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Figure 28: The change in serum (1) total retinol (violet)
by fluorometry; (2) retinol (black); (3) retinol 
palmitate (green) by HPLC and (4) triglyceride 
(red) after an oral dose of 300,000 IU of retinol 
palmitate in a fatty meal
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It can be seen that retinol palmitate increased in each 
subject with the peak concentration reached by 8 hours. In one 
subject in whom further samples were taken there was a second 
peak of retinol palmitate after 12 hours.
Serum retinol levels measured by HPLC remained 
unchanged following a dose of retinol palmitate in all subjects. 
The total serum retinoids measured by fluorimetry followed that 
of retinol palmitate peaks for each subject except that the 
concentration was lower than expected from the HPLC results.
The figures also show that triglyceride increased 
rapidly and reached a peak after 6 hours. It then dropped 
sharply at 8 hours and reached the starting concentration in all 
subjects by 24 hours.
Discussion
Vitamin A is a lipid soluble micronutrient. The factors 
affecting its transport and absorption in the small intestine 
have been summarised in Sections 1.3 and 1.4.
In lymph, Vitamin A appears as retinyl ester, while in 
plasma over 90% of vitamin A occurs as retinol. Immediately 
after a dose of retinol palmitate and when chylomicron floods the 
circulation, there is a substantial increase in the retinyl ester 
(Goodman et al 1965) . The ratio of esterralcohol is rapidly 
restored to fasting levels as the tissues, particularly the 
liver, take up the newly absorbed vitamin (Underwood, 1974). Thus 
for a short time, which was found to be approximately 8 hours, 
retinyl esters bound to lipoprotein enter the blood stream via 
the lymph appearing in plasma. Then they find their way into 
tissues where they are stored. On the other hand, absorbed
triglyceride in the lymph also appears in chylomicrons (which are 
very small particles composed of a core of triglyceride, with an 
outer film of phospholipid, cholesterol and protein). In some 
subjects, retinol palmitate and cholesterol began to increase in 
serum after triglyceride. Chylomicron catabolism is normally a 
rapid process that proceeds in at least two phases; one is to 
activate enzyme lipoprotein lipase, leading to the hydrolysis of 
chylomicron core triglycerides. This phase of chylomicron 
metabolism takes place at the surface of capillary endothelium of 
extrahepatic tissues. The hydrolysis of triglyceride results in 
shrinkage of the chylomicron core and transfer of redundant 
surface components into HDL (Goodman and Blaner, 1984). The long 
process of chylomicron metabolism leads to the formation of a 
smaller spherical lipoprotein particle called a chylomicron 
remnant (Redgrave, 1970). The remnant is depleted in 
triglyceride and more enriched in cholesteryl ester, phospholipid 
and protein. Hazz and Bierman (1976) found that these remnants 
are also relatively enriched in vitamin A, which may explain why 
triglyceride falls before vitamin A. This may also be due to 
quicker absorption, hydrolysis and re-esterification of tri­
glyceride than vitamin A.
Serum retinol and retinyl esters are transported by 
separate carrier proteins. (Ganguly et al 1952). RBP shows no 
change after an ordinary meal or high oral dose of retinol 
palmitate, because it correlated with retinol which did not 
change during the study (HPLC) over the 24 hour period.
It is particularly interesting to us that the serum 
retinol did not change, despite the large increase in serum 
retinol palmitate. This is presumably due to the rapid uptake 
and storage of retinyl esters by the liver in the post absorptive 
period.
Mejia et al (1984) indicated that up to 4 hours after a 
vitamin A-rich meal, there was no significant difference in serum 
concentration of retinol, RBP and carotenoids. Although retinol 
palmitate was not measured in his study, our results agreed with 
this finding. It is possible that after ingesting a meal, the 
rate of gastric emptying was not fast enough to provide at one 
point an amount of retinol for intestinal absorption, sufficient 
to cause a detectable change in the serum concentration of the 
vitamin.
Kasper et al (1979) found in an experiment carried out 
on female subjects that total vitamin A concentration reached a 
peak 3 to 7 hours after oral administration of 300,000 IU (160 
mg/1) of retinol palmitate. The time depended on the type of 
fibre added to the diet formula. Dietary fibre appears to 
increase the rate of absorption of retinol palmitate. When no 
fibre was added, a similar rate of absorption was found as in our 
study.
Retinol and its esters are the only naturally-occurring 
retinoids that fluoresce appreciably under normal conditions. 
Goodman and Leslie (1972) suggested that when retinol is attached 
to specific proteins in plasma such as retinol-binding protein 
(RBP) the fluorescence is much enhanced. Because retinol 
palmitate does not bind to RBP there is no increase in
fluorescence. Moreover, retinol acetate which is used for 
standardisation of the fluoresence assay, may fluoresce better 
than retinol palmitate. This may explain why serum levels of 
retinol palmitate measured by HPLC are higher than serum levels 
of total vitamin A measured by the fluorimetric method.
3.2.4) Studies on patients 
3.2.4.1) Home TPN (IVN)
A number of patients require IVN at home as a result of 
major intestinal resection or severe inflammatory disease leading 
to malabsorption. A register of such patients in the United 
Kingdom is kept at the Department of Surgery, Hope Hospital, 
Salford. As part of a review of the micronutrient status of 
these patients samples were requested from the consultants in 
charge of patients in various parts of the country. These 
patients are an interesting group to study, not only because they 
have been maintained on artificial nutrition for prolonged 
periods, but also because they are not acutely ill, the effect of 
any acute phase reaction on measurements should be small. We 
therefore measured plasma retinol, retinol-binding protein, 
albumin and C-reactive protein (CRP) on 20 of these patients, 
and related this to the vitamin A intake and duration of 
nutritional support. These patients were supplied with IVN from 
local hospital pharmacies or a commercial company (Travenol) . 
Some patients had a small amount of oral intake. Intravenous fat 
soluble vitamins were given eg 'Multibionta' infusion 590 0 ug of 
retinol palmitate, and was provided daily for most patients, or 
as Vitlipid Adult infusion 750 pg ranging from daily - twice per 
week. Table 35 shows the amount given (pg/day) for each patient.
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Result
The mean plasma level for retinol (3.4 2.2 pmol/1) was
not significantly different from a normal population (3.2 + 0.9 
pmol/1) (Figure 29). Five patients had high levels between 5.9 - 
8.5 pmol/1; six patients showed low levels between 0.3 -1.6 
pmol/1. Figure 30 shows the lack of correlation (r = 0.2) 
between serum retinol levels and the amount of vitamin A which 
had been taken (pg/day).
RBP and albumin were measured as an assessment of 
protein status to show the relation to vitamin A status. Figure 
31 shows the correlation between RBP and serum retinol (r = 
0.98) . The mean level of albumin was 33.5 +_ 7.0 g/1 and there
was a poor correlation (r = 0.2) with RBP (Figure 32).
C-reactive protein (CRP) was measured and there was no 
correlation between CRP and serum retinol or RBP (r = 0.1 and r = 
0 .01) respectively, while there was a negative correlation 
between CRP and albumin (r = 0.6). These results are incon­
clusive because only one patient had a significantly elevated CRP 
(> 50 mg/1). This patient had a low serum retinol, RBP and 
albumin.
Discussion
The relationship between retinol and RBP is discussed in 
Section 1.4. Patients with high levels of serum retinol show 
also high RBP levels, although two of these patients received as 
little as 214 pg/day and 750 pg/day intravenous vitamin A. There 
was a good correlation between serum retinol and RBP (r = 0.98). 
There was no correlation with albumin. Figure 30 shows a poor 
correlation between vitamin A intake/day and plasma retinol. This
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Figure 29: Serum retinol in normal individuals and
patients on home IVN
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Figure 30: Correlation between vitamin A intake and serum
retinol in home IVN patients
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Figure 31: Correlation between serum retinol and retinol-
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Figure 32: Correlation between albumin and retinol-binding
protein in home IVN patients.
is presumably because vitamin A is stored in the liver, so the 
amount which has been taken should not be the same as that 
released from the liver. Four of the six patients who had low 
levels of plasma retinol were not receiving intravenous vitamin A 
supplements, and two were receiving only 214 and 750 pg/day 
intravenously. These patients also had low serum RBP, albumin 
concentration, two having concentrations of RBP and albumin (7,13 
mg/1, and 18,34 g/1) respectively. Perhaps, the plasma retinol 
was a reflection of protein depletion rather than retinol 
deficiency, or this may due to net protein catabolism in response 
to infection.
During the acute phase response, which is observed 
within hours or days after the onset of infection or inflam­
mation, the liver dramatically increases the synthesis of certain 
proteins, whereas albumin synthesis is reduced (Dinarello, 1984) . 
One of the proteins increased is C-reactive protein, which begins 
to rise very rapidly soon after injury (Kushner, 1982). Pepys 
and Baltz, (1983) found that CRP can rise from <10 to 200 mg/1 in 
inflammation. Approximately 50% of the home IVN patients had a 
normal CRP (< 10) implying no inflammation and the rest were 
slightly higher with the range 11-71, but only one had a high 
concentration indicating acute inflammation.
The lack of correlation between CRP and RBP/retinol or 
albumin reflects the small range of CRP concentration. Therefore 
retinol concentrations are probably not affected by an acute 
phase reaction in these patients, and these concentrations 
therefore indicate protein nutritional status as well as vitamin 
status. Most of these patients studied had normal serum albumin,
suggesting good protein status, although other markers of protein 
status, eg skeletal muscle may be helpful. Serum retinol in 
these patients was therefore probably a reasonable marker of 
vitamin A status.
The low serum retinol in some patients may also be due 
to inadequate supplement of vitamin A orally, leading to poor 
absorption. Ten of the patients, 4 oral and 6 IV, had been given 
less than the vitamin A daily intake recommended by HMSO (UK) 
1979 (750 pg) or RDA by NA of Sciences (USA) 1980, (1000 pg) and 
50% of these patients had levels of serum retinol below the 
normal range. It is interesting how many patients received high 
intakes of vitamin A in comparison with the RDA. Although there 
was no correlation of plasma retinol with level of input, none of 
the patients with an intake of > 2000 pg/day had a low serum 
retinol concentration. As far as we know none of these patients 
had any clinical evidence of vitamin A toxicity. Further studies 
on liver biopsies would be necessary to clarify the adequacy of 
vitamin A status in these patients.
3.2.4.2) Determination of serum retinol in surgical patients
receiving nutritional support
Ten surgical patients, 4 male and 6 female, mean age 47 
years, range 17-72, received nutritional support before and after 
operation. Five patients were fed intravenously according to a 
standard regimen, throughout treatment. The average daily intake 
was 3000 ml containing 14 gm N and 30 00 kcal (2000 kcal carbo­
hydrate/1000 kcal fat). The infusion was provided with all water 
soluble nutrients (except vitamins) in a 3 L bag over 24 hours, 
together with a separate infusion of Intralipid 20% (500 ml) 
containing 1 vial SolivitoR (water-soluble vitamins) , and 1 vial 
VitlipidR (fat-soluble vitamins) which was given over 8 hours. 
2500 IU (750 pg) retinol palmitate were provided each day. Four 
patients received enteral nutrition orally, with different 
amounts of tube feed. One patient received a combination of IVN 
and enteral nutrition at different times.
The duration of the study was 2 months - 3 years. 
Nutritional assessment included regular (every 1-2 weeks) 
measurement of transferrin, albumin, RBP, serum retinol and body 
weight. CRP was measured for 7 patients only (Figures 33-42; 
Tables 36 and 37) .
Discussion
In plasma, retinol is transported bound to RBP in a one 
to one molar relationship. RBP is a serum protein with a short 
biological half-life and serum levels of retinol appear 
intimately associated with the capacity of the liver to synthesis 
RBP and hence mobilise vitamin A stored in the liver (Ingenbleek
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Figure 33: Patient 1. The change in serum
1) RBP (black)
2) Albumin (violet)
3) Retinol (blue)
4) Transferrin (red)
5) Body weight (green)
6) CRP (brown),
prior to surgical operation
IVN = intravenous nutrition
Op = operation
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Figure 34: ‘ Patient 2. The change in serum:
1) RBP (black)
2) Albumin (violet)
3) Retinol (blue)
4) Transferrin (red)
5) Body weight (green)
6) CRP (brown)
before and after surgical operation
IVN = intravenous nutrition
Op = operation
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Patient 3. The change in serum
1) RBP (black)
2) Albumin (violet)
3) Retinol (blue)
4) Transferrin (red)
5) Body weight (green)
6) CRP (brown)
after surgical operation
IVJN = intravenous nutrition
Op = operation
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Figure 36: Patient 4. The change in serum:
1) RBP (black)
2) Albumin (violet)
3) Retinol (blue)
4) Transferrin (red)
5) Body weight (green)
6) CRP (brown)
prior to surgical operation
IVN = Intravenous nutrition 
Op = operation
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Figure 37: Patient 5. The change in serum:
1) RBP (black)
2) Albumin (violet)
3) Retinol (blue)
4) Transferrin (red)
5) Bocy weight (green)
after surgical operation
Op = operation
IVN = intravenous nutrition
OD = oral diet
D = drainage
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Figure 38: Patient 6. The change in serum
1) RBP (black)
2) Albumin (violet)
3) Retinol (blue)
4) Transferrin (red)
5) Body weight (green)
6) CRP (brown)
after operation
Op = operation
GFD = gluten free diet
NG = naso-gastric feed
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Figure 39: Patient 7. The change in serum:
1) RBP (black)
2) Albumin (violet)
3) Retinol (blue)
4) Transferrin (red)
5) Body weight (green)
6) CRP (brown)
after surgical operation
Op = operation
NG = nasogastric feed
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Figure 40: Patient 8. The change in serum
1) RBP (black)
2) Albumin (violet)
3) Retinol (blue)
4) Transferrin (red)
5) Body weight (green)
6) CRP (brown)
after surgical operation
Op = operation
NG = nasogastric feed
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Figure 41: Patient 9: The change in serum:
1) RBP (black)
2) Albumin (violet)
3) Retinol (blue)
4) Transferrin (red)
5) Body weight (green)
after surgical operation-
Op : = Operation
JF = Jejunostomy feed
EV = Extra vitamin
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Figure 42: Patient -10. The change in serum:
1) RBP (black)
2) Albumin (violet)
3) Retinol (blue)
4) Transferrin (red)
5) Body weight (green)
before and after surgical operation
nasogastric feed 
operation
intravenous nutrition
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et al, 1975). Any function affecting RBP affects serum retinol.
In patients there are different factors affecting the serum 
concentration of RBP.
Firstly, an acute-phase response which relates to 
different types of disease, operation or infection; where the 
fall in plasma retinol concentration in most patients may have 
been due to net protein catabolism (either reduced hepatic 
synthesis or increased catabolism) rather than temporary inter­
ruption of vitamin A supplements. This fact is supported by the 
fall in several plasma proteins measured including RBP. On the 
other hand, many proteins increase, eg CRP due to the acute-phase 
response. Dinarello, (1984) explains that tissue damage after 
injury leads to stimulation of macrophages to produce 
Interleukin-1 which causes liver to 'switch on' the synthesis of 
acute-phase proteins, with consequent increase in their concen­
tration in plasma. Fleck et al (1985) suggested that the degree 
of tissue damage was evidently of importance in the activation of 
the acute-phase response, although the relationship is unclear. 
He explained why some concentrations of plasma proteins decrease 
after trauma, while others increase after showing an initial fall 
by a mechanism called a 'Two-compartment model'. This depends on 
many factors eg vascular permeability, molecular size and 
physical properties of the individual proteins. RBP has a small 
molecular weight (21,000), while albumin is 66,000 and trans­
ferrin is 80,000 and CRP is 105,000.
This may explain why RBP decreases before the other 
proteins after injury. Many factors may affect vascular 
permeability including Interleukin-1 and possibly other
r
endocrine effects. These factors may also affect synthetic rate. 
Therefore, an inverse relationship between CRP and RBP/retinol 
may be found in these patients, as was seen in the present study.
Aronsen et al (1972), Johansson et al (1972), Moody 
(1982) found in contrast to the acute-phase proteins there are 
many other proteins, whose concentrations fall after trauma and 
remain low for several days, eg albumin, transferrin, 
pre-albumin. In this study, these proteins also show such an 
effect. Fleck et al (1985) noted that the concentration of 
protein in plasma does not necessarily reflect its rate of 
synthesis or breakdown. Other factors such as vascular 
permeability can exert a greater influence on the concentration 
of proteins with a very rapid rate of turnover such as RBP, to 
which large and rapid changes in the rate of synthesis may lead 
within a day or two to significant changes in its concentration.
While the rise in serum retinol concentration with 
nutritional support in some patients was possibly due to a 
reduction in the acute-phase response, the other factors which 
affect RBP are vitamin A and protein nutritional status. The 
dependence of plasma vitamin A concentration on protein 
nutritional status makes it difficult to assess adequacy of 
provision of vitamin A. Lowry et al (1978) found that 2 patients 
continued to have low levels of plasma vitamin A for 10 days, 
despite receiving daily infusions of 720 ug and 860 ug vitamin A 
respectively. However, Nichoalds• et al (1977) demonstrated that 
serum vitamin A concentrations can be raised to the normal range 
by giving 1,300 pg/day, whereas a similar regimen providing 1,000 
pg/day failed to achieve normal serum vitamin A levels. Most of
our patients had positive N balance especially when RBP and 
retinol increased. Although our patients had vitamin A sup­
plements the acute-phase response is greater and is usually the 
dominant effect. This appeared to be even stronger than in long 
term IVN patients, because the blood collected after injury and 
infection had higher CRP concentrations.
Peterson et al (1974), Smith et al (1975) suggested 
that malnutrition, disease and low diet protein, affect 
utilization, transportation and storage of vitamin A as well as 
the corresponding carrier protein from liver. Although these 
patients reported here were receiving nutritional support pre-and 
post-operation, the decrease in RBP in some cases may be due to 
trauma or sepsis which change the concentration of RBP rapidly, 
because of its short half-life and as a result of the acute phase 
response. Assessment of vitamin A status in such patients is 
therefore not possible using plasma measurements alone, and 
estimates of tissue content, eg from liver biopsy is probably 
necessary.
3.2.5) Studies on animals
3.2.5.1) Effect of vitamin A free diet on rats
Male rats (5 5-75 g) were studied in the Department of 
Surgery, Hope Hospital, Salford. They were initially fed on 
complete diet with a vitamin A supplement, until they were 3 
weeks old to ensure relatively large initial liver vitamin A 
storage and to make them familiar with the experimental 
conditions. Forty rats were put on a vitamin A-free diet and 40 
rats on complete diet (control). Five rats were killed from both 
deficiency diet group and complete diet group each week from week 
1 to week 8 . Rats were anaesthetised with fluothane and a blood 
sample collected by cardiac puncture into 0.3 ml heparin. Liver 
was removed and frozen until required for analysis. As part of 
another study 0.3 ml dextran was added per 1 ml blood, left at 
37°C (in dark) for 30 min, then the plasma/dextran fraction was 
removed, centrifuged to remove leucocytes and then frozen in 
0.5-1.0 ml aliquots until analysis. Table38 shows the 
composition of the diet fed to the animals and compared with 
those used by other workers.
Results
No difference was seen in weight gains of rats from
control and deficiency groups as was shown in Figure 43. This
finding confirms earlier observations by other investigators 
(Morita and Nakano, 1982). Changes in the serum levels of
retinol in each dietary group are shown in Figure 44. Serum
retinol levels decrease in both groups, but in the deficiency 
rats the decrease was greater and more rapid with a significant 
difference of p < 0.001 between the groups. The fall in the
TABLE 38
COMPOSITION OF THE DIET FED TO RATS, AND 
COMPARED WITH OTHER STUDIES
1* 2 3**
L  ..
Ingredient g/kg g g/kg
Casein 'essentially 
vitamin free' 250 240 200+
Rice Starch (BDH) 660 659 700
Briggs salt mix (BP) 40 50 60
Corn oil 20 30 20++
Choline dry mix 
(20% choline chloride 
pre-mixed in c o m  
starch) 10
Vitamin A (acetate) 3 .0 mg 10 10
Water soluble 
vitamin 8.5 g 10 -
Crude-protein 
content (N x 5.7)
_ _
- 150
* Morita and Nakano (1982)
2 This study (1984)
** Muhilal and Glover (1974)
Soya bean meal*r“T* *
Arachis oil containing (per kg) Vit D, E 
and phyloquinone
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Figure 43: Weight of rats fed on a normal diet (+) and on
vitamin A-free diet(*). The value represents 
the mean weight in each week.
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Figure 44: Serum retinol of rats fed on normal diet (+) and
rats fed on vitamin A-free diet (*). The values 
are mean ± 1SD.
n = 5 for each group except week 8 deficiency group 
and control group n = 2
control group is not significant between week 1 and week 6 . the 
increase after week 7 in the deficient group and the decrease in 
the control group may be artefacts, because at the end of week 8 
only two rats were left in each group. In the control group, the 
total liver content of retinol gradually increased throughout the 
experiment, whereas it decreased rapidly in the deficiency groups 
and reached undetectable levels by week 2 (Figure 45).
Figure 46 shows the relationship between mean serum 
retinol and mean weight of animal in both control and deficiency 
groups. The heavier the animal becomes the lower the serum 
retinol levels.
Figure 47 shows the correlation between mean of serum 
retinol and total liver retinol. In general, the higher the 
amount of retinol stored in the liver, the lower the levels in 
serum.
Clinical signs of vitamin A deficiency were absent. The 
animals looked entirely healthy with no changes to their eyes or 
fur. The only complications were rather sudden death and the 
development of respiratory distress. Post-mortem examinations 
were done by the Veterinary School in Liverpool, England on a 
reasonable selection of the rats who died, and the cause of death 
was bronchopneumonia, although the organisms differed widely.
Discussion
The growth rate, liver and serum concentrations in this 
study agree with those of Morita and Nakano, (1982) who also 
found that animals grew well on a vitamin A-free diet.
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Figure 45: Liver total retinol in rats fed on normal diet (+)
and rats on vitamin A-free diet (*). The values 
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Lewis et al (1972) believed that plasma tends to resist 
to a certain extent, any changes in its vitamin A concentration 
despite wide variations in the amount stored in the liver. While 
stores remain in the liver, retinol is maintained in plasma and 
resists any change in concentration in the diet. Although there 
was a slight tendency for plasma retinol to fall in the control 
animals, overall the concentration was well maintained during the 
study. The fall in plasma retinol appeared to be related to an 
accumulation of retinol in the liver, whilst the animal was 
growing. In the deficiency groups the plasma level decreased to 
a low level when the amount in the liver was undetectable.
Glover et al- (1947) found that plasma vitamin A levels 
in rats are proportional to the concentration of vitamin A 
alcohol in the liver, and not proportional to the total liver 
stores of vitamin A which consist mainly of esters. Plasma 
vitamin A levels are maintained near normal, even when liver 
stores approach exhaustion.
Ganguly and Kr insky (1953) used several groups of male 
rats ; receiving various diets and supplements. Despite the 
variation of the liver vitamin A alcohol, the plasma vitamin A 
alcohol remained constant. Only in the group of rats 2 months 
old fed a vitamin A-free diet were the liver vitamin A alcohol 
and plasma vitamin A undetectable. The results in this study are 
similar to those of Robison et al (1980) who found that after 14 
weeks of deficiency of vitamins A and E, plasma and liver vitamin 
A were undetectable. In contrast, in the present study, liver 
vitamin A was undetectable after only 2 weeks on vitamin A-free
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diet in 3 week old rats. The explanation for this is not clear, 
but it may be related to the rapid rate of growth of these 
animals.
Another explanation of this is that the liver plays a 
central role in maintaining blood retinol levels. Vitamin A is 
stored in liver for supplying tissue needs, when the dietary 
intake of vitamin A decreases. The liver also synthesises 
retinol carrier proteins to circulate stored retinol to the 
tissues. Morita and Nakano (1982) examined the concentration of 
vitamin A in kidney and other tissues at the same times they 
measured vitamin A in liver and plasma. They found that vitamin 
A concentration increased in the kidney. They suggested that 
perhaps the kidney was playing an important role in storing the 
vitamin A, when the exogenous supply to animals decreased. High 
(1954); Peterson et al (1973), suggested that vitamin A 
accumulated in this organ may be re-circulated into blood. They 
suggested also, that retinol may be released from its carrier 
protein in the kidney, where the carrier protein is catabolised, 
and then re-circulated to the blood. Kidney was not examined in 
our study.
Resistance of these animals to infection was reduced and 
this may be related to the bronchopneumonia and death (Section 
1.7) .
Scrimshaw et al (1968), Gruber et al (1976), suggested 
that the susceptibility to infection in vitamin A-deficiency 
appears to be due at least in part to an inability of epithelial 
cells to synthesise the secretory component of secretory-IgA, 
such that local immune responses are impaired.
It is interesting to note that despite a vitamin A-free 
diet, rats could still grow at a normal rate for the duration of 
the study. However, in such animals, liver stores are rapidly 
depleted but no physical signs were apparent up to 8 weeks. Since 
these rats had a low serum and liver vitamin A, it is probable 
that a deficiency state would develop if the study was continued.
3.3) CANCER STUDIES
3.3.1) Studies on patients
3.3.1.1) Concentration of serum retinol, cholesterol and tri­
glyceride and relation to colorectal cancer
A random sample of 70 persons with no known ill-health and 
between the ages of 40 and 86, born in the Eastern District of 
Glasgow were studied. A further 70 patients with a history of 
colorectal cancer, and born in the same district were also 
studied. A fasting blood sample was taken from both groups. In 
the colorectal group the blood samples were taken between 7 days 
and 12 years (median one year) post operations. At the same time 
a medical history was obtained, including age, sex, height, 
weight, any personal or family history of cancer, heart disease, 
diabetes or hypertension, occupation, smoking and drinking 
habits, exposure to drugs and medication (carried out by local 
General Practitioner) . Blood samples were analysed for serum 
retinol, total cholesterol and triglyceride.
Results
The 70 patients had mean serum retinol levels slightly 
lower than control with p < 0.01 (t-test). The difference between 
males with treated cancer and controls was also significant (p < 
0.01). There was no significant difference between the serum 
retinol concentration of females with treated cancer, and controls 
(Table 39). Male controls had a higher serum retinol value than 
females (p <0.05). There was no significant difference in serum 
retinol between smoking (20 cigarettes/day) and non-smoking in 
control subjects (Table 40).
TABLE 39
SERUM RETINOL IN SUBJECTS WHO HAD BEEN TREATED FOR CANCER 
AND CONTROL (mean 1 1SD)
Subjects No. of 
Cancer
patients
No. of
control
patients
Cancer
(jjmol/1)
Control
(jjmol/1)
Total 70 70 2 .7±1.1 3.2±0.9
Male 35 27 2.7±1.2 3.411.1
Female 35 31 2 .6± 1.0 2.910.8
TABLE 40
COMPARISON BETWEEN SERUM RETINOL OF SMOKING AND NON­
SMOKING CONTROLS (mean 1 1SD)
Subject No. of
smoking
subjects
No. of 
non-smoking 
subj ects
Smoking
(jjmol/1)
Non-smoking
(jjmol/1)
Total. 26 16 3.010.9 3.4±1.0
Male 14 6 3 .3±0.9 3.7±1.3
Female 12 10 2.8±0.7 3.2±0.8
TABLE 41
THE EFFECT OF AGE ON SERUM RETINOL IN CANCER PATIENTS 
AND CONTROLS (mean ± 1SD)
Age No. of 
Cancer 
patients
No. of
Control
patients
Cancer
(jjmol/1)
Control
(jjmol/1)
< 50 4 24 2.711.2 3.111.0
51-60 8 22 2.611.1 3.311.0
> 60 31 12 2.411.1 3.010.7
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Age also did not affect the results since there was no 
significant difference between different age groups (Table 41).
Tables 42-44 show the comparison between serum 
cholesterol in cancer cases and control patients and the effect 
of smoking and age. No significant difference was found between 
cancer cases and controls in any comparison.
Tables 45-47 show no significant difference in serum 
triglyceride between cancer patients and control and no effect 
of sex, smoking and age respectively.
Figures 48-53 show the correlation between serum 
retinol and total cholesterol, serum retinol and triglyceride and 
triglyceride and total cholesterol in both control and cancer 
patients respectively. Poor correlation was found in both groups 
(Table 48).
Correlation of r = 0.5 (p < 0.001) was found between 
total serum cholesterol and serum retinol in cancer patients.
Patients who had metastases in liver had significantly 
lower serum retinol and cholesterol than cancer patients without 
metastases (Figures 54,55 and Table 49).
Figure 56 shows the lack of relationship between serum 
retinol and the time of diagnosis (r = 0 .2) in all cancer 
patients,! There is a poor correlation
between serum retinol, total cholesterol and the time from 
diagnosis r = 0.6, r = 0 . 5  respectively in metastases cases. 
Most patients with metastases show low serum retinol and 
cholesterol, with significant difference of p < 0.01 from no 
metastases and control. However, their blood samples had mainly 
been taken 7-15 days post-operation. On the other hand, most of
TABLE 42
COMPARISON IN TOTAL SERUM CHOLESTEROL BETWEEN CANCER 
PATIENTS AND CONTROL (mean ± 1SD)
Subject No. of 
cancer 
patients
No. of
control
subjects
Cancer 
(mmol/l)
Control
(mmol/1)
Total 64 63 6.0±2.1 5.911.1
Male 32 27 5.712.3 5.810.98
Female 32 31 6 .211.8 6.011.2
TABLE 43
COMPARISON BETWEEN TOTAL SERUM CHOLESTEROL IN 
SMOKING AND NON-SMOKING CONTROLS (mean ± 1SD)
Subj ect No. of 
smoking
No. of 
non­
smoking
smoking
(mmol/1)
non-smoking 
(mmol/l)
Total 26 16 5.811.1 6.211.1
TABLE 44
EFFECT OF AGE. ON TOTAL SERUM CHOLESTEROL BETWWEN CANCER 
PATIENTS AND CONTROL (mean 1 1SD)
Age No. of 
cancer 
patients
No. of 
control
Cancer 
(mmol/l)
Control
(mmol/1)
< 50 2 24 4.911.2 5.811. 1
51-60 7 22 6.012.7 6.111.3
> 6 0 29 12 5.912.5 5.710.8
TABLE 45
COMPARISON OF SERUM TRIGLYCERIDE BETWEEN CANCER 
PATIENTS AND CONTROL (mean ± 1SD)
Subject No. of 
Cancer 
patients
•No. of 
Control
Cancer
(mmol/1)
Control 
(mmol/1)
Total 64 63 1.9±0.9 .1. 6± 1.2
Male 32 27 1.9±1.0 1.510.6
Female 32 31 1.9±0.8 1.611.5
TABLE 46
EFFECT OF SMOKING ON SERUM TRIGLYCERIDE ON CONTROL 
(mean ± 1SD)
Subj ect No. of 
smoking
No. of 
non-smoking
Smoking 
(mmol/l)
Non-smoking 
(mmol/l)
Total 26 16 1.410.6 1.410.6
TABLE 47
COMPARISON OF THE EFFECT OF AGE ON SERUM TRIGLYCERIDE 
BETWEEN CANCER AND CONTROL (mean ± 1SD)
Age No. of 
Cancer 
patients
No. of 
Control
Cancer
(mmol/1)
Control
(mmol/1)
< 50 2 24 1.610.0 1.310.6
51-60 7 22 1.810.8 1.811.7
> 60 29 12 1.710.9 1.610.7
SE
RU
M 
CH
OL
ES
TE
RO
L 
CM
MO
L/
L)
10“l
8 -
4-
2 -
2 3 40 1 5 6
SERUM RETINOL CJJMOL/L)
Figure 48: Correlation between serum retinol and
cholesterol in control patients.
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Figure 49: Correlation between serum retinol and
triglyceride in control patients.
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Figure 50: Correlation between serum cholesterol and
triglyceride in control patients
SE
RU
M 
CH
OL
ES
TE
RO
L 
CM
MO
L/
L)
+
10 -
8 -
6-
4-
2 -
61 2 3 4 50
SERUM RETINOL CpMOL/L)
Figure 51: Correlation between serum retinol and
cholesterol in;colorectal cancer patients.
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Figure 52: Correlation between serum retinol and
triglyceride in colorectal cancer patients.
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Figure 53: Correlation between serum cholesterol
and triglyceride in colorectal cancer 
patients
TABLE 48
CORRELATION BETWEEN SERUM CHOLESTEROL, TRIGLYCERIDE 
AND SERUM RETINOL IN BOTH CANCER PATIENTS AND 
CONTROL PATIENTS
Cases Cholesterol
V
Retinol
Triglyceride
V
Retinol
Cholesterol
V
Triglyceride
Control r = 0.4 r = 0.3 r = 0.3
p < 0.001 p < 0.01 p < 0.02
Cancer r = 0.5 r = 0.2 r = 0. 2
p < 0.001 p < 0.05 p < 0.05
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Figure 54: Difference in serum retinol in colorectal
cancer patients with or without metastases
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Figure 55: Difference in serum cholesterol in
colorectal cancer patients with or 
without metastases
TABLE 49
COMPARISON OF SERUM RETINOL AND CHOLESTEROL BETWEEN 
METASTASES AND NON-METASTASES (Mean ± 1SD)
Subject Metastases Non-Metastases
Retinol (jjmol/l) 1.6 ± 1.6 2.5 ± 0.9 p < 0.01
Cholesterol (mmol/1) 4.1 ± 1.3 6.5 ± 2.0 p < 0.001
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Figure 56: Regression of serum retinol on time from operation
in patients with colorectalcarcinoma
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the patients without metastases at operation had samples taken 
later in the post operation period (Figure 59) and there was no 
correlation between serum retinol and time after operation, and 
with no significant difference of control.
Discussion
Taken overall there appears to be a relationship between 
low serum retinol levels and patients having had a previous 
operation for colorectal cancer. Table 39 shows that cancer 
cases had lower serum retinol than control (p < 0 .01) and this 
relationship is independent of age, smoking habit or serum 
triglyceride concentration. Liver metastases were found to be 
associated with lower serum retinol levels and lower cholesterol 
if compared to 'no metastases1 patients. However, closer 
examination of the patient population shows that the metastases 
group of patients were primarily sampled in the early post­
operative period, whereas the non-metastases groups were sampled 
over a more prolonged period (up to 12 years) following 
operation. This reflects the much better prognosis in the 'no 
metastases group'. The main reason for the low serum retinol in 
the metastasis group is therefore probably an acute phase 
response to the surgery. When the samples taken within 1 month 
of operation are excluded, ■' then the serum retinol on the 
remaining cancer patients is not significantly different from the 
control population. Patients who have previously developed a 
colorectal cancer do not therefore have a long-term underlying 
abnormality in serum retinol. It is important to know that 'no 
metastases' group of patients had already undergone removal of 
their carcinoma, and were believed to be free of neoplastic
SE
RU
M 
RE
TI
NO
L 
Cp
MO
L/
L>
5
+
4
3 -
2 _
NO OF POINTS - 52 
CORR COEFFT - .1355 
GRADIENT - . 397205E- 
INTERCEPT - 2.68643
10 12
TIME FROM OPERATION (YEARS)
Figure 59: Regression of serum retinol on time from operation
in patients with colorectal carcinoma without 
metastases
disease following surgery, when the blood samples were collected.
In addition, these patients were not undergoing any other kind 
of therapy, eg chemotherapy or radiotherapy. There was a 
correlation of r = 0.6 and r = 0.5 between low serum retinol and 
low cholesterol respectively with time of diagnosis. These 
findings appeared in blood samples collected 7 to 15 days 
post-operatively. Basu et al (1985) investigated serum retinol 
levels and RBP in post-operative colorectal cancer patients. He 
found that plasma retinol levels in the post operative disease- 
free colorectal cancer patients were lower than those in normals. 
This finding was confirmed in the present study (Table 39). 
Furthermore, the initial plasma retinol level in conjunction with 
RBP was found to be lower in patients who subsequently had cancer 
recurrence than in those who remained free of apparent cancer. 
They found low serum retinol levels and low RBP and a correlation 
between poor metabolic vitamin A status and subsequent relapse.
All these observations may have prognostic and predictive 
significance in colorectal cancer.
The difference in serum retinol between cancer patients 
and controls in the early post operative period appeared to be 
greater in males than in females. A similar observations was 
found by Wald et al (1980) in patients with lung cancer.
Ten out of eleven retrospective studies (Kummet and 
Meyskens, 1983) concluded that low levels of serum retinol 
existed in the cancer population. The difference between cancer 
cases and controls ranged from 0.1 pmol/1 to 1.7 pmol/1 with an 
average of 0.7 pmol/1.
The only correlation we found was between serum retinol 
and total cholesterol (r = 0.5) in cancer patients (Table 48) and 
this correlation disappeared if samples taken within one month of 
operation were excluded. These cancer patients already had 
surgery, but some had low serum cholesterol especially those who 
had metastases and had blood collected 7-15 days post operations. 
This could be a response to the cancer process. In previous 
studies, the relationship with cancer was stronger with serum 
retinol than with cholesterol. Kark et al (1982) suggested that 
the association with cholesterol might be secondary.
It is however more likely that the acute phase response 
accounts for the lower serum cholesterol observed in patients 
with metastases. Serum apolipoprotein B is known to decrease as 
a result of operation (Ballantyne et al 1979). Therefore it 
cannot be concluded from this study whether a low serum 
cholesterol is associated with metastases.
Triglyceride did not have any association with either 
serum retinol or cholesterol or occurrence of cancer.
Further studies were carried out (in the Department of 
Genetics, University of Aberdeen) on the genotype of lipoprotein 
in controls and relating this to the risk of cancer. There was 
no relationship with age, sex (except HDL2 in females). For the 
same genotype there were small, but statistically significant 
relationships with cigarettes and/or alcohol consumption. The 
most remarkable feature found was a negative correlation between 
serum retinol and HDL2 concentration in females. Why a relation­
ship was found between HDL2 and retinol in females, although 
there was no such relationship found in males, may be due to 
other factors in females affecting such a relationship.
Adams et al (1985) studied the association of lipo­
protein cholesterol with vitamin A. They investigated the 
relationship between serum carotene and cholesterol in multi­
racial groups of college volunteers. These results were 
consistent with the hypothesis that the association between serum 
cholesterol concentration and cancer may be the result of a 
relationship between lipoprotein cholesterol concentration and 
vitamin A metabolism. As indicated, the association is likely to 
be indirect between low serum cholesterol and cancer risk. One 
possible mediator is carotene. The lipoprotein subfractions are 
involved in the transport of carotene. Simpson and Chichester 
(1981) found more than 50% of the carotenoids in the low-density 
lipoproteins (LDL) and the remainder in HDL. The evidence of a 
relationship between cholesterol concentrations and cancer has 
implicated primarily total cholesterol and LDL cholesterol and 
not HDL cholesterol.
Undoubtedly, multiple factors contribute to the develop­
ment of cancer. Additional epidemiological and experimental 
studies are needed to assess the relationships among vitamin A, 
cholesterol and cancer risk to clarify the mechanisms involved, 
and to distinguish the role of vitamin A in the aetiology of 
cancer. Further study is required to elucidate the exact 
relationship between vitamin A and its transport protein with 
epithelial and non epithelial tumours (Tyler et al 1985).
From the present study, it cannot be deduced whether 
impaired vitamin.A status predisposes to development of cancer of 
colon or .to metastases occurring, or whether the 
cancer/metastases causes the change in plasma retinol 
concentration. Although the cancer group appeared to have no 
long-term abnormality in retinol status, the association of 
retinol with HDL2 -in females is worthy of further study.
3.3.1.2) Determination of serum retinol in patients with oral
diseases
Patients from the Dental Hospital out-patient department 
(Glasgow) with disease of the mouth were studied. Biopsy of the 
mouth lesion was taken at the same time as a venous blood sample.
Histology indicated that 19 patients had oral cancer, 11 
leukoplakia of the oral cavity and 7 Crohn's disease. Forty-five 
individuals with no oral lesion were studied to establish the 
normal levels of serum retinol and vitamin E in this population 
(Table 50) .
Figures 60 and 6 1 and Table 50 shows mean serum 
retinol and vitamin E levels in each group. There was no 
significant difference in serum retinol between patients with 
oral cancer or leukoplakia and normal subjects, while there was a 
significant difference between patients with Crohn's disease and 
normal subjects (p < 0.001). For serum vitamin E there was a 
significant difference between normal and cancer patients (p < 
0.01; Mann-Whitney test).
If we group these cases according to whether the serum 
retinol is below or above 2 SD of normal subjects, 20% of cancer 
cases show low values, whereas 57% of Crohn's disease patients 
had serum retinol levels below the normal range (Table 51).
Discussion
The results obtained show that there were no significant 
differences in serum retinol between oral cancer or leukoplakia 
and normal cases, although it was expected that lower levels of 
serum retinol may have been associated with oral cancer and 
leukoplakia (a lesion which might progress to cancer).
TABLE 50
SERUM RETINOL AND VITAMIN E IN DIFFERENT DISEASES OF ORAL CAVITY 
(mean ± 1SD)
Case No. of cases 
'studied
Serum retinol 
(jjmol/1)
Vitamin E 
(jjmol/1)
Normal 45 . 2.58±0.69 29.0149.2
Cancer 19 2.39±1.24 11.719.3
Leukoplakia 11 2.45±0.93 22.318.9
Crohn’s Disease 7 1.510.55 18.715.5
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TABLE 51
INCIDENCE OF .ABNORMAL SERUM RETINOL
Case Low Normal High
Normal 2(4%) 43(96%) -
Cancer 4(21%) 14(74%) 1
Leukoplakia 0 10(90%) 1
Crohn's Disease 4(57%) 3(43%) - -
Moore (1967); Toyoshima and Leighton (1975) described 
that the deficiency of vitamin A causes keratinization or 
squamous metaplasia of mucous epithelia in which mucous membrane 
change from single layer of mucin-secreting and ciliated 
epithelium to multiple layers of epithelial cells, with overlying 
keratin, resembling those of skin. Patients became unable to 
take their food properly and so they were undernourished. Where 
squamous metaplasia occurs there are grounds for suspecting 
increased risk of cancer development.
Abels et al (1942) studied in his patients the patho­
logical changes associated with papillary atrophy of the tongue 
and oral leukoplakia. The hepatic dysfunction and abnormalities 
of the gastrointestinal tract were considered to be factors which 
might contribute to the existence of a dietary deficiency.
Wahi et al (1965) showed that 76.2% of oral cancer 
patients had subnormal levels of vitamin A. These low serum 
levels of vitamin A may have been the result of improper 
nutrition. However, one has to keep in mind the possibility that 
hypovitaminosis A may be due to the presence of tumour itself. 
Wahi et al (1958) suggested that dietary deficiency of certain 
factors may be an important cause of oral cancer.
Previous workers carried out most of their studies in 
poor countries, and used spectro-analysis and Carr-Price method 
for vitamin A analysis (Wahi et a l . 1962; Wahi et al 1965;
Ibrahim et al 1977). Most studies suggested that dietary 
deficiency is associated with oral cancer.
In the present study no clinical evidence of vitamin A 
deficiency was observed, which might lead to increased risk of 
oral cancer. Moreover, no differences were found in serum 
retinol between these groups and normal groups and only 21% of 
cancer cases showed serum retinol below normal.
In the Crohn's disease group, 57% of patients had serum 
retinol below normal. There was however, no clinical evidence of 
vitamin A-deficiency. Dark-adaptation testing was not done here.
Full nutritional assessment was not performed, so it is not 
known if these patients also had protein or energy malnutrition. 
The serum vitamin E in the Crohn's patients are mainly within the 
normal range, so fat malabsorption did not occur, suggesting that 
the low serum retinol is due to protein malnutrition. On the 
other hand, cancer patients did show significant differences from 
normal in vitamin E (p < 0.01). This has been previously 
observed in some cases of breast cancer, but the significance is 
not clear (Wald et al, 1984). Main et al (1983) showed a close 
relationship between vitamin A and protein, and the importance of 
protein nutrition for transport of serum retinol to its target 
tissues. They showed that vitamin A-deficiency poses a signifi­
cant clinical problem in severe Crohn's disease. Our data show 
low levels of serum retinol, so there is a risk of developing 
vitamin A deficiency. Vitamin A supplements may be required in 
these patients. Depending on the degree of small intestinal 
involvement in Crohn's disease, protein supplements may also be 
required.
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3.3.1.3) Estimation of vitamin A in liver biopsy and serum
Liver biopsies were taken at operation,with the fully 
informed consent of the patient,from 23 patients aged from 29-83 
years undergoing abdominal surgery for various disease states. The 
protocols were approved by the Hospital Ethical Committee. Eight 
patients had benign disease and fifteen had neoplastic disease. 
Biopsies were stored at -20°C until analysis. Total vitamin A as 
well as retinol ester was analysed. A venous blood sample was 
withdrawn before operation to estimate retinol in serum. Table 52 
shows the concentrations of vitamin A in liver and serum.
There was no significant difference between total 
control and total cancer patients with respect to liver concen­
tration of total vitamin A, retinol or retinol esters, or in 
serum retinol (Table 52 and Figures 62-64 respectively)
Considering patients with rectal cancer only, serum 
retinol was significantly different from controls (p < 0.05) . 
There was also a significant differencein serum retinol between 
control and cancer females (p < 0 .01) while there was no such 
difference between males and females in both control and cancer 
groups for total vitamin A in liver or serum (Table 53).
There was no correlation between age and serum retinol 
or vitamin A in liver.
There was a poor correlation between total vitamin A in 
liver and serum retinol in cancer cases (r = 0 . 5 )  (Figure 65) 
and in controls (r = 0.3) (Figure 66). There was however, better 
correlation between free retinol in liver and serum retinol in 
control cases (r = 0.8) (Figure 67) , but no similar correlation 
in cancer cases (r = 0.3) (Figure 68).
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Figure 62: Total vitamin A in liver from patients with
benign and malignant disease.
DU = duodenal ulcer
GB = gall bladder disease
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Figure 63: Liver retinol from patients with benign and
malignant disease.
DU = duodenal ulcer
GB = gall bladder disease
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Figure 64: Pre-operative serum retinol from patients with
benign and malignant disease
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TABLE 53
COMPARISON OF LIVER AND SERUM VITAMIN A IN FEMALES AND 
MALES WITH OR WITHOUT CANCER. MEDIAN (RANGE)
Sex No. Total Vitamii
(pg/g) 
Control (C)
i^A in liver 
Cancer (Ca)
Serum Retii 
Control
10I (jjmol/1) 
Cancer
Female
Male
3C
6Ca
5C
9Ca
1094
(800-3900)
NS
550
(458-1000)
667
(88-2357)
NS
860
(125-2363)
3.5
(1.0-4.0) 
NS
1.9
(1.0-3.6)
0.9 
(0 .6- 1.6)
.NS
1.7
(0.5-4.4)
Ca = cancer 
C = control
NS = No significance between male and females
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Figure 65: Correlation between serum retinol, and total
vitamin A in liver in patients with malignant 
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Figure 66: Correlation between serum retinol, and total
vitamin A in liver in patients with benign disease.
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Approximately 70% of patients had a liver content of 
. vitamin'A around O-IOOOpg/g, while 3 0% had values higher than 
1000 pg/g.
Histological examination showed hepatic metastases in 
some of the cancer patients. Table 54 shows median (range) of 
serum retinol (pmol/1), total vitamin A and free retinol in liver 
(pg/g) in patients with and without metastases. Figure 69 shows 
mean serum retinol (pmol/1) in both metastases and no metastases 
groups. No significant differences were found 
Discussion
’Experiments on rats and other animals (Sherman and 
Boynton, 1925; Kerppola, 1930; Moore, 1931) established that the 
body's main stores of vitamin A are in the liver. So the hepatic 
concentration will provide us with an index to the overall 
vitamin A status. There have been many studies on liver biopsy 
and post mortem samples (Table 55). A wide variety of vitamin A 
concentrations have been observed in normal individuals and in 
different diseases. Under normal conditions of vitamin A 
sufficiency, 90% or more of the total body reserve of vitamin A 
is stored in the liver and only 1-3% circulates in the plasma 
(Moore, 1957; Raica et al 1972). So little correlation would be 
expected between serum retinol and total liver vitamin A, which 
. we confirmed in this study. However, there was a correlation of 
-r = 0.8 between serum retinol and free retinol in liver in normal 
cases, which may -relate to transport of retinol. This 
correlation was not seen in patients with cancer.
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Figure 69: Pre-operative serum retinol in patients with
malignant diseases with or without metastases
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Neither benign surgical disease nor cancer showed any 
effect on vitamin A levels in liver or on serum retinol. On the 
other hand, the low values of serum retinol in the pre-operative 
period found in rectal cancer may be due to liver disease 
leading to disturbance in mobilization or to protein deficiency. 
Although most of the rectal cancer patients had metastases, 
there was no significant difference between serum retinol of 
patients with metastases compared with non-metastatic cases (Fig 
69) . This contrasts with the significant difference found in 
patients with metastases, who underwent colorectal cancer 
surgery, but whose samples were collected in the early post­
operative period (Table 49).
Certain individuals had low levels of vitamin A in liver 
in our study. This was not necessarily associated with low serum 
retinol. This is further complicated by the heterogenous 
distribution of vitamin A in the liver (Amedee-Manesme et al 19841 
Similarly, patients with low serum retinol did not always have 
low liver vitamin A. This could result from impaired protein 
nutrition, or from an acute-phase reaction to the tumour. 
Therefore, liver vitamin A measurements are necessary as part of 
the assessment of vitamin A status.
3.3.2) Studies on animals
3.3.2.1) The effect of iron deficiency and experimental carcino­
genesis on vitamin A status in rats
Iron deficiency in common with other nutritional 
deficiencies, causes widespread and diverse tissue change. In 
regions of the world where iron deficiency is a serious public 
health problem there is often a high incidence of oral cancer 
(Prime et al 1983). Brown-Kelly (1919) and Paterson (1919) were 
the first to report the association between iron deficiency 
anaemia and post-cricoid carcinoma. Iron deficiency is reported 
as causing epithelial atrophy, koilonychia, glossitis and 
dysphagia. Prime et al (1983) investigated the suggested 
association between iron deficiency and development of oral 
squamous-cell carcinoma in the rat. In a subsequent study he 
investigated whether the influence of iron deficiency in 
producing earlier tumour in response to carcinogenic application 
was due to an effect on initiation or promotion. Aspects of 
their studies will be reported here, in terms of vitamin A 
status.
Vitamin A is well known for its importance in general 
growth and differentiation of epithelial tissues, and its 
deficiency has been shown to lead to metaplastic changes in the 
epithelia of the respiratory, urogenital and gastrointestinal 
tracts (Harris et al 1972; Wolback, 1954) .
In this study we therefore investigated if there is an 
association between carcinogenic application, iron deficiency and 
vitamin A in serum andliver., Specifically, my role in
this study was to assist in collection of serum and liver samples 
from the many different groups of rats, and to perform all vitamin A 
analyses.
In Study I Prime et al (1983) investigated the effect 
of iron deficiency on oral carcinogenesis by using 30 young adult 
male Charles River white rats. These rats aged 6-8 weeks were 
housed in polyethylene cages 2 or 3 per cage. They were divided 
into 2 groups, iron sufficient (Group 1) and iron deficient 
(Group 2) . In group 1 , 15 rats were fed a specially-prepared 
powdered diet with an iron concentration of approximately 140 
mg/kg of diet (the iron used was in the form of ferrous 
sulphate). Group 2, 15 rats received a similar diet with iron 
concentration 12 mg/kg (National Academy of Science, 1978, 
indicated that 35 mg/kg iron is necessary for growth). The diet 
was prepared taking account of the other nutrients, carbohydrate, 
protein, fats and vitamins. All animals received 15 g of diet 
daily and had glass distilled water ad-lib. Blood samples were 
collected from control animals in group 1 on 6 occasions during 
the course of the experiment in order to monitor the iron status. 
It had been hoped that iron deficiency anaemia could be induced 
in group 2 animals by dietary means alone, but after 8 weeks of 
iron deficient diet the animals showed an average fall of only 
1.56 g/dl of haemoglobin. A regime of repeated bleeding was 
instituted both to induce and to maintain further iron 
deficiency. In group 2, animals were bled at 2-3 week intervals, 
but towards the end of the experiment this was extended to 3-4 
weeks. In total the iron deficient animals were bled on 13 
occasions throughout the course of the experiment.
The carcinogen application technique was that described 
by Wallenius and Lekholm (1973). All animals were treated with 
0.5% 4-Nitroquinoline-N-oxide in propylene glycol which was
painted on the palate 3 times weekly. After the application of 
carcinogen, the animals were followed up till sacrifice. The 
oral cavity of each rat was examined weekly. The results in iron 
deficient and iron sufficient rats with and without carcinogen 
were compared.
In Study I all animals (Groups 1 and 2) were painted 
with 4NQ0 for most of the period of study while in study II 6 0 
animals were used and painted with 4 NQO for 8 weeks (Groups 3 
and 4) or 14 weeks (Groups 5 and 6) and were then monitored until 
40 weeks, when they were sacrificed. The protocol of the two 
studies are summarised in Table 56.
In Study I blood and liver samples were taken at 
sacrifice, while in Study II, blood was taken at the start of the 
study, 1-2 weeks after 8 or 14 weeks of carcinogen application, 
and at sacrifice. Liver was collected at the end of the 
experiment (sacrifice). The effect of iron status, weight and of 
carcinogen on vitamin A status was studied.
Results
In Study I, the mean haemoglobin values of group 1 did 
not change significantly from a starting value of 14.1 g/dl to 
13.8 g/dl at the sacrifice. In group 2 the mean haemoglobin 
values at the start of the diet was not significantly different 
from that of group 1. However, the mean haemoglobin of the 
animals fell steadily until at the time of the first carcinogen 
application it was 10.1 g/dl and by sacrifice it had reached 8.2 
g/dl and was significantly different from group 2 (p < 0 .001) at 
the time of first carcinogen application and at sacrifice. Both 
groups developed similar squamous cell carcinomas, but tumour
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development was significantly earlier in iron deficient groups 
mean 183 day (85-224) compared with control (iron sufficient 
group) mean 229 days (174-257) with p < 0.02). Iron deficient 
animals showed a significantly greater incidence of tongue 
tumours (p < 0 .01) and iron-sufficient animals (control) showed 
a significantly greater incidence of palatal tumours (p < 0 .01) 
(Table 57).
The mean weights of animals in the iron-sufficient and 
iron-deficient rats throughout the experiment are shown in Table 
58.
No significant difference in weights were found between 
the two groups at the start of diet, start of carcinog'en 
application or at sacrifice.
Retinol in serum was measured at sacrifice only and all 
rats showed a very low serum concentration. There was no 
significant difference between iron sufficient and iron deficient 
rats in terms of retinol and sacrifice (Table 59).
Liver retinol and retinol palmitate were undetectable at 
the time of sacrifice.
In Study II, the mean haemoglobin value of the iron 
sufficient group 3 showed a change from 11.2 g/dl at the start to
12.3 g/dl at sacrifice. In the iron deficient group 4, the mean
haemoglobin values showed a change from 11.1 g/dl at the start of
the study to 7.2 g/dl, at sacrifice with a significant
difference (p < 0.001) between the two groups at 1-2 weeks after 
8 weeks carcinogen application and sacrifice (Table 60).
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TABLE 59
SERUM RETINOL IN GROUPS 1 AND 2 AT SACRIFICE (MEAN)
Group Iron
status
No. of rats Serum retinol at 
sacrifice (pmol/1)
1 +Fe 9 0.1 
<0. 1
(4 animals) 
(5 animals)
2 -Fe 9 0.1 
<0.1
(6 animals) 
(3 animals)
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There was no significant difference in the weights of 
iron-sufficient and iron-deficient animalsat all time points 
(Table 61). Mean serum retinol in both groups fell approxi­
mately 1.3 pmol/i by 1-2 weeks after 8 week carcinogen 
application from the start of the experiment and continued to 
fall to very low values at the time of sacrifice (Table 62). 
There was no significant difference in serum retinol between the 
iron-sufficient and deficient group at any time.
Figure 70 shows the change in weight between the start 
of experiment and 1-2 weeks post carcinogen application plotted 
against serum retinol in the iron-sufficient group. The 
correlation was r = -0.8. There was also a correlation in both 
groups between the change in serum retinol and change in haemo­
globin from the start of the study to the end of carcinogen, 
between end of carcinogen and time of sacrifice, and between 
start of study and time of sacrifice and these correlations were 
greater for iron-deficient rats (Table 63 and Figures 71 and 72) .
The mean haemoglobin in iron sufficient group 5 showed a 
minimal change from 13.1 g/dl at the start of study to 12.9 g/dl 
at sacrifice. In iron-deficient group 6 the mean haemoglobin 
values showed a change from 13.9 g/dl at the start of the study 
to 8.0 g/dl at sacrifice with significant difference of p < 0.001 
between the two groups at 1-2 weeks post 14 weeks of carcinogen 
application and at sacrifice (Table 64).
The iron sufficient group 5, was heavier than the iron 
deficient group 6, both after 14 weeks of carcinogen application 
and at sacrifice (Table 65, Figure 76).
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Figure 70: Correlation between serum retinol and change in
weight. A blood sample was taken at start, and 
1-2 weeks post carcinogen in iron-sufficient rats 
treated for 8 weeks, and the change in weight was 
noted.
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Figure 71: Correlation between decrease in serum retinol
and haemoglobin. Blood samples were taken 
1-2 weeks post carcinogen and at sacrifice 
in iron-deficient rats treated with carcinogen 
for 8 weeks.
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Figure 72: Correlation between decrease in serum retinol
and in haemoglobin. Blood samples were taken 
from iron-deficient rats at start and at 
sacrifice (40 weeks) having been treated with 
carcinogen for 8 weeks.
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The mean serum retinol dropped during carcinogen 
application from the start of the study (Table 66) . Carcinogen 
application for 14 weeks in iron sufficient rats led to a fall in 
serum retinol from 2.4 4- 1.0 pmol/1 to 0.3 + 0.4 pmol/1, which 
was significantly lower than in iron sufficient rats of 8 weeks 
application 2.4 0.4 pmol/1, 1.1 +_ 0.5 pmol/1. The fall
continued and reached very low values at sacrifice in both iron 
sufficient (0.16 pmol/1, 0.25 pmol/1) and iron deficient (0.17 
pmol/1 , 0.18 pmol/1) groups with no significant difference
between the two groups at any time.
There was a significant correlation in the change in 
haemoglobin between 1-2 weeks after 14 weeks of carcinogen 
application and sacrifice plotted against the change in serum 
retinol in the iron sufficient group (r = 0.7) but these changes 
were very small (Figure 73) Iron deficient animals showed a 
correlation between the changes in haemoglobin between start of 
the study and sacrifice plotted against the change of serum 
retinol (r = 0.6) (Figure 74).
Figures 7 5 and 76 show the weight of the two groups (3 
and 4; 5 and 6) at 1-2 weeks after 8 or 14 weeks of carcinogen
application respectively and at sacrifice. There is a signifi­
cant difference between iron sufficient and iron deficient groups 
5 and 6 (p < 0.001) but there was no difference between iron- 
sufficient and iron deficient groups 3 and 4 at either of these 
time points. In group 4 the iron deficient rats were signifi­
cantly heavier at sacrifice than group 6 (p < 0 .01) but no such 
difference was found between iron sufficient groups 3 and 5.
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Figure 73: Correlation between increase in serum retinol
and decrease in haemoglobin. Blood samples 
were taken from iron-sufficient rats at 
1-2 weeks post carcinogen and at sacrifice 
(40 weeks) having been treated with carcinogen 
for 14 weeks.
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Figure 74: Correlation between decrease in serum retinol
and decrease in haemoglobin concentration. 
Blood samples were taken from iron-deficient 
rats, at start and at sacrifice (40 weeks) 
having been treated with carcinogen for 14 
weeks.
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Figure 75: Weight of iron-sufficient,and iron-deficient
animals at 1-2 weeks post carcinogen and at 
sacrifice (40 weeks), having been treated with 
carcinogen for 8 weeks.
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Figure 76: Weight of iron-sufficient,and iron-deficient
animals at 1-2 weeks post-carcinogen and at 
sacrifice (40 weeks) having been treated with 
carcinogen for 14 weeks.
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Figures 77-79 show the mean weight, serum retinol and 
haemoglobin values of all the experimental animals at the start 
of the study, end of 8 or 14 weeks carcinogen application and at 
the time of sacrifice respectively.
No detectable vitamin A could be found at sacrifice in 
the liver of all animals treated with carcinogen. The values of 
vitamin A in liver stored for one year of control male animals 
fed on normal food at the same time as the experimental animals 
are shown in Table 67, in comparison with fresh liver from male 
rats. The results indicate that after one year of storage most 
of the retinol palmitate has been converted to other retinol 
esters or to free retinol. It is however readily detected by 
saponification and measurement of total retinol.
In Study II, the scores which are an arithmetic figure 
to produce the degree of dysplasia, show that palate atypia 
scores in iron-deficiency animals were significantly higher than 
the tongue atypia scores (less severe stage) in each group (p < 
0.01). Both atypia represent pre-malignant stages. The tongues 
of most animals showed absent or minimal dysplasia and no 
differences were found between the groups.
The palates of animals painted for 14 weeks showed 
significantly higher atypia scores than animals painted for 8 
weeks in both iron-sufficient and iron-deficient groups (p < 
0.003) . There was no significant difference if comparison was 
made between the palatal atypia scores of the iron-deficient 
animals with the corresponding iron-sufficient animals after 
either 8 weeks or 14 weeks of carcinogen application (Table 68).
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Figure 77: Mean weight of animals in each group during the
study period.
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Table 69 shows a correlation between epithelial atypia 
scores and serum retinol in both groups. The only correlation
found is between scoring in tongue and serum retinol 1-2 weeks
post carcinogenesis in iron-deficiency rats painted for 8 weeks.
Groups of iron-sufficient and iron-deficient male rats 
without carcinogen were study as control. There was no signifi­
cant difference between the weight of animals or serum retinol in 
the two groups or in comparison with control rats fed on a normal 
diet. Table 70 shows the weight, serum retinol levels and 
haemoglobin for these rats.
Discussion
In both studies, carcinogen had no effect on weight and 
the animals gained weight from the start of the experiment until 
sacrifice. There was no difference between the weight at the end 
of the experiment compared with those of normal rats. Figure 70 
shows an inverse correlation between the increase in weight and 
serum retinol (r = -0 .8), in iron sufficient groups after 8 weeks 
of carcinogen application. This suggests that the more rapid the 
rate of growth, the greater the fall in serum retinol. After 14 
weeks this correlation was not observed (r = 0.1). This probably 
results from the low plasma retinol seen in all animals after 14 
weeks.
On the other hand, serum retinol dropped to very low 
values at the time of sacrifice, and the animals show a 
remarkable change from the starting point to 1-2 weeks post 
application period. The animals who were treated for 14 weeks 
show a lower value of serum retinol than those treated for 8 
weeks. Carcinogen had no effect on weight of animals in both
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TABLE 70
WEIGHT, SERUM RETINOL AND HAEMOGLOBIN OF CONTROL RATS 
(MEAN ± 1SD)
No. of 
rats
Iron
Status
Weight at 
sacrifice 
(gm)
Serum retinol 
(jimol/1)
Haemoglobin 
(g/dl)
5 +Fe 331 ± 35 1.4 ± 0.3 14.0
5 -Fe 343 ± 20 0.96 ± 0.3 6.6
6 Control 340 1.6 ± 0.4 — ■
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iron-sufficient or iron-deficient groups, and no changes were 
found when compared with the non-carcinogen group of rats. 
However group 5 of iron-sufficient rats became heavier than 
group 6 iron-deficient rats, whereas this was not observed 
between group 3 iron-sufficient and group 4 iron-deficient, which 
were treated similarly except for longer periods of application 
of carcinogen in groups 5 and 6. All animals had undetectable 
liver vitamin A at sacrifice perhaps because the animals used it 
to increase growth rate.
Only 2 of the animals developed a tumour, squamous cell 
carcinomas arising in the treated epithelium. Both of these were 
in the palates of iron-deficient animals, one of which had 
received carcinogen application for 8 weeks and the other for 14 
weeks, and all other animals were in a pre-malignancy state. 
Prime et al (1986) found that iron status did not affect either 
initiation or promotion. He explained the failure to demonstrate 
this effect possibly since termination of the experiment after 
40 weeks gave insufficient follow-up time for differences between 
the groups to become apparent. It would be wrong on the basis of 
this experiment to suggest iron-deficiency was not influencing 
initiation or the stage of promotion prior to the development of 
recognisable tumours. It is also possible, however, that the 
influence of iron-deficiency is in the later stages of 
carcinogenesis where the depressed cell mediated immunity known 
to be present in iron deficiency (Joynson.et al, 1972) may play a 
role in allowing overt malignancy to become manifest.
The iron status did not affect overall mean vitamin A 
concentration either at the end of carcinogen or at sacrifice. 
However, there was a correlation between the decrease in serum 
retinol and the decrease in haemoglobin (Figs 71, 72 and 74) and 
the correlation was greater for iron deficiency animals, while 
Figure 73 showed increase in serum retinol against decrease in 
haemoglobin in iron sufficient groups. One explanation for this 
m a y b e  that the low levels of serum retinol occur due to the 
technique used to make the animals iron deficient which may have 
caused a deficiency of nutrients other than iron. However, care 
was taken to ensure that the diet was sufficient. It is also 
possible that iron is required to maintain serum retinol. Mejia 
and Arroyave (1982) found in experiments a very highly 
significant positive correlation (p < 0.001) between the change 
in serum retinol and the change in serum level of iron (r = 0.6) . 
On the other hand, retinol may be used up, in some way when 
animals are iron deficient. This is likely to be an effect of 
carcinogen rather than iron status, because no correlation was 
found in iron deficiency animals without carcinogen between the 
change of serum retinol and haemoglobin.
It is very difficult to explain the relationship between 
cancer and vitamin A in general, due to the different factors 
which affect this relationship. Further studies are needed. 
Sporn and his team (1976 and 1977) showed that high amounts of 
retinoids administered during the last period of tumour develop­
ment can drastically lower tumour incidence. Here the retinoids 
act more like pharmodynamic than nutritional substances. This 
may explain why low serum retinol and liver vitamin A were found
in our studies, although we have supplied the animals with 
vitamin A containing diet. Nettesheim and Williams, 1976; 
Siddik et al, 1980 showed that vitamin A deficiency stimulated 
lung carcinogenesis induced by polycyclic hydrocarbons, possibly 
by altering the activities of enzymes involved in the metabolism 
of the carcinogens. There have been few studies showing the 
effect of low body vitamin A status on the enzymes involved in 
the metabolism of chemical carcinogens in liver. This may be 
relevant to our study.
The main feature of the present study is that retinol 
appears to have been exhaustively used up by the animal in 
response to the carcinogen. This loss of retinol from the liver 
occurs before visible oral tumour occurs. It may therefore be 
concluded that retinol is rapidly used up during growth of the 
animal, either during normal circumstances (Section 3.2.5.1) or 
when exposed to a carcinogen. Carcinogen however, leads to 
further requirements for retinol. It would therefore be of great 
interest to determine the effect of large vitamin A supplements 
on the rate of tumour development.
4) DISCUSSION
4.1) GENERAL DISCUSSION
The assays described in this study for analysis of 
retinol and its metabolites have several advantages over other 
currently available and widely used methods. In particular, use 
of HPLC provides the specificity lacking in most other methods. 
Other workers have used different mobile phases and extraction 
procedures as well as different chromatographic techniques 
(Section 2.1.3) . Many of these methods have been investigated 
during the course of this study, but we were unable to achieve 
satisfactory accuracy and specificity. As far as we know, all 
previous studies did not achieve a separation of retinol and 
other metabolites at the same time using an isocratic HPLC 
system. Separation has been achieved in gradient HPLC system by 
Amedee-Manesme et al (1984); Roberts et al (1978) but this leads 
to some artifactual peaks at solvent changes and also requires a 
more complex and expensive HPLC system.
Great care was taken during the present study to ensure 
that all retinol metabolites were separated. It can therefore be 
confidently concluded that normal human or rat serum, and also 
serum from humans and animals with certain forms of cancer do not 
have any detectable retinoic acid or retinal in the serum. This 
will facilitate future studies on the effects of retinol 
analogues in prevention or treatment of certain cancers.
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Although this assay could separate retinal sufficiently 
to permit the conclusion that it was not present in biological 
samples, it was not possible to obtain good recoveries. Further 
studies would be necessary if accurate quantitation of retinal is 
needed in other investigations.
This specificity has also led to greater accuracy in 
analysis of retinol. Most other methods are subject to inter­
ference, and the commonly used fluorescence method has been found 
to produce results which correlate poorly with specific results 
achieved by HPLC. This i*s because the fluorimetric method is 
less accurate since it does not differentiate between retinol, 
its metabolites and other interfering substances or drugs (Tables 
4 and 34).
Despite this poorer specificity of the fluorimetric 
method, in many cases, the HPLC results were higher than the 
fluorimetric ones. This slightly surprising result is probably 
due to inefficient extraction of retinol during the fluorometric 
method and also to quenching of the fluorescent signal (Thompson 
et al 1971).
All of the analyses described can be performed on one 
column, using a simple isocratic system, only a slight change in 
solvent being required for analysis of all retinol metabolites. 
It should therefore be possible for any laboratory with access to 
HPLC to perform these analyses.
In plasma, retinol is found in two major forms, as a 
specific complex with R BP, and as an esterified component of 
chylomicra. The complex with RBP is formed in the liver, is 
associated with prealbumin in the plasma, and is involved in
transporting vitamin A in fasting plasma, whereas chylomicra are 
derived from the diet and are transported to the liver and to 
other organs (Ismadi and Olson, 1975) . RBP binds only with free 
retinol and this explains the good correlation between RBP and 
retinol (by HPLC) consistently found during the present study. Of 
the vitamin A measured in fasting plasma less than 5% is normally 
in the form of retinyl esters (Smith and Goodman, 1976) , and this 
was confirmed in the present study (Section 3.2.3).
Approximately 90% of vitamin A is stored in the liver of 
man and experimental animal's. It is probable that the vitamin is 
distributed unevenly, with the right central lobe having the 
higher concentration and left lobe having relatively low concen­
tration (Olson et al 1979).
This was confirmed in the present study in control rat 
livers, where the right lobe had approximately 100 ug/g; and the 
left lobe had 70 ug/g. For ease of handling, during the animal 
studies reported here, the overall liver content was measured, 
and this probably gives a better general assessment of liver 
stores. For the human studies, biopsy was taken from the most 
convenient area, which was usually the lower edge of the right 
lobe.
Clinical interest in evaluating vitamin A nutrition has 
increased in recent years, due to the importance of vitamin A in 
various disease states, especially severely ill patients. 
Measurements of liver retinol stores, mainly retinol palmitate, 
provide a good index of total body vitamin A (Section 1.8). 
Consistency in sampling site is necessary to reduce between-lobe 
variations. In this study, no correlation was found between
liver retinol metabolites and plasma retinol (Figures 47, 65 and 
66). Therefore plasma measurements cannot be used to assess total 
body vitamin A content. It should however, be noted that liver 
free retinol (Figure 67) correlated with plasma retinol but this 
is of little value since liver retinol comprises only 3-23% of 
the total. There is a wide range in total liver retinol in biopsy 
samples from normal subjects (Table 52) which further complicates 
the interpretation of total body status.
Measurement of retinol in plasma is widely performed 
because of the ease of sampling and of analysis. As indicated 
above, this rarely reflects body vitamin A status, except in 
cases of severe vitamin A deficiency where both liver and plasma 
concentration may be affected by other factors which alter the 
plasma level of RBP. In protein malnutrition, RBP synthesis is 
reduced (Arroyave et al 1961; Friend et al 1961, Smith et al 
1973 a,b) and therefore plasma retinol is low. When protein 
nutrition is improved, for example by provision of IVN (Section 
3.2.4.2) the plasma retinol simultaneously increases. On the 
other hand, patients with an acute illness eg operation or 
infection, develop an acute-phase response with the preferential 
synthesis of certain liver proteins, such as CRP (Laurell 1985; 
Kushner et al• 1981) . In this situation RBP synthesis is reduced 
(Fleck et al 1985). There is therefore an inverse correlation 
between serum retinol (or RBP) concentration and serum CRP 
(Figures 35, 38-40). This may also be in part the explanation for 
the early fall in serum retinol in our rats treated with oral 
carcinogen, although acute-phase protein data is not available 
for these studies.
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Liver stores of vitamin are usually sufficient for at 
least half a year in man (OlSon, 1969). Prolonged inadequate 
intake is therefore necessary to exhaust liver stores. In the rat 
studies, 2 and 5 weeks were required for liver and plasma 
concentrations respectively to fall to very low levels. Similar 
results were obtained by Dowling and Wald (1958).
In rats this depletion is of course accelerated because 
the animals were very young and rapidly growing. In grown man, 
it would take much longer for deficiency to develop. After 
serious illness, among the many nutritional problems, there may 
be a combination of protein depletion and retinol depletion. 
Treatment by oral or parenteral route is necessary to correct 
this situation.
There has been concern about the delivery of vitamin A 
to patients who require TPN. In particular various workers have 
shown that retinol may be degraded by exposure to light or losses 
may occur on the plastic of the infusion set (McKenna and Bieri, 
1980; Gutcher et al 1984). In this study therefore we have 
confirmed using the specific HPLC method, that the retinol 
palmitate added to the TPN emulsion can be protected by mainten­
ance of the emulsion at 4°C in the dark. Approximately 40% was 
lost in 24 hours or 80% lost in a week if the bottle was exposed 
to daylight. Care must therefore be taken during the infusion 
procedure. Recently it has been shown that more adsorbed losses 
to the infusion set occur with retinol supplements rather than 
retinol palmitate (Riggle and Brandt, 1986). We found minimal
loss of retinol palmitate in the present study. We also can 
therefore be confident that the daily dose of vitamin A was 
delivered to patients being intravenously fed.
There was a wide variety of intakes of vitamin A in 
patients receiving home IVN, ranging from 107 to 3214 pg/day 
retinol palmitate. This compares with the oral recommendation of 
1 ,000 pg of retinol by the Food and Nutrition Board of the US 
Academy of Sciences (1980), and also 1,000 pg for intravenously 
fed patients, recommended by the Expert Committee of the American 
Medical Association (1979).* It is apparent that there was no 
correlation between plasma retinol and the daily intake (Figure 
30). However, none of the patients with an intravenous intake of 
> 2000 pg/day had low serum retinol concentration, confirming the 
adequacy of this amount. It is possible that if there is an 
excessive intake over prolonged periods, toxicity may occur. This 
was not observed in any of the current patients, although a case 
has been reported of vitamin A toxicity in a four and a half year 
old, receiving 3000 pg/day on home IVN for six weeks (Seibert _et 
al 1981) . Nonetheless, high serum retinol levels were observed 
in some of our patients (as high as 8.5 pmol/1) and similar high 
serum levels have been reported by Shils et al (1985) in some 
patients receiving 1000 pg retinol/day whilst on long-term home 
IVN.
It is important therefore to define the minimum vitamin 
A intake necessary to maintain optimal vitamin A status. Lowry 
et al (1978) showed that most postoperative patients maintained 
blood retinol concentration with an intake of 450-600 pg/day. On 
the other hand, in this study it was found that an IV intake of
107-750 pg/day, or oral supplements, did not consistently 
maintain vitamin A and RBP. concentration in plasma. As previously 
discussed, this may not solely be due to inadequate retinol 
intake, but may also reflect an acute phase protein response. 
However, only one patient receiving home IVN had a CRP concen­
tration greater than 30 mg/1, hence the extent of the acute phase 
response in this patient group was small. Indeed, Nichoalds et 
al (1977) found that 1000 pg retinol/day in post operative 
patients would not maintain plasma retinol concentration, but 
1 300 pg/day was more effe'ctive. Stromberg et al (1981) also 
found that 750 pg was sufficient to maintain serum vitamin A only 
in those patients who commenced IVN with normal biochemical 
measurements. Patients commencing with low vitamin A were not 
consistently improved at this amount of intake. Liver biopsy 
data would be of great value in assessing the overall adequacy of 
these different levels of intake, but this cannot be justified on 
ethical grounds.
In short-term TPN patients who received a mean retinol 
intake of 800 ug, the fall in plasma concentration may be due to 
net protein catabolism in response to infection and surgery 
rather than temporary interruption of supply of vitamin A. The 
increase of serum retinol concentration with TPN supplements was 
possibly due to an increase in RBP synthesis. The rise in serum 
retinol (and RBP) invariably occurred when patients were in 
positive N balance. The correlation between RBP and serum 
retinol was better than with other proteins eg albumin, transfer­
rin. Arroyave and Calcano, (1979) found that infection lowers 
the serum level of retinol and RBP. They suggested that the
mechanisms by which serum retinol is reduced are related to an 
impaired release of retinol from the liver or to an increased 
turnover of RBP. This is consistent with the inverse correlation 
found in the study between CRP and RBP (and hence retinol).
Similar results were obtained for surgical patients 
receiving nutritional support enterally by fine bore nasogastric 
tube (Table 37). The average intake of these patients was 3391 
pg/day (range 2860-4153 ). One patient received separately 
oral/enteral and IVN, and mean overall intake was 2668 pg/day. 
Vitamin A orally fed to adults is based upon the amount of 
retinol necessary to maintain an adequate blood concentration and 
to prevent all deficiency symptoms, plus an amount above the 
requirement to permit liver storage. Arroyave (1969) , Popper and 
Steigmann (1943) explain that the signs of vitamin A deficiency 
may be detected due to immobilization of liver vitamin A in 
certain diseases as well as to malnutrition. No patients in the 
present study developed clinical signs of vitamin A deficiency.
The overall bioavailability of parenterally-administered 
pharmacological doses of vitamin A is unknown. Considering the 
probable loss of some vitamin A from TPN solutions and the degree 
of illness of the patients, it is surprising that there are not 
more reports of hypovitaminosis A in TPN. Perhaps the amount 
delivered to patients on short-term TPN is sufficient to prevent 
the development of deficiency symptoms over the time period 
studied, while patients on long-term TPN may not present with 
overt vitamin A deficiency (Sitren, 1984). Physical examination 
eg dark adaptation may be required over a prolonged period to 
detect sub-optimal intake. Most studies have assessed vitamin A
status in parenterally fed patients, only by measuring plasma 
retinol or RBP concentrations. These are less reliable 
indicators of vitamin A nutrition if the patients are well 
nourished with respect to energy and/or protein. The dependence 
of plasma vitamin A concentration on protein nutritional status 
and on inflammatory status make it difficult to assess adequacy 
of provision of vitamin A. Taken overall, the intakes of 
800-1000 ug in short-term and in long-term studies seem adequate 
to prevent deficiency or depletion occurring. This would agree 
with the current recommendation of the FNB and of the AMA for 
seriously ill patients. Further studies including liver biopsy 
and dark adaptation testing are required to characterise the 
optimal intake in relation to disease and long term support.
It has been suggested according to various evidence that 
nutrition in general or specific nutritional components, in 
various parts of the world may play an important role in the 
causation and development of a number of types of cancer 
(Weisburger, 1985).
A major physiological role of vitamin A is to control 
cell differentiation. Since loss of cell differentiation is a 
basic feature of cancer, there is ample reason to suspect that 
intake of vitamin A may be related to cancer incidence (Willett 
and MacMahon, 1984) .
For these reasons the association between serum and 
liver retinol levels with various cancer states, in animal and 
man have been studied in the present work. A major question has
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been whether a low plasma vitamin A predisposes to the develop­
ment of cancer, or whether it occurs in response to the presence 
of a cancer.
In most previous studies low circulating levels of 
vitamin A were observed in subjects who subsequently developed 
cancer of epithelial cell origin (Wald et al 1980, Kark et al
1981). However, Willett et al (1984) found mean serum retinol 
was similar for cases and controls (95% confidence limits for 
case-control difference). In eighteen subjects with subsequent 
lung cancer in their study, mean base-line retinol level was 
found to be higher than that in their matched controls. The 
explanation of these higher values is unknown.
Studies we performed on the effect of oral carcinogens 
in rats led to two different effects:- in one series of studies 
rats were treated with carcinogen for 8 or 14 weeks and then 
followed until 40 weeks, but in only 2 cases did an epithelial 
cancer develop. In most of the animals, atypia was present to a 
variable extent, and this was quantified (by Dr S Prime) using 
the system of Smith and Pindborg (1969). On the other hand, rats 
treated with carcinogen for prolonged periods almost invariably 
developed an oral carcinoma after 26-32 weeks of application. We 
are thus able to compare vitamin A status in animals in the 
pre-cancer situation with those which developed oral cancer.
Plasma retinol fell in response to carcinogen 
application, with those animals treated for 14 weeks having a 
lower plasma retinol than those treated with carcinogen for 8 
weeks. Both groups had very low plasma retinol at the time of 
sacrifice (40 weeks) although tumours were not present, and
plasma concentrations of retinol were similar to those found in 
animals with oral cancers. Similarly liver vitamin A was not 
detected at the time of sacrifice in any of the animals treated 
with carcinogen whether or not an oral cancer had developed. This 
suggests that the vitamin A had been used by the rat in response 
to the carcinogen application, before a tumour had developed. 
The mechanism of this utilisation is not known. It can be 
speculated that vitamin A may be taken up from plasma by tissue 
exposed to a carcinogen in an attempt to maintain normal cell 
structure and function. 'This in turn may lead to increased 
mobilization of vitamin A from the liver.
This situation may relate to the increased incidence of 
cancer in individuals with vitamin A deficiency. Vitamin A 
deficiency in animals has been shown to increase susceptibility 
to chemical carcinogenesis in the respiratory tract (Nettesheim 
and Williams 1976); skin (Davies, 1967); bladder (Cohen et al 
1976) and colon (Newberne and Rogers, 1973).
Wormsley, (1985) suggested that in pancreatic cancer 
after injury if at any time the replicating tissues are exposed 
to an initiating carcinogen, cancer may occur. Dogra e t a l  
(1985) proposed that vitamin A deficiency may enhance the process 
of tumourigenesis both at the initiation (the irreversible 
genetic alteration of a target cell by a carcinogen) and 
promotion phase (resulting in a phenotypic expression of that 
genetic alteration).
On the other hand studies in man, of patients with 
leukoplakia which is regarded as a pre-malignant disease (Silber, 
1 985) did not show a significant difference in serum vitamin A
compared with control (Table 50). It is noteworthy that patients 
with Crohn's Disease showed much lower serum retinol levels when 
compared with control or patients with leukoplakia. These 
patients are at risk of protein malnutrition as a result of the 
disease or resected small bowel. It would be of interest in 
leukoplakia patients to monitor the changes in serum retinol, 
over a period of careful observation of the leukoplakia 
especially if oral cancer developed.
Once a tumour has developed, low vitamin A status is 
probable. All rats with tumour in this study had low serum and 
liver vitamin A. Basu et al 1976; Atukorala et a l - 1979
reported that low serum retinol was associated with bronchial 
carcinoma. Ibrahim et al (1977) reported this association with 
carcinoma of oral cavity and oropharynx as well.
In the present study patients undergoing abdominal 
surgery for neoplastic disease of stomach or colon, did not have 
significantly different serum retinol from control. However, 
patients in whom the neoplasm was present in the rectum showed a 
significantly lower plasma retinol (p < 0.05) from control cases 
and those with gastric or other colon cancer. This difference is 
surprising but indicates that different tumours may be associated 
in different ways with vitamin A.
Although there was a tendency for patients with hepatic 
metastases at the time of operation to have lower plasma and 
liver retinol concentrations than those without metastases, there 
was no statistically significant difference. The liver stores of 
vitamin A are so varied that no difference was observed between 
patients with cancer and those with benign disease (Table 52).
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Patients who had been treated surgically for colorectal 
cancer 7 days - 12 years before sampling, showed a significantly 
lower plasma retinol (p < 0.01) than controls and the difference 
was greater in males than in females (Table 39) . This 
reduction was more apparent in patients with metastases (Figure
54) who were sampled within one month of operation. There, were 
inadequate controls of patients without metastases sampled at the 
same time, to allow an assessment of the effect of tumour level. 
It was found that the significant difference described above 
disappears if samples taken* within one month after operation are 
excluded. It is probably that this was due to the acute phase 
response with decreased RBP synthesis in the post operative 
period.
It has been suggested that there is a relationship 
between low cholesterol concentration and increased cancer risk.... 
Williams et al (1981) suggested that it reflected the physio­
logical response to early undiagnosed stages of cancer. Adams.et 
al (1985) explained that it is possible that the association 
observed between low cholesterol concentration and increased risk 
is mediated through an unknown factor. In the present study, a 
correlation of r = 0.5 was found between cholesterol and serum 
retinol in the post-colorectal cancer situation and this was 
mainly observed in patients with liver metastases (Figures 51, 54 
and 55). If the samples taken within one month after operation 
are excluded, there is no such correlation. This correlation in 
our study may therefore be due to the acute-phase response on 
apolipoproteins as well as on RBP. ~
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Kark et al (1982) offered three conflicting hypotheses 
to explain the inverse association found in other studies. 
First, low cholesterol values before detection of cancer may be a 
result of the cancer process. Second, low cholesterol values may 
precede the development of cancer, but the association with the 
cancer is secondary. Third, low cholesterol values may precede 
the development of cancer and may be causually associated with 
occurrence of some forms of cancer. Until the major routes are 
understood, along with the kinetics of transfer, it may be 
impossible to make any correlation between cholesterol, beta 
carotene and risk of cancer (Peto, 1981). Adams et al (1985) in 
recent studies demonstrated a significant relationship between 
carotene and lipoprotein cholesterol in a healthy group of 
college students. It is probable therefore that the association 
of cancer with cholesterol is secondary, due to the correlation 
of retinol with cholesterol concentration.
On the other hand, Jagadeesan and Reddy (1978) found 
there was a significant correlation between vitamin A and 
haemoglobin concentration. Stored iron may be mobilized by 
improving the vitamin A nutritional status (Mejia and Arroyave,
1982). Overall we did not find any correlation or effect of iron 
status on vitamin A, since plasma retinol concentrations were 
similar in both iron-sufficient and iron-deficient groups. 
However, the observation that in rats treated with carcinogen for 
8 weeks there was a significant inverse correlation between the 
magnitude of the fall in haemoglobin with the fall in plasma 
retinol (Figures 71 and 72) suggests that in some way, retinol 
may be involved in the maintenance of haemoglobin levels in
iron-deficient rats. This observation was not confirmed in rats 
treated with carcinogens for 14 weeks, suggesting that the effect 
of the carcinogen on retinol concentration is greater than the 
role of retinol in haemoglobin metabolism.
Although iron deficiency was associated with earlier 
development of oral tumours (mean 183 days) than iron sufficient 
rats (mean 229 days) when carcinogen was continuously applied, 
the shorter periods of carcinogen application did not demonstrate 
any significant difference in atypia scores for iron-sufficient 
and deficient rats. It is noteworthy that in all studies no 
difference in serum or liver retinol was observed between 
iron-sufficient or deficient rats. Thus any effects of iron- 
deficiency are unlikely to be mediated through vitamin A.
The role of vitamin A deficiency in tumourigenesis has 
been studied by several investigators. However, the exact 
mechanism by which vitamin A influences the process has not been 
delineated:-
i) Additional epidemiological and experimental studies are 
needed before definite conclusions can be drawn about the role of 
various forms of vitamin A in the aetiology of cancer. In the 
present study there is limited data showing the relationship 
between retinol status and cancer occurrence or subsequent cancer 
recurrence in patients who underwent surgery.
\
ii) The present study has indicated weak association 
between retinol and cholesterol, but prospective studies are 
needed to assess the relationships between carotene, cholesterol 
and cancer-risk to clarify the mechanisms involved.
iii) Vitamin A is altered by carcinogens during tumour 
induction (Nutrition Reviews, 1979). Further evidence for this 
has been obtained in the present study.
iv) Chytil and Ong and their co-workers (1978a,b) found 
specific intracellular retinoid-binding proteins, similar to 
steroid-binding proteins, in many tissues affected by vitamin A. 
They suggested that retinoids may act like steroids, which exert 
their effect on gene-expression, and this has considerable 
support (Sitren, 1984). Zile and Cullum (1983) suggested that 
the role of vitamin A in reproduction -is mediated by specific 
intracellular protein carriers. If intracellular retinoid- 
binding protein mediates the effect of vitamin A, then its 
presence in various non-epithelial cells suggests that these cell 
types may also be targets. Further work on these binding 
proteins is required. In the case of this study the fall in 
serum retinol in rats may be due to carcinogens causing some 
effect on the number of receptors or in the amount of intra­
cellular binding proteins.
v) Another possible mechanism of action of retinoids is 
their effect on glycoprotein synthesis. Deluca (1978) suggested 
that phosphorylated retinol or retinoic acid derivatives may 
participate in glycosylation of membrane glycoproteins by acting 
as carriers of monosaccharides across the hydrophobic lipid 
bilayer.
Several other mechanisms of action have been postulated.
However, most of them have not been supported by subsequent 
investigations.
4.2) Conclusions
The main conclusions which can therefore be drawn from
the present studies are as follows:-
i) A method has been developed to separate retinol and its
derivatives qualitatively and quantitatively in serum, liver and 
IVN solutions.
ii) In normal man or rat and in those with certain types of 
tumour, the only serum retinoid detectable is retinol.
iii) There is a poor correlation between the commonly-used 
fluorometric assay and the specific HPLC assay. The fluorometric 
assay is only useful in the absence of interfering substances in 
the diet, such as pigment, and when all dietary triglyceride has 
been cleared from the circulation.
iv) The vitamin A in IVN solutions must be protected from
degradation prior to infusion.
v) Plasma retinol can be maintained in patients receiving 
IVN or enteral nutrition. However the acute-phase reaction may 
interfere with the use of this measurement in assessing vitamin A 
status.
vi) Vitamin A deficiency in rats can be achieved with 
depletion of liver vitamin A stores within 2 weeks, followed by a 
fall in plasma retinol after about 5 weeks.
vii) Plasma retinol in rats falls in response to application 
of an oral carcinogen and low levels are obtained before a tumour 
develops.
viii) In man, leukoplakia was not associated with low serum 
retinol. In patients with intestinal cancer, low serum retinol 
was found in patients with rectal carcinoma and in those with
metastases. In liver there was no significant difference between 
patients with benign and malignant disease (with or without 
metastases) for retinol or its metabolites.
ix) Vitamin A status was not found to be associated with 
iron status in rats. The development of tumours was more rapid 
in iron-deficient rats and this is therefore unlikely to be 
mediated through the effects of retinol.
x) Serum cholesterol was associated with serum retinol in 
patients with metastatic cancer of rectum but this was mainly due 
to the acute phase response to surgery.
4.3) Further studies which might be performed to extend the
above work might be:-
a) Liver biopsy samples would be valuable to assess the 
vitamin A stores in patients on various forms of nutritional 
support. This should be related to dark-adaptation studies.
b) The kinetics of change in serum and liver vitamin A in 
rats in response to carcinogen should be studied in more detail 
to determine the time course of depletion.
c) Longer term studies on the effects of carcinogen are 
needed.
d) The reason for the rapid fall in vitamin A after oral 
carcinogen should be studied eg by metabolism of labelled 
retinol.
e) Iron status in liver could be assessed in relation to 
vitamin A status.
f) The effects of vitamin A supplements on the response to 
carcinogen should be studied.
128 .
g) Studies on intracellular binding proteins in response to
carcinogen would be of interest.
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